EP1461059A1 - Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts - Google Patents

Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts

Info

Publication number
EP1461059A1
EP1461059A1 EP03702392A EP03702392A EP1461059A1 EP 1461059 A1 EP1461059 A1 EP 1461059A1 EP 03702392 A EP03702392 A EP 03702392A EP 03702392 A EP03702392 A EP 03702392A EP 1461059 A1 EP1461059 A1 EP 1461059A1
Authority
EP
European Patent Office
Prior art keywords
active ingredients
acid
lactobacillus
fermentation
skin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP03702392A
Other languages
German (de)
French (fr)
Inventor
Philippe Moussou
Louis Danoux
Gilles Pauly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BASF Health and Care Products France SAS
Original Assignee
Cognis France SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis France SAS filed Critical Cognis France SAS
Publication of EP1461059A1 publication Critical patent/EP1461059A1/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9728Fungi, e.g. yeasts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/08Antiseborrheics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/14Drugs for dermatological disorders for baldness or alopecia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00Anti-perspirants or body deodorants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/005Preparations for sensitive skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/85Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225Lactobacillus

Definitions

  • the invention is in the field of cosmetics and relates to new active ingredients from fermented plant components and / or vegetable extracts, a process for their preparation, preparations containing these active ingredients and a large number of uses for the new active ingredients.
  • kefir for skin treatment and as an agent against eczema, mycoses and acne is known from EP-A2 0315541 (L'Oreal).
  • ES-Bl 2116201 (Javier Uruena Mendez) further suggests using kefir for the regeneration of capillary vessels.
  • the object of the present invention was therefore to provide new active ingredients which meet the complex requirement profile described above.
  • this “multifunctional active ingredient” be a herbal product.
  • the invention relates to cosmetic and / or pharmaceutical active ingredients which can be obtained by fermenting plant components, such as roots, tubers, leaves, fruits and / or plant extracts.
  • the fermentation products have a large number of advantageous properties which are important for use in cosmetics for protecting and caring for the skin and hair.
  • the active ingredients protect against the damaging effects of UV rays and have an anti-inflammatory effect, for example when sunburned. They stimulate metabolism in a variety of ways, for example they stimulate the synthesis of dermal macromolecules and at the same time inhibit their breakdown. They improve skin hydration and skin feel.
  • the invention further relates to a process for the production of cosmetic and / or pharmaceutical active substances, in which plant constituents and / or plant extracts are fermented. In doing so
  • the vegetable constituents to be processed into a fermentation broth are selected from the group of seeds, tubers, roots, leaves, fruits, vegetable protein concentrates, isolates and / or hydrolyzates. Fruits and seeds are preferably used as plant components.
  • Tubers, roots, leaves and preferably seeds and / or fruits are used in comminuted and / or pressed and / or extracted form, selected from the group of plants and / or plant components of potatoes, rice, soybeans, wheat, barley, oats, Rye, buckwheat, beans, peas, linseed, cotton, sesame, lupine, rapeseed, hemp, coconut palm, sunflower, alfalfa, hibiscus, maca, quinoa, almond, moringa, silk, baobao, cassia, irvinga, thistle and oil palm; or selected from the group of fruits of apples, pears, fifths, medlar, rose hips, cherries, plums, peaches, apricots, pomegranates, berries, grapes, lemons, pineapples, cherimoya, guavas, mango, carambola, litchi, kiwi, banana, coconut, almonds, papa
  • mixtures of different microorganisms which on the one hand contain at least one member from the group Lactobacillus, Lactococcus and Leuconostoc and on the other hand contain at least one yeast.
  • Suitable microorganisms are the following: Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus caucasicus, Lactobacillus cellobiosus, Lactobacillus delbruecki, Lactobacillus helveticus, Lactobacillact hilobacillii, Lactobacillus hilobardus bacillus kefiranofaciens, Lactobacillus kefirgranum, Lactobacillus parakefir, Lactobacillus plantarum, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp.
  • Both the bacteria and the yeast can be used in different weight ratios, especially since they change during fermentation.
  • the oculate of the lactic acid bacteria is between 10 2 and 10 8 cfu / ml, preferably between 10 3 and 10 6 cfu / ml.
  • the ratio of different lactic acid bacteria Lactobacillus, Lactococcus and Leuconostoc to each other can be 1: 1000 to 1000: 1, preferably 1: 100 to 100: 1.
  • Yeast ocules contain between 10 2 and 10 7 cfu / ml, preferably between 10 3 and 10 5 cfu / ml.
  • the ratio of lactic acid bacteria to yeast is 1: 100000 to 100000: 1, preferably 1: 1000 to 1000: 1.
  • the microorganisms can be used purely, but it is also possible to use kefir or tibi mixtures which are commercially available as such.
  • the fermentation can be divided into five phases:
  • the plant starting materials such as, for example, comminuted plant parts, plant extracts, comminuted and / or extracted Seeds, tubers, roots or leaves, protein concentrates, hydrolysates or isolates, chopped and / or extracted fruits are ground directly according to their hardness or first broken up and then further processed into an aqueous, organic or aqueous / organic dispersion.
  • the extracts can be prepared in a manner known per se, ie for example by aqueous, alcoholic or aqueous-alcoholic extraction of the plants or parts of plants.
  • Fresh plants or parts of plants can be used as the starting material, but usually dried plants and / or parts of plants are used, which can be mechanically comminuted before extraction. All comminution methods known to the person skilled in the art are suitable here, freeze grinding being mentioned as an example.
  • Organic solvents, water or mixtures of organic solvents and water, in particular low molecular weight alcohols with more or less high water contents, can be used as solvents for carrying out the extractions. Extraction with methanol, ethanol, pentane, hexane, heptane, acetone, propylene glycols, polyethylene glycols and ethyl acetate as well as mixtures thereof and their aqueous mixtures is particularly preferred.
  • the extraction is usually carried out at 20 to 100 ° C, preferably at 30 to 60 ° C.
  • the extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc.
  • the crude extracts obtained can optionally be subjected to further customary steps, such as purification, concentration and / or decolorization.
  • the organic solvents are removed completely or almost completely, for example by distillation or evaporation. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients.
  • the extraction can take place to any degree of extraction, but is usually carried out to exhaustion.
  • the present invention encompasses the knowledge that the extraction conditions and the yields of the final extracts can be selected by the person skilled in the art depending on the desired field of use.
  • These extracts generally have a solids content in the range from 0.5 to 10% by weight.
  • Suitable organic solvents in this connection are, for example, the aliphatic alcohols having 1 to 6 carbon atoms (for example ethanol), ketones (for example acetone), lower esters or polyols (for example glycerol or glycols).
  • the fermentation broth is preferably prepared by extraction of the vegetable material, if appropriate also repeatedly, with water in the weakly alkaline range, insoluble solids possibly being separated off, for example by filtration or centrifugation.
  • the extraction likewise takes place in an aqueous medium, but in an acidic range, the proteins precipitating, being separated and redissolved with water in the weakly alkaline range.
  • the plant material is merely comminuted, ground and dispersed in water or an alkaline aqueous medium and fermented directly without further extraction or separation.
  • the fermentation broth is produced from vegetable protein isolates or concentrates, which are commercially available and are dispersed in water or an alkaline aqueous medium.
  • fruits serve as raw materials, they can either be ground or pressed so that the pulp or juice can be used without further extraction.
  • Pasteurization or sterilization of the fermentation broths is usually carried out at temperatures in the range from 60 to 135 ° C. over a period of 1 to 30 minutes.
  • the lactic acid bacteria and the yeast can be used in different amounts and weight ratios.
  • the bacteria are typically used in amounts of 10 2 to 10 8 , preferably 10 3 to 10 6 cfu / ml.
  • the weight ratio of the various lactic acid bacteria to one another that is to say Lactobacillus, Lactococcus and Leuconostoc, can each be 1: 1,000 to 1,000: 1 and preferably 1: 100 to 100: 1.
  • the yeasts can be used in amounts of 10 2 to 10 7 , preferably 10 3 to 10 5 cfu / ml.
  • the weight ratio between bacteria and enzymes can finally be 1: 100,000 to 100,000: 1 and preferably 1: 1,000 to 1,000: 1.
  • the fermentation is usually carried out at temperatures in the range from 10 to 47 ° C., preferably from 20 to 37 ° C. in a static or a closed stirred tank.
  • the fermentation time can vary between a few hours and a few days and is usually between 12 and 48 hours.
  • the fermentable sugars are converted into organic acids, ethanol, carbon dioxide and aromatics.
  • a drop in the pH value can be observed, which usually levels off at 4 to 5.
  • the proteins contained are proteolysed to form short-chain peptides and amino acids, which are precipitated as a result of the acidic pH.
  • the fermentation products which are obtained either as soluble fractions as solid residues, are the crude fermentation broth, the crude soluble fractions obtainable therefrom, the low molecular weight metabolites (amino acids, Oligopeptides, oligosaccharides, organic acids, aromatics etc.), the solid residues of the precipitated fermented proteins and the fermented polysaccharides in question.
  • separation processes known per se such as, for example, centrifugation, membrane filtration (microfiltration, ultrafiltration, nanofiltration), liquid-liquid or solid-phase extraction, chromatography, precipitation from solvents and the like.
  • the microorganisms still contained in the fermentation products must, of course, be separated, destroyed or inactivated before being made up as end products.
  • Known techniques such as thermal treatment (pasteurization, sterilization), cell destruction, microfiltration, centrifugation and the like can be considered. If fermented proteins are obtained as end products, they can either be used as solid precipitates or used as solutions by lowering the pH.
  • the invention further relates to cosmetic and / or pharmaceutical preparations which contain the new active ingredients preferably in amounts of 0.01 to 5, in particular 0.1 to 2 and particularly preferably 0.5 to 1% by weight, based on the composition - contain. If necessary, the fermentation products can be enclosed in micro- or nanocapsules prior to incorporation into cosmetic and / or pharmaceutical agents using the usual methods.
  • the preparations according to the invention such as, for example, hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations, powders or can also be used as further auxiliaries and additives, mild surfactants, Oil bodies, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, UV light protection factors, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, self-repellant inhibitors (Depigmenting agent), hydrotropes, solubilizers, preservatives, perfume oils, dyes and the like.
  • surfactants such as, for example, hair shampoos, hair lotions, foam baths, shower baths, creams, gels,
  • Anionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants may be present as surface-active substances, the proportion of which in the compositions is usually about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight.
  • anionic surfactants are soaps, finsulfonate alkylbenzenesulfonates, alkanesulfonates, olefinsulfonates, alkyl ether sulfonates, glycerol ether, ⁇ -methyl ester sulfonates, sulfonic fofettTalkren, alkyl sulfates, fatty alcohol ether sulfates, Glycerol ether, Fettklareethersulfa- te, Hydroxymischethersulfate, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkylsulfosuccinates, mono- and dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides
  • anionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or alkyl glucoramide acid, vegetable glucoramide acid derivatives, glucoronic acid protein derivatives, and glucoronic acid protein derivatives based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are Fettalkoholpolyglycol- ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, ethercarboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates , the latter preferably based on wheat proteins.
  • oil body preferably based on wheat proteins.
  • esters of linear C 6 -C 22 fatty acids with linear or branched C 6 -C 2 fatty alcohols or esters of branched C 6 -C ⁇ come as oil bodies, for example 3 - carboxylic acids with linear or branched C 6 -C 22 -fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristylisostearat, myristyl, Myrist lbehenat, rucat Myristyle-, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearylmyristat, stearyl, stearyl, Stearylisostearat, stearyl, stearyl, Stearyle
  • esters of linear C 6 -C 22 fatty acids with branched alcohols especially 2-ethylhexanol
  • esters of C 8 -C 38 alkyl hydroxy carboxylic acids with linear or branched C 6 -C 22 fatty alcohols especially dioctyl malates
  • esters of linear and / or branched fatty acids with polyhydric alcohols such as propylene glycol, dimer diol or trimer triol
  • triglycerides based on C 6 -C ⁇ 0 fatty acids liquid mono- / di- / triglyceride mixtures based on C 6 -C ⁇ 8 - Fatty acids
  • esters of C 6 -C 22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids especially benzoic acid, esters of C 2 -C 2 -dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) (e.g. cellulose) saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 mol ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. C 12 18 - fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic preparations.
  • Alkyl and / or alkenyl oligoglycosides their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable.
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid, Isostearinklarediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolklaremoglycerid, Ricinolklarediglycerid, Linolklaremonoglycerid, Linolklarediglycerid, Linolenchuremonoglycerid, linolenic acid diglyceride, Erucaklaremonoglycerid, Erucaklakladiglycerid, Weinklaremonoglycerid, Weinkladodiglycerid, Citronenklamonoglycerid, Citronendiglycerid, ⁇ pfelklaklamo- noglycerid, Apfelklarochrediglycerid and their technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably
  • sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan come diisostearate, sorbitan triisostearate, Sorbita nmonooleat monooleate, sorbitan dioleate, trioleate, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, sorbitan tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitan monotartrate, sorbitan sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan
  • polyglycerol esters are polyglyceryl-2 dipolyhydroxystearates (Dehymuls® PGPH), polyglycerol-3-diisostearates (Lameform® TGI), polyglyceryl-4 isostearates (Isolan® GI 34), polyglyceryl-3 oleates, diisostearoyl polyglyceryl-3 dihydrogen - sostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Creophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl
  • polystyrene resin examples include the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, taig fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
  • Typical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Amphoteric and cationic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid.
  • Amphoteric and cationic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylm -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glyc
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, apart from a C i8-alkyl or acyl group, contain at least contain a free amino group and at least one -COOH or -SO 3 H group 8 / and are capable of forming inner salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group .
  • ampholytic surfactants are the N-cocoalkylaminopropionate, the cocoacylaminoethylaminopropionate and the C 2 / i 8 ⁇ acyl sarcosine.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, ie solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids
  • waxes include natural waxes, such as candelilla wax, carnauba wax, Japanese wax, espresso wax, cork wax, guaruma wax, rice germ oil wax, Sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walnut, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, micro waxes; chemically modified waxes (hard waxes), such as, for example, montan ester waxes, Sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as, for example, polyalkylene waxes and polyethylene glycol waxes.
  • natural waxes such as candelilla wax, carnauba wax, Japanese wax, espresso wax, cor
  • lecithins In addition to fats, fat-like substances such as lecithins and phospholipids can also be used as additives.
  • lecithins are those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC). Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats.
  • glycerol phosphates glycerol phosphates
  • sphingosines or sphingolipids are also suitable.
  • Pearlescent waxes are: alkylene glycol esters, especially ethylene glycol stearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms
  • Suitable consistency agents are primarily fatty alcohols or hydroxy fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and, in addition, partial glycerides, fatty acids or hydroxy fatty acids.
  • a combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydro- xypropyl cellulose, also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, (eg Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Coloid ), Polyacrylamides, polymers, polyvinyl alcohol and polyvinyl pyrrolidone.
  • Aerosil types hydrophilic silicas
  • polysaccharides in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydro- xy
  • Bentonites such as Bentone® Gel VS-5PC (Rheox), which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate, have also proven to be particularly effective.
  • Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyloligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate are used.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available from Amerchol under the name Polymer JR 400®, cationic starch, copolymers of diallylammonium salts and acrylic amides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® ( BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as amodimethicone, copolymers of adipic acid and cartiethydroxyaminodiamine (sandethylaraminohydroxy) ), Copolymers of acrylic acid with dimethyl-
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and polyesters and their esters, uncrosslinked , Acrylamido-propyltrimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert.butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / teraminate / vinyl acrylate methacrylate / vinyl methacrylate methacrylate
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl modified silicone compounds which are both liquid and resinous at room temperature can.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again.
  • UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2 ⁇ cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4 ⁇ -methylbenzophenone, 2,2-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably 4-methoxybenzmalonic acid di-2-ethylhexyl ester;
  • Triazine derivatives such as, for example, 2,4,6-trianilino- (p-carbo ⁇ 2 , -ethyl-f-hexyloxy) -l, 3,5-triazine and octyl triazone or dioctyl butamido triazone (Uvasorb® HEB);
  • Typical UV-A filters are, in particular, derivatives of benzoyl methane such as l- (4 ⁇ -tert.Butylphenyl) -3- (4-methoxyphenyl) propan-l, 3-dione, 4-tert-butyl -4 , - methoxydibenzoylmethane (Parsol® 1789), l-phenyl-3- (4-isopropylphenyl) propane-l, 3-dione and enamine compounds.
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • Particularly favorable combinations consist of the derivatives of benzoylmethane, for example 4-tert-butyl-4 , methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid 2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate and / or propyl 4-methoxycinnamate and / or isoamyl 4-methoxycinnamate.
  • benzoylmethane for example 4-tert-butyl-4 , methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid 2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhexyl
  • Such combinations with water-soluble filters such as 2-phenylbenzimidazole-5- are advantageous sulfonic acid and their alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts combined.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm.
  • the pigments can also be surface treated, i.e. are hydrophilized or hydrophobized.
  • Typical examples are coated titanium dioxides, e.g. Titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.
  • secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • amino acids e.g. glycine, histidine, tyrosine, tryptophan
  • imidazoles e.g. urocanic acid
  • peptides such as D, L-camosine, D-camosine, L-carnosine and their derivatives (e.g.
  • carotenoids carotenoids
  • carotenes eg ⁇ -carotene, ⁇ -carotene, lycopene
  • chlorogenic acid and their derivatives lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiou-racil and other thiols (eg thioredoxin, Glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters ) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleic acid and
  • (metal) chelators e.g. ⁇ -hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. ⁇ -linolenic acid, oleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g.
  • biogenic active ingredients are tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, ⁇ -glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudo-ceramides, penal ceramides, Plant extracts, such as To understand prunus extract, Bambaranus extract and vitamin complexes.
  • Cosmetic deodorants counteract, mask or eliminate body odors.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers.
  • germ-inhibiting agents such as.
  • Esterase inhibitors are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT).
  • the substances inhibit enzyme activity and thereby reduce odor.
  • esterase inhibitors include sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesteric, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, Adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid and malonic acid diethyl ester, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester and zinc glycinate.
  • dicarboxylic acids and their esters such as, for example, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, Adipic acid, adipic acid monoethyl ester, a
  • Suitable odor absorbers are substances that absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixators", such as, for example, the main component. B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance.
  • Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from Flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type.
  • Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the joonones and methylcedryl ketone
  • the alcohols are anethole
  • Citronellol Citronellol
  • eugenol isoeugenol
  • geraniol linalool
  • the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbaneum oil, labdanum oil and lavandin oil.
  • Antiperspirants reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor.
  • Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
  • non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
  • Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients.
  • suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. B. with propylene glycol-1,2.
  • conventional oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants.
  • Such oil soluble aids can e.g. his:
  • water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusting agents, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as e.g. Xanthan gum, hydroxyethyl cellulose, polyvinyl pyrrolidone or high molecular weight polyethylene oxides.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Piroctone olamine (l-hydroxy-4-methyl-6- (2,4,4-trimythylpent ⁇ l) -2- (lH) -pyridinone monoethanolamine salt), Baypival® (climbazole), ketocona zol®, (4-acetyl-l - ⁇ - 4- [2- (2.4-dichlorophenyl) r-2- (lH-imidazol-l-ylmethyl) -l, 3-dioxylan-c-4-ylmethoxyphenyl ⁇ piperazine, ketoconazole, elubiol, selenium disulphide, sulfur colloidal, sulfur polyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid monoethanolamide sulfosuccinate Na salt, Lamepon® UD (protein undecyle
  • Montmorillonites, clay minerals, pemulene and alkyl-modified carbopol types can serve as swelling agents for aqueous phases.
  • Possible insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl butyl acetylaminopropionate
  • Dihydroxyacetone is suitable as a self-tanner.
  • Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
  • Hydrotropes such as ethanol, isopropyl alcohol or polyols can also be used to improve the flow behavior.
  • Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
  • Alkylene glycols such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as, in particular, trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Lower alkyl glucosides especially those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside; > Sugar alcohols with 5 to 12 carbon atoms, such as sorbitol or mannitol,
  • Dialcohol amines such as diethanolamine or 2-amino-l, 3-propanediol.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid, as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, cumin, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme) ), Needles and twigs (spruce, fir, pine, mountain pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linylbenzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexyl benzylatepylpropylate, stylate propionate, stylate propionate.
  • the ethers include, for example, benzyl ethyl ether
  • the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal
  • the ketones include, for example, the jonones, ⁇ -isomethyl ionone and methyl cedryl ketone
  • the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol
  • the hydrocarbons mainly include the terpenes and balsams.
  • fragrance oils of lower volatility which are mostly Mako components are used as perfume oils, such as sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • Suitable flavors are, for example, peppermint oil, spearmint oil, anise oil, star anise oil, cumin oil, eucalyptus oil, fennel oil, lemon oil, winter green oil, clove oil, menthol and the like.
  • the dyes which can be used are those which are suitable and approved for cosmetic purposes. Examples are culinary red A (CI 16255), patent blue V (CI42051), indigotine (CI73015), chlorophyllin (C.L75810), quinoline yellow (CI47005), titanium dioxide (CI77891), indanthrene blue RS (CI 69800) and madder varnish ( C.L58000). Luminol may also be present as the luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • the new active ingredients have a variety of properties that make them interesting for the protection and care of skin and hair. Another object of the invention therefore relates to their for the production of cosmetic or pharmaceutical preparations. Further advantageous embodiments of the invention relate to the use of the active ingredients
  • Example 1 500 g of pea seed was ground, dispersed in a 10-fold amount of water and the pH was adjusted to 4.7 by adding sulfuric acid. The suspension was then stirred at 52 ° C. for 2 h, cooled and the undissolved constituents were separated off by centrifugation. 0.36 kg of the acidic residue (Pea Acid Precipitate) was again suspended in 750 ml of water, stirred for 45 min and the pH was gradually increased to 7.5 by adding sodium hydroxide solution. Then the undissolved portions were separated again. The soluble extract (0.8 kg) was transferred to a fermentation tank where it was incubated at 90 ° C for 20 min. The preparation was then cooled to 20 ° C.
  • Example 2 Example 1 was repeated, but the fermentation was carried out with 800 g of pea extract, 0.8 yeast extract and 4 g of sodium chloride. After freeze-drying, the yield of fermentation products was 9% by weight, based on the starting materials (g / g dry weight of the Pea Acid Precipitate). The end product had a nitrogen content of 4% by weight.
  • Example 3 Example 2 was repeated. After centrifugation of the fermentation broth, the fermented protein fraction was separated and resuspended in 5 times the volume of water. The suspension was stirred for 30 min and the pH was gradually adjusted to 7.6 by adding sodium hydroxide solution. The suspension was then incubated at 90 ° C. for 20 min and freeze-dried. The fermentation product was obtained in a yield of 8% by weight based on the starting materials (g / g dry weight of the Pea Acid Precipitate) and had a nitrogen content of 12% by weight.
  • the fermentation product was obtained in a yield of 60% by weight, based on the dry matter of the fermentation broth.
  • the resulting product had a nitrogen content of 3.5% by weight.
  • Example 5 Fruits of the Bactris palm were broken up in the presence of water, giving a suspension with a solids content of 10% by weight. This was incubated at 110 ° C. for 30 min, cooled to 30 ° C. and mixed with the commercially available Kefir Fruit fermentation from Yalacta, which contained the following microorganisms: Lactococcus lactis, Lactococcus cremorius, Lactococcus dieacetylactis, Leuconostoc, Lactobacillus cauccususlactus, Lactobacillus caucasicus , lactis and Saccharomyces florentinus.
  • Yalacta which contained the following microorganisms: Lactococcus lactis, Lactococcus cremorius, Lactococcus dieacetylactis, Leuconostoc, Lactobacillus cauccususlactus, Lactobacillus caucasicus , lactis and Saccharomyces florentin
  • Example 6 Example 5 was repeated. The fermentation broth was produced with an initial content of 5% w / g dry weight of the fruits of the Bactris palm and 1.25% by weight glucose and 0.04% by weight malt extract. The fermentation product was obtained in a yield of 45% by weight based on the dry weight of the fermentation broth.
  • Example 7. 1 kg of maca root powder (Amazonian Natural Product, Peru) was dispersed in distilled water so that there was a 10% by weight dispersion. The pH was adjusted to pH 7-7.2 with a 4 N sodium hydroxide solution. The suspension was stirred at room temperature (22 ° C ⁇ 2 ° C) for one hour and then incubated with 0.1% (w: v) of a commercial kefir culture (Kefir Cl from Wiesby).
  • the maca broth was fermented at room temperature between 20 and 25 ° C and a stirring speed of 100 rpm. After 1.5 days (pH 4), the broth was heated to 70-80 ° C. for 15 minutes and then centrifuged and filtered to remove insoluble constituents. The solution thus obtained was freeze-dried. A fermentation product was obtained with a yield of 28% by weight, based on the dry weight of the Maca powder, which had a nitrogen content of 2.6% by weight.
  • Example 8 5 g of quinoa seeds were crushed and dispersed to a 10% by weight dispersion in distilled water. The pH of the dispersion was adjusted to pH 7-7.2 using a 4 N sodium hydroxide solution. The suspension was stirred at room temperature (22 ° C. + 2 ° C.) for one hour and then incubated with 1% (w: v) of a commercial kefir culture (Kefir Cl from Wiesby). This quinoa broth was fermented at room temperature (22 ° C ⁇ 2 ° C) and a stirring speed of 110 rpm (preculture). After 24 hours (pH 4.2), this fermentation broth (preculture) was used to incubate 5 kg of suspension from 500 g of crushed quinoa seeds as previously prepared.
  • a commercial kefir culture Kefir Cl from Wiesby
  • the quinoa broth was fermented at room temperature (22 ° C ⁇ 2 ° C) and a stirring speed of 300 rpm. After 28 hours (pH 4.3), the broth was heated to 70-80 ° C. for 15 minutes and then centrifuged and filtered in order to remove insoluble constituents. The solution thus obtained was freeze-dried. A fermentation product was obtained with a yield of 11% by weight, based on the dry weight of the quinoa powder, which had a nitrogen content of 6.9% by weight.
  • fibroblasts After an incubation of 72 h in a nutrient solution, fibroblasts form saturated monolayers, the fibroblasts cease their activity and growth stops.
  • ATP adenosine triphosphate
  • the protein content in the cells was determined by the Bradford method [cf. Anal. Biochem. 72, 248-254 (1977)].
  • Glutathione (GSH) is a special protein that is produced by the cells to protect against oxidative stress and environmental toxins, especially against heavy metals.
  • the three amino acids involved in the reduced form of the GSH are linked to special cytoplasmic enzymes that require ATP for activation.
  • An increase in GSH concentration leads to an increase in glutathione S-transferase activity, a detoxification enzyme.
  • the GHS content was determined using the Hissin method [cf. Anal. Biochem. 74, 214-226 (1977)].
  • the growth-stimulating effects of the test substances were investigated on human fibroblasts. For this purpose, in a first test series, the fibroblasts were incubated in a nutrient medium for 1 day at 37 ° C. and 5% by volume CO 2 , the nutrient medium was exchanged for a medium which contained the test substances, and again incubated for 3 days at 37 ° C.
  • the protein content in the cells and the ATP concentration were then determined.
  • the fibroblasts were first incubated in a nutrient solution at 37 ° C. for 3 days and then in a test solution at the same temperature for 3 days.
  • the protein content in the cells and the GSH concentration were then determined.
  • the number of living cells was measured in some experiments by measuring the content of cellular ATP and cellular DNA. The results are summarized in Table 1. The results of 3 series of measurements with triple determination in% -rel compared to a blank sample are given.
  • test substances stimulate the metabolism with regard to the growth and protection of the fibroblasts.
  • Table 1 The examples show that the test substances stimulate the metabolism with regard to the growth and protection of the fibroblasts.
  • leucocytes such as the polymorphonuclear neutrophil granulocytes (PMN)
  • PMN polymorphonuclear neutrophil granulocytes
  • peptides such as cytokines to send out messenger substances such as leukotriene, which are released in the dermis by activated or necrotic cells.
  • ROS such as superoxides and hypochlorite anions, which have the task of destroying invaded pathogenic germs or fungi.
  • This activity of the PMN during inflammation is known as a so-called respiratory burst and can lead to additional damage to the tissue.
  • a cell line of human leukemic granulocytes of this PMN was put together incubated with the test substances of 5% by volume of CO 2 at 37 ° C. After triggering the respiratory outbreak by adding a yeast extract (zymosan) to the cell solution, the release of superoxide anions was determined by their reaction with luminol 2. The cell numbers and the amount of released ROS are given in% -rel to the standard as the mean value of a series of measurements with triplicate determination.
  • UVB was chosen as a stress factor because the rays cause cutaneous inflammation (erythema, edema) by activating arachidonic acid-releasing enzymes, such as phospholipase A2 (PLA2).
  • PHA2 phospholipase A2
  • the influence of UVB rays on the keratinocytes was determined in vitro via the release of cytoplasmic enzymes, such as LDH (lactate dehydrogenase), which runs parallel to cell damage and the formation of PGE2.
  • a fibroblast culture with fetal calf serum was set up and vaccinated with the test substances 2 days later. After an incubation of 36 h at 37 ° C and a CO 2 level of 5 vol.%, The nutrient medium was replaced by an electrolyte solution and the fibroblasts were damaged with a defined amount of UVB radiation (50 mJ / cm 2 ). After trypsination, the amount of keratinocytes was determined using a cell counter, the LDH concentration was determined enzymatically and the PGE2 formed was measured by the Elisa test. The results are summarized in Table 3. The activity is given in% -rel against a standard as the mean of two test series with double determination. Table 3
  • test substances significantly reduce the harmful effects of UVB rays and in particular reduce the release of LDH and PGE2.
  • UV-A radiation penetrates through the epidermis and induces damage by oxidative stress in the area of the dermis (DALLE CARBONARE M, PATHAK MA; Skin photosensitizing agents and the role of reactive oxygen species in photoaging; JOURNAL OF PHOTOCHEMISTRY & PHOTOBIOLOGY, 1992, 14, 1-2, 105-124.
  • the number of cells was measured by the Bradford method on the gehlat of cellular proteins.
  • the results in Table 4 are given in% against the control (without exposure to UV light) as the mean of two determinations in triplicate.
  • the fermentation products investigated lead to a significant reduction in the damage caused by UV-A radiation. Therefore, the cementation products are advantageous for improving the resistance of the skin and hair follicles to oxidative stress, which is exerted by UV radiation, but also by environmental toxins. They protect the skin and hair follicles against aging.
  • Elastase is a protease that is excreted by leukocytes during an inflammatory process or by fibroblasts after exposure to UV radiation or through aging. It is an enzyme that catalyzes the destruction of essential dermal proteins such as proteoglycans, elastin or collagen fibers and in this way induces intrinsic aging as well as photo-aging of human skin.
  • ROBERT L LABAT ROBERT J: Vieill negligence et tissu conjonctif. Annee Geront unanimous, 23-37, 1992).
  • the test was carried out with elastase from pancreas stained with Congo red.
  • the incubation time at room temperature was 30 minutes and the optical density of the Congo red released was determined after centrifugation at a wavelength of 520 nm.
  • the fermentation product investigated had a good inhibition of the release of elastase and can therefore be used successfully against skin aging and damage caused by UV radiation.
  • the influence on melanogenesis was determined by means of a test with an in vitro culture of B16 melanocytes.
  • FCS fetal calf serum
  • the fermented product investigated showed a high potential for modulating melanin synthesis in in vitro cultures of melanocytes.
  • Immune stimulation is understood to mean biochemical processes in which messenger substances, such as beta glucans, stimulate the body's defenses, for example to bind and excrete toxic substances and to accelerate the renewal of skin cells. It is known that organisms lose this ability with age.
  • the immune stimulation can be observed in vitro using human leukocytes which have been activated beforehand with a yeast extract (zymosan) [cf. Capsoni et al. Int.J.Immunopharm. 10 (2), 121-133 (1998)].
  • a culture of polymorphonuclear neutrophil granulocytes (PMN) was incubated together with the test substances over a period of 24 hours at 37 ° C. and 5% by volume CO 2 . The respiratory outbreak was triggered by the addition of Zymosan.
  • test substances stimulate the immune system and sustainably strengthen the body's defenses, especially of the skin cells.
  • the dry stratum corneum is a dielectric medium with poor conductivity. If moisture is added to it, the conductivity increases due to the bipolar nature of the water molecules. Conductometry is therefore a suitable method for determining the state of hydration of the stratum corneum. If the conductivity is improved by adding test substances, it can be concluded that these have a moisturizing effect.
  • an in vitro skin model was used, which had previously been produced according to the instructions of Obata and Tagami in J. Soc.Cosmet.Chem., 41, 235-242 (1990). The preparations were equilibrated in chambers of defined air humidity and then tested under three or four different conditions:
  • the examples show that the addition of the test substances significantly improves the state of hydration of the stratum corneum in comparison with known moisturizers.
  • a cream with 1.5% by weight of the extract according to Example 4 an improvement in hydration of more than 160% was found after just 30 minutes, while a comparison cream with an equal weight of glycerol only showed an improvement of around 75%. rendered.
  • the state of hydration of the skin can also be determined in-vivo using conductometry as part of a non-invasive measurement.
  • the conductivity is first determined on an area of 4 cm 2 on the inside of the forearm without treatment with the test substance (TO value). 4 ⁇ l / cm 2 of test substance are then applied, dried for 15 minutes and the conductivity is then determined again (T15 value).
  • T15 value the conductivity of a neighboring skin area is also measured, which had not been treated with the test substance.
  • the results are expressed as a percentage ratio T15 / T0 and are summarized in Table 6.
  • test substances significantly improve the state of hydration of the skin. Improve skin roughness
  • test substances exert on the roughness or softness of the skin can be determined in vivo with the help of fructiometry.
  • the principle of this measurement is based on the fact that a rotating body exerts constant pressure on the skin surface.
  • the force required for this is measured via which the friction coefficient can be determined.
  • the force to be applied is directly dependent on the roughness of the skin. It follows that the higher the hydration state of the skin, ie the softness, the greater the coefficient.
  • the friction is first determined on an area of 9 cm 2 on the inside of the forearm without treatment with the test substance (T0 value). Then 4 ⁇ l / cm 2 of test substance are applied, dried for 15 minutes and then the friction is determined again (T15 value).
  • T15 value As a control, the conductivity of a neighboring skin area is also measured, which had not been treated with the test substance. The results are expressed as a percentage ratio T15 / T0 and are summarized in Table 7.
  • test substances significantly improve the roughness of the skin and make it significantly softer.

Abstract

The invention relates to cosmetic and/or pharmaceutical active substances that are obtained by fermenting plant components and/or plant extracts and to a corresponding method. Said method comprises the following steps: (a) the plant components and/or plant extracts are reduced in size and/or pressed out and/or extracted and processed to a fermentation broth; (b) the fermentation broth is optionally pasteurized or sterilized; (c) the fermentation broth so prepared is inoculated with microorganisms; (d) the fermentation broth so inoculated is fermented; and optionally (e) after completion of fermentation, the fermentation broth is reprocessed and the active substances are removed.

Description

WIRKSTOFFE FÜR KOSMETISCHE UND/ODER PHARMAZEUTISCHE VERWENDUNG, ACTIVE SUBSTANCES FOR COSMETIC AND / OR PHARMACEUTICAL USE,
DIE AUS DER FERMENTATION VON PFLANZENBESTANDTEILEN UND/ODERFROM FERMENTATION OF PLANT COMPONENTS AND / OR
PFLANZLICHEN EXTRAKTEN ERHALTEN WERDENHERBAL EXTRACTS ARE OBTAINED
Gebiet der ErfindungField of the Invention
Die Erfindung befindet sich auf dem Gebiet der Kosmetik und betrifft neue Wirkstoffe aus fermentierten Pflanzenbestandteilen und/oder pflanzlichen Extrakten, ein Verfahren zu deren Herstellung, Zubereitungen, die diese Wirkstoffe enthalten sowie eine Vielzahl an Verwendungen für die neuen Wirkstoffe.The invention is in the field of cosmetics and relates to new active ingredients from fermented plant components and / or vegetable extracts, a process for their preparation, preparations containing these active ingredients and a large number of uses for the new active ingredients.
Stand der TechnikState of the art
Schon in den Zeiten der Antike hat der Wunsch nach ewiger Schönheit und Jugend bestanden. Während von Kleopatra überliefert ist, dass sie regelmäßig ein Bad in Eselsmilch zu nehmen pflegte - heute wissen wir um die Wirkung der darin enthaltenen Milchproteine - mussten weniger begüterte Frauen darauf hoffen, dass ihr Wunsch von den Göttern erhört würde. Es steht zu vermuten, dass dies nur selten von Erfolg gekrönt worden ist. Heutzutage ist jugendliches Aussehen und eine faltenarme Haut kein Privileg einiger weniger Verbraucherinnen, sondern steht trotz teilweise erheblicher Preisunterschiede bei den Präparaten grundsätzlich allen Frauen zur Verfügung. Auch wenn die kosmetische Chemie keine Wunder vollbringen kann, hat aber gerade in den letzten Jahren das Wissen um die biochemischen Abläufe in den Zellen von Haut und Haaren sprunghaft zugenommen. Konsequenterweise haben sich dadurch natürlich Ansätze ergeben, auf welche Weise man Schädigungen, die durch natürliche Alterung oder Umwelteinflüsse eintreten, verhindern oder beheben kann. In gleicher Weise sind jedoch auch die Anforderungen gestiegen, die die Verbraucherinnen (und zunehmend auch Verbraucher) an solche sogenannten „Anti-Ageing Mitteln" stellen. Ganz abgesehen davon, dass die Zubereitungen grundsätzlich einen pflegenden Charakter aufweisen sollen, die Haut gegen Austrocknung schützen sollen und optimal haut- und gegebenenfalls schleimhautverträglich sein müssen, sollen sie vor UV-Strahlung und Umweltgiften schützen, das Immunsystem stimulieren und anti-inflammatorisch wirksam sein.The desire for eternal beauty and youth has existed since ancient times. While it has been handed down from Cleopatra that she regularly took a bath in donkey milk - today we know about the effect of the milk proteins contained in it - less wealthy women had to hope that their wishes would be answered by the gods. It can be assumed that this has rarely been crowned with success. Nowadays, youthful appearance and wrinkle-free skin is not a privilege of a few consumers, but is generally available to all women despite the sometimes considerable price differences in the preparations. Even if cosmetic chemistry cannot work miracles, knowledge about the biochemical processes in the cells of skin and hair has increased by leaps and bounds in recent years. As a consequence, approaches have naturally arisen in which way one can prevent or remedy damage caused by natural aging or environmental influences. In the same way, however, the requirements that consumers (and increasingly also consumers) place on such so-called "anti-aging agents" have risen. Quite apart from the fact that the preparations should in principle have a nourishing character, which should protect the skin against dehydration and must be optimally compatible with the skin and possibly mucous membranes, they should protect against UV radiation and environmental toxins, stimulate the immune system and have an anti-inflammatory effect.
In diesem Zusammenhang sei darauf hingewiesen, dass die Verwendung von Fermentationsprodukte von Milchproteinen, wie beispielsweise Kefir, Kumys, Kuban, Leben und Mazun für die menschliche Ernährung hinreichend bekannt sind [vgl. z.B. Hesseltine, Mycologia 57, 1-148 (1965)]. Fermentationsprodukte der Agave sind als Pulque bekannt. Durch Fermentation von Sucrose, Rosinen oder Zitronen werden Tibi oder Ginger Ale erhalten. Un- ter Busa versteht man ein Getränk, welches man durch Fermentation von Reis und Zucker erhält. Bislang ist über den Einsatz von Fermentationsprodukten in der Kosmetik jedoch wenig bekannt. Von fermentierter Molke ist bekannt, dass sie das äußere Erscheinungsbild der Haut verbessern soll [F -Bl 2718752, World Trust Investment]. Die Verwendung von Kefir für die Hautbehandlung sowie als Mittel gegen Ekzeme, Mycosen und Akne ist aus der EP- A2 0315541 (L'Oreal) bekannt. In der ES-Bl 2116201 (Javier Uruena Mendez) wird weiter vorgeschlagen, Kefir für die Regeneration von Kapillargefäßen einzusetzen.In this context, it should be pointed out that the use of fermentation products from milk proteins, such as kefir, kumys, kuban, life and mazun, is well known for human consumption [cf. e.g. Hesseltine, Mycologia 57, 1-148 (1965)]. Agave fermentation products are known as pulque. By fermenting sucrose, raisins or lemons, Tibi or Ginger Ale are obtained. U.N- ter Busa is a drink that is obtained by fermenting rice and sugar. So far, little is known about the use of fermentation products in cosmetics. Fermented whey is known to improve the external appearance of the skin [F -Bl 2718752, World Trust Investment]. The use of kefir for skin treatment and as an agent against eczema, mycoses and acne is known from EP-A2 0315541 (L'Oreal). ES-Bl 2116201 (Javier Uruena Mendez) further suggests using kefir for the regeneration of capillary vessels.
Die Aufgabe der vorliegenden Erfindung hat folglich darin bestanden, neue Wirkstoffe zur Verfügung zu stellen, die das oben beschriebene komplexe Anforderungsprofil erfüllen. Im Hinblick auf die BSE-Diskussion bestand ferner der Wunsch, dass es sich bei diesem „Multi- funktionswirkstoffen" um pflanzliches Produkte handelt.The object of the present invention was therefore to provide new active ingredients which meet the complex requirement profile described above. With regard to the BSE discussion, there was also a desire that this “multifunctional active ingredient” be a herbal product.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung sind kosmetische und/oder pharmazeutische Wirkstoffe, die dadurch erhältlich sind, dass man Pflanzenbestandteile, wie beispielsweise Wurzeln, Knollen, Blätter, Früchte und/oder pflanzliche Extrakte fermentiert .The invention relates to cosmetic and / or pharmaceutical active ingredients which can be obtained by fermenting plant components, such as roots, tubers, leaves, fruits and / or plant extracts.
Überraschenderweise wurde gefunden, dass die Fermentationsprodukte über eine Vielzahl von vorteilhaften Eigenschaften verfügen, die für den Einsatz in der Kosmetik zum Schutz und zur Pflege von Haut und Haaren wichtig sind. So schützen die Wirkstoffe gegen den schädigenden Einfluss von UV-Strahlen und wirken beispielsweise bei Sonnenbrand anti- inflammatorisch. Sie stimulieren den Metabolismus in vielfältiger Weise, beispielsweise regen sie die Synthese von dermalen Makromolekülen an und inhibieren gleichzeitig deren Abbau. Sie verbessern die Hydratation der Haut und das Hautgefühl.Surprisingly, it was found that the fermentation products have a large number of advantageous properties which are important for use in cosmetics for protecting and caring for the skin and hair. The active ingredients protect against the damaging effects of UV rays and have an anti-inflammatory effect, for example when sunburned. They stimulate metabolism in a variety of ways, for example they stimulate the synthesis of dermal macromolecules and at the same time inhibit their breakdown. They improve skin hydration and skin feel.
Ein weiterer Gegenstand der Erfindung betrifft ein Verfahren zur Herstellung von kosmetischen und/oder pharmazeutischen Wirkstoffen, bei dem man Pflanzenbestandteile und/oder pflanzliche Extrakte fermentiert. Dabei werdenThe invention further relates to a process for the production of cosmetic and / or pharmaceutical active substances, in which plant constituents and / or plant extracts are fermented. In doing so
(a) die Pflanzenbestandteile und/oder pflanzliche Extrakte zerkleinert und/oder aus- presst und/oder extrahiert und zu einer Fermentationsbrühe verarbeitet,(a) the plant constituents and / or plant extracts are crushed and / or pressed and / or extracted and processed into a fermentation broth,
(b) gegebenenfalls die Fermentationsbrühe pasteurisiert bzw. sterilisiert,(b) optionally pasteurized or sterilized the fermentation broth,
(c) die so vorbereitete Fermentationsbrühe mit den Mikroorganismen inoculiert, (d) die so inoculierte Fermentationsbrühe fermentiert, und gegebenenfalls(c) the fermentation broth thus prepared inoculates with the microorganisms, (d) fermenting the fermentation broth thus inoculated, and optionally
(e) nach Beendigung der Fermentation die Fermentationsbrühe aufgearbeitet und die Wirkstoffe abgetrennt.(e) after the end of the fermentation, the fermentation broth is worked up and the active compounds are separated off.
Die zu einer Fermentationsbrühe zu verarbeitenden pflanzlichen Bestandteile werden ausgewählt aus der Gruppe der Samen, Knollen, Wurzeln, Blätter, Früchte, pflanzlichen Proteinkonzentraten, -isolaten und/oder -hydrolysaten. Bevorzugt werden als Pflanzenbestandteile Früchte und Samen eingesetzt.The vegetable constituents to be processed into a fermentation broth are selected from the group of seeds, tubers, roots, leaves, fruits, vegetable protein concentrates, isolates and / or hydrolyzates. Fruits and seeds are preferably used as plant components.
Pflanzenbestandteile und/oder pflanzliche ExtraktePlant components and / or plant extracts
Es werden Knollen, Wurzeln, Blätter und bevorzugt Samen und/oder Früchte in zerkleinerter und/oder ausgepresster und/oder extrahierter Form eingesetzt, ausgewählt aus der Gruppe der Pflanzen und/oder Pflanzenbestandteile von Kartoffeln, Reis, Soja, Weizen, Gerste, Hafer, Roggen, Buchweizen, Bohnen, Erbsen, Leinsamen, Baumwolle, Sesam, Lupinen, Raps, Hanf, Cocuspalme, Sonnenblumen,Luzerne, Hibiscus, Maca, Quinoa, Mandel, Moringa, Seide, Baobao, Cassia, Irvinga, Distel und Ölpalme; oder ausgewählt aus der Gruppe der Früchte der Äpfel, Birnen, Quinten, Mispel, Hagebutten, Kirschen, Pflaumen, Pfirsiche, Aprikosen, Granatäpfel, Beeren, Trauben, Zitronen, Ananas, Cherimoya, Guaven, Mango, Karambole, Litchi, Kiwi, Banane, Cocusnuß, Mandeln, Papaya, Avocado, Tamarinde, Baobao, Stachelanone, Netzanone, Mamay-Apfel, Atemoya, Ilama, Sancoya, Granadillo, Sapodilla, Rambutan, Mangostane, Durian, Karambola, Bibasse (Wolltraube), Pricky Pear Kaktus, Pitahaya, Langsat, Jackfrucht, Chemdak, Virginische Dattelpflaume, Sharon Frucht (Kaki).Tubers, roots, leaves and preferably seeds and / or fruits are used in comminuted and / or pressed and / or extracted form, selected from the group of plants and / or plant components of potatoes, rice, soybeans, wheat, barley, oats, Rye, buckwheat, beans, peas, linseed, cotton, sesame, lupine, rapeseed, hemp, coconut palm, sunflower, alfalfa, hibiscus, maca, quinoa, almond, moringa, silk, baobao, cassia, irvinga, thistle and oil palm; or selected from the group of fruits of apples, pears, fifths, medlar, rose hips, cherries, plums, peaches, apricots, pomegranates, berries, grapes, lemons, pineapples, cherimoya, guavas, mango, carambola, litchi, kiwi, banana, Coconut, almonds, papaya, avocado, tamarind, baobao, spiked apple, Netzanone, Mamay apple, Atemoya, Ilama, Sancoya, Granadillo, Sapodilla, Rambutan, Mangostane, Durian, Karambola, Bibasse (wool grape), Pricky Pear cactus, Pitahaya, Langsat , Jackfruit, chemdak, virgin date plum, sharon fruit (persimmon).
Mikroorganismenmicroorganisms
Im Hinblick auf eine optimierte Ausbeute an Wirkstoffen hat es sich als vorteilhaft erwiesen, die Fermentation in Gegenwart einer Mischung verschiedener Mikroorganismen durchzuführen. Besonders bevorzugt ist es dabei, wenn man Mischungen verschiedener Mikroorganismen einsetzt, die einerseits wenigstens einen Vertreter aus der Gruppe Lactobacillus, Lacto- coccus und Leuconostoc und andererseits wenigstens eine Hefe enthalten. Typische Beispiele für geeignete Mikroorganismen sind die folgenden : Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus caucasicus, Lactobacillus cellobiosus, Lactobacillus delbruecki, Lactobacillus helveticus, Lactobacillus hilgardii, Lactobacillus kefir, Lacto- bacillus kefiranofaciens, Lactobacillus kefirgranum, Lactobacillus parakefir, Lactobacillus plantarum, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetilactis, Lactococcus lactis subsp. lactis, Lactococcus plantarum, Leuconostoc citreum, Leuconostoc citrove- rum, Leuconostoc dextranicum, Leuconostoc kefir, Leuconostoc mesenteroides, Leuconostoc pseudomesenteroides, Candida kefir, Candida tenuis, Kluyveromyces bulgaricus, Kluyvero- myces fragilis, Kluyveromyces lactis, Saccharomyces carbajali, Saccharomyces carlbergensis, Sacharomyces cerevisiae, Saccharomyces delbrueckii, Saccharomyces florentinus, Saccharomyces globosus, Saccharomyces kefir, Saccharomyces marxianus, Saccharomyces, unispo- rus, Torula homii, Torula kefir, Streptococcus thermophilus, Streptococcus durans, Aceto- bacter aceti und Acetobacter rasens sowie deren Gemische. Sowohl die Bakterien als auch die Hefen können in unterschiedlichen Gewichtsverhältnissen eingesetzt werden, zumal sich diese während der Fermentation ändern. Das Okulat der Milchsäurebakterien beträgt zwischen 102 und 108 cfu/ml, vorzugsweise zwischen 103 and 106 cfu/ml. Das Verhältnis von unterschiedlichen Milchsäuebakterien Lactobacillus, Lactococcus und Leuconostoc zueinander kann 1:1000 bis 1000 : 1, vorzugsweise 1:100 bis 100 : 1 betragen. Okulate von Hefen enthalten zwischen 102 und 107 cfu/ml, vorzugsweise zwischen 103 und 105 cfu/ml. Das Verhältnis von Milchsäurebakterien zu Hefen beträgt 1 : 100000 bis 100000 : 1, vorzugsweise 1:1000 bis 1000:1. Die Mikroorganismen können rein eingesetzt werden, es können aber auch Kefir- oder Tibi-Mischungen zum Einsatz gelangen, die als solche käuflich zu erwerben sind.With regard to an optimized yield of active ingredients, it has proven advantageous to carry out the fermentation in the presence of a mixture of different microorganisms. It is particularly preferred if mixtures of different microorganisms are used which on the one hand contain at least one member from the group Lactobacillus, Lactococcus and Leuconostoc and on the other hand contain at least one yeast. Typical examples of suitable microorganisms are the following: Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus caucasicus, Lactobacillus cellobiosus, Lactobacillus delbruecki, Lactobacillus helveticus, Lactobacillact hilobacillii, Lactobacillus hilobardus bacillus kefiranofaciens, Lactobacillus kefirgranum, Lactobacillus parakefir, Lactobacillus plantarum, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetilactis, Lactococcus lactis subsp. lactis, Lactococcus plantarum, Leuconostoc citreum, Leuconostoc citroveurum, Leuconostoc dextranicum, Leuconostoc kefir, Leuconostoc mesenteroides, Leuconostoc pseudomesenteroides, Candida kefir, Candida tenuis, Kluyveromyces bulgaricus, Sacuycharomyces, Sacuycharomyces, Kluyveromyces bulgaricus, lactuycharis , Saccharomyces delbrueckii, Saccharomyces florentinus, Saccharomyces globosus, Saccharomyces kefir, Saccharomyces marxianus, Saccharomyces, unisporus, Torula homii, Torula kefir, Streptococcus thermophilus, Streptococcus durans, Acetobacter aceti and their Acetobacter rasi and their Acetobacter. Both the bacteria and the yeast can be used in different weight ratios, especially since they change during fermentation. The oculate of the lactic acid bacteria is between 10 2 and 10 8 cfu / ml, preferably between 10 3 and 10 6 cfu / ml. The ratio of different lactic acid bacteria Lactobacillus, Lactococcus and Leuconostoc to each other can be 1: 1000 to 1000: 1, preferably 1: 100 to 100: 1. Yeast ocules contain between 10 2 and 10 7 cfu / ml, preferably between 10 3 and 10 5 cfu / ml. The ratio of lactic acid bacteria to yeast is 1: 100000 to 100000: 1, preferably 1: 1000 to 1000: 1. The microorganisms can be used purely, but it is also possible to use kefir or tibi mixtures which are commercially available as such.
Fermentationfermentation
Die Fermentation kann in fünf Phasen untergliedert werden:The fermentation can be divided into five phases:
1. Herstellung der Fermentationsbrühe/Extraktion,1. Preparation of the fermentation broth / extraction,
2. gegebenenfalls Pasteurisierung bzw. Sterilisierung,2. optionally pasteurization or sterilization,
3. Inoculation,3. Inoculation,
4. Eigentliche Fermentation sowie gegebenenfalls4. Actual fermentation as well as if necessary
5. Aufarbeitung der Produkte.5. Refurbishment of the products.
Herstellung der Fermentationsbrühe / ExtraktionPreparation of the fermentation broth / extraction
Zur Herstellung der Fermentationsbrühe werden die pflanzlichen Ausgangsstoffe wie beispielsweise zerkleinerte Pflanzenteile, pflanzliche Extrakte, zerkleinerte und/oder extrahierte Samen, Knollen, Wurzeln oder Blätter, Proteinkonzentrate, - hydrolysate oder -isolate, zerkleinerte und/oder extrahierte Früchte entsprechend ihrer Härte direkt gemahlen oder zunächst aufgebrochen und dann weiter zu einer wässrigen, organischen oder wäss- rig/organischen Dispersion verarbeitet. Die Herstellung der Extrakte kann in an sich bekannter Weise erfolgen, d.h. beispielsweise durch wässrigen, alkoholischen oder wässrig- alkoholischen Auszug der Pflanzen bzw. Pflanzenteile. Bezüglich der geeigneten herkömmlichen Extraktionsverfahren wie der Mazeration, der Remazeration, der Digestion, der Bewegungsmazeration, der Wirbelextraktion, Ultraschallextraktion, der Gegenstromextraktion, der Perkolation, der Reperkolation, der Evakolation (Extraktion unter vermindertem Druck), der Diakolation und Festflüssig-Extraktion unter kontinuierlichem Rückfluss die in einem Soxhlet- Extraktor durchgeführt wird, die dem Fachmann geläufig und im Prinzip alle anwendbar sind, sei der Einfachheit halber beispielsweise auf Hagers Handbuch der Pharmazeutischen Praxis, (5. Auflage, Bd. 2, S. 1026-1030, Springer Verlag, Berlin-Heidelberg-New-York 1991) verwiesen. Für den großtechnischen Einsatz vorteilhaft ist die Perkolationsmethode.To produce the fermentation broth, the plant starting materials, such as, for example, comminuted plant parts, plant extracts, comminuted and / or extracted Seeds, tubers, roots or leaves, protein concentrates, hydrolysates or isolates, chopped and / or extracted fruits are ground directly according to their hardness or first broken up and then further processed into an aqueous, organic or aqueous / organic dispersion. The extracts can be prepared in a manner known per se, ie for example by aqueous, alcoholic or aqueous-alcoholic extraction of the plants or parts of plants. Regarding the suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, for the sake of simplicity, for example, in Hager's Handbook of Pharmaceutical Practice, (5th edition, vol. 2, pp. 1026-1030, Springer Verlag, Berlin-Heidelberg-New-York 1991). The percolation method is advantageous for large-scale use.
Als Ausgangsmaterial können frische Pflanzen oder Pflanzenteile eingesetzt werden, üblicherweise wird jedoch von getrockneten Pflanzen und/oder Pflanzenteilen ausgegangen, die vor der Extraktion mechanisch zerkleinert werden können. Hierbei eignen sich alle dem Fachmann bekannten Zerkleinerungsmethoden, als Beispiel sei die Gefriermahlung genannt. Als Lösungsmittel für die Durchführung der Extraktionen können organische Lösungsmittel, Wasser oder Gemische aus organischen Lösungsmitteln und Wasser, insbesondere niedermolekulare Alkohole mit mehr oder weniger hohen Wassergehalten, verwendet werden. Besonders bevorzugt ist die Extraktion mit Methanol, Ethanol, Pentan, Hexan, Heptan, Ace- ton, Propylenglykolen, Polyethylenglykolen sowie Ethylacetat sowie Mischungen hieraus sowie deren wässrige Gemische. Die Extraktion erfolgt in der Regel bei 20 bis 100 °C, bevorzugt bei 30 bis 60°C. Die Extraktionszeiten werden vom Fachmann in Abhängigkeit vom Ausgangsmaterial, dem Extraktionsverfahren, der Extraktionstemperatur, vom Verhältnis Lösungsmittel zu Rohstoff u.a. eingestellt. Nach der Extraktion können die erhaltenen Rohextrakte gegebenenfalls weiteren üblichen Schritten, wie beispielsweise Aufreinigung, Konzentration und/oder Entfärbung unterzogen werden. Vor der Inokulation mit Mikroorganismen werden die organischen Lösungsmittel beispielsweise durch Destillation oder Evaporieren vollständig oder annähernd vollständig entfernt. Falls wünschenswert, können die so hergestellten Extrakte beispielsweise einer selektiven Abtrennung einzelner unerwünschter Inhaltsstoffe, unterzogen werden. Die Extraktion kann bis zu jedem beliebigen Extraktionsgrad erfolgen, wird aber gewöhnlich bis zur Erschöpfung durchgeführt. Typische Ausbeuten (= Trockensubstanzmenge des Extraktes bezogen auf eingesetzte Rohstoffmenge) bei der Extraktion der Saaten liegen im Bereich von 3 to 30, insbesondere 6 bis 25 Gew.-%. Die vorliegenden Erfindung umfasst die Erkenntnis, dass die Extraktionsbedingungen sowie die Ausbeuten der Endextrakte vom Fachmann ja nach gewünschtem Einsatzgebiet gewählt werden können. Diese Extrakte weisen in der Regel einen Feststoffgehalt im Bereich von 0,5 bis 10 Gew.-% auf. Als organische Lösungsmittel kommen in diesem Zusammenhang beispielsweise die aliphatischen Alkohole mit 1 bis 6 Kohlenstoffatomen (z.B. Ethanol), Ketone (z.B. Aceton), niedere Ester oder Polyole (z.B. Glycerin oder Glycole) in Frage.Fresh plants or parts of plants can be used as the starting material, but usually dried plants and / or parts of plants are used, which can be mechanically comminuted before extraction. All comminution methods known to the person skilled in the art are suitable here, freeze grinding being mentioned as an example. Organic solvents, water or mixtures of organic solvents and water, in particular low molecular weight alcohols with more or less high water contents, can be used as solvents for carrying out the extractions. Extraction with methanol, ethanol, pentane, hexane, heptane, acetone, propylene glycols, polyethylene glycols and ethyl acetate as well as mixtures thereof and their aqueous mixtures is particularly preferred. The extraction is usually carried out at 20 to 100 ° C, preferably at 30 to 60 ° C. The extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc. After the extraction, the crude extracts obtained can optionally be subjected to further customary steps, such as purification, concentration and / or decolorization. Before inoculation with microorganisms, the organic solvents are removed completely or almost completely, for example by distillation or evaporation. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients. The extraction can take place to any degree of extraction, but is usually carried out to exhaustion. Typical yields (= dry matter amount of the extract based on the amount of raw material used) in the extraction of the seeds are in the range from 3 to 30, in particular 6 to 25% by weight. The present invention encompasses the knowledge that the extraction conditions and the yields of the final extracts can be selected by the person skilled in the art depending on the desired field of use. These extracts generally have a solids content in the range from 0.5 to 10% by weight. Suitable organic solvents in this connection are, for example, the aliphatic alcohols having 1 to 6 carbon atoms (for example ethanol), ketones (for example acetone), lower esters or polyols (for example glycerol or glycols).
Vorzugsweise erfolgt die Herstellung der Fermentationsbrühe durch Extraktion des pflanzlichen Materials, gegebenenfalls auch mehrfach, mit Wasser im schwach alkalischen Bereich, wobei gegebenenfalls unlösliche Feststoffe beispielsweise durch Filtration oder Zentrifugieren abgetrennt werden. In einer weiteren vorteilhaften Ausführungsform der Erfindung erfolgt die Extraktion ebenfalls im wässrigen Medium, jedoch im sauren Bereich, wobei die Proteine ausgefällt, abgetrennt und mit Wasser im schwach alkalischen Bereich wieder gelöst werden.The fermentation broth is preferably prepared by extraction of the vegetable material, if appropriate also repeatedly, with water in the weakly alkaline range, insoluble solids possibly being separated off, for example by filtration or centrifugation. In a further advantageous embodiment of the invention, the extraction likewise takes place in an aqueous medium, but in an acidic range, the proteins precipitating, being separated and redissolved with water in the weakly alkaline range.
In einer weiteren Ausführungsform wird das pflanzliche Material lediglich zerkleinert, gemahlen und in Wasser oder alkalisch wässrigem Medium dispergiert und direkt fermentiert ohne weitere Extraktion oder Auftrennung.In a further embodiment, the plant material is merely comminuted, ground and dispersed in water or an alkaline aqueous medium and fermented directly without further extraction or separation.
In einer weiteren Ausführung der Erfindung wird die Fermentationsbrühe aus pflanzlichen Proteinisolaten oder - konzentraten hergestellt, die kommerziell zu erwerben sind und in Wasser oder alkalisch wässrigem Medium dispergiert werden.In a further embodiment of the invention, the fermentation broth is produced from vegetable protein isolates or concentrates, which are commercially available and are dispersed in water or an alkaline aqueous medium.
Dienen Früchte als Ausgangsstoffe so können diese entweder zermahlen oder gepresst werden, so dass die Pulpe oder Saft ohne weitere Extraktion eingesetzt werden.If fruits serve as raw materials, they can either be ground or pressed so that the pulp or juice can be used without further extraction.
Zur Herstellung der Fermentationsbrühe kann diesen Ausgangsstoffen weitere typische Additive hinzugefügt werden, wie beispielsweise Sojapepton, Malzextrakt oder fermetierbare Zucker (z.B. Saccharose oder Glucose). Es hat sich als vorteilhaft erwiesen, die Fermentationsbrühen auf einen Ausgangs-pH-Wert von 4,5 bis 8,5, bei proteaginösen Edukten auf 6,5 bis 8 einzustellen. Pasteurisierung bzw. SterilisierungTo produce the fermentation broth, other typical additives can be added to these starting materials, such as soy peptone, malt extract or fermentable sugars (eg sucrose or glucose). It has proven to be advantageous to adjust the fermentation broths to a starting pH of 4.5 to 8.5, and to 6.5 to 8 for proteaginous starting materials. Pasteurization or sterilization
Die Pasteurisierung bzw. Sterilisierung der Fermentationsbrühen wird üblicherweise bei Temperaturen im Bereich von 60 bis 135 °C über einen Zeitraum von 1 bis 30 min durchgeführt.Pasteurization or sterilization of the fermentation broths is usually carried out at temperatures in the range from 60 to 135 ° C. over a period of 1 to 30 minutes.
Inoculationinoculation
Im Rahmen der Inoculation können die Milchsäurebakterien und die Hefen in unterschiedlichen Mengen und Gewichtsverhältnissen eingesetzt werden. Typischerweise werden die Bakterien in Mengen von 102 bis 108, vorzugsweise 103 bis 106 cfu/ml verwendet. Das Gewichtsverhältnis der verschiedenen Milchsäurebakterien untereinander, also Lactobacillus, Lactococcus und Leuconostoc, kann jeweils 1 : 1.000 bis 1.000 : 1 und vorzugsweise 1 : 100 bis 100 : 1 betragen. Die Hefen können in Mengen von 102 bis 107, vorzugsweise 103 bis 105 cfu/ml eingesetzt werden. Das Gewichtsverhältnis zwischen Bakterien und Enzymen kann schließlich 1 : 100.000 bis 100.000 : 1 und vorzugsweise 1 : 1.000 bis 1.000 : 1 betragen.As part of the inoculation, the lactic acid bacteria and the yeast can be used in different amounts and weight ratios. The bacteria are typically used in amounts of 10 2 to 10 8 , preferably 10 3 to 10 6 cfu / ml. The weight ratio of the various lactic acid bacteria to one another, that is to say Lactobacillus, Lactococcus and Leuconostoc, can each be 1: 1,000 to 1,000: 1 and preferably 1: 100 to 100: 1. The yeasts can be used in amounts of 10 2 to 10 7 , preferably 10 3 to 10 5 cfu / ml. The weight ratio between bacteria and enzymes can finally be 1: 100,000 to 100,000: 1 and preferably 1: 1,000 to 1,000: 1.
Fermentationfermentation
Die Fermentation wird üblicherweise bei Temperaturen im Bereich von 10 und 47 °C, vorzugsweise zwischen 20 und 37 °C in einem statischen oder einem geschlossenen Rührtank durchgeführt. Die Fermentationszeit kann zwischen einigen Stunden und einigen Tagen variieren und liegt in der Regel zwischen 12 und 48 h. Im Zuge der Fermentation findet die Umwandlung der fermentierbaren Zucker in organische Säuren, Ethanol, Kohlendioxid und Aromaten statt. In der Folge ist ein Abfall des pH-Wertes zu beobachten, der sich in der Regel bei 4 bis 5 einpendelt. Des weiteren kommt es zu einer Proteolyse der enthaltenen Proteine unter Bildung von kurzkettigen Peptiden und Aminosäuren, die infolge des sauren pH- Wertes niedergeschlagen werden.The fermentation is usually carried out at temperatures in the range from 10 to 47 ° C., preferably from 20 to 37 ° C. in a static or a closed stirred tank. The fermentation time can vary between a few hours and a few days and is usually between 12 and 48 hours. In the course of fermentation, the fermentable sugars are converted into organic acids, ethanol, carbon dioxide and aromatics. As a result, a drop in the pH value can be observed, which usually levels off at 4 to 5. Furthermore, the proteins contained are proteolysed to form short-chain peptides and amino acids, which are precipitated as a result of the acidic pH.
ProduktaufarbeitungDownstream Processing
Als Fermentationsprodukte, die entweder als lösliche Fraktionen als feste Rückstände anfallen, kommen die rohe Fermentationsbrühe, die daraus erhältlichen rohen löslichen Fraktionen, die während der Fermentation gebildeten niedermolekularen Metaboliten (Aminosäuren, Oligopeptide, Oligosaccharide, organische Säuren, Aromaten etc.), die festen Rückstände der niedergeschlagenen fermentierten Proteine sowie die fermentierten Polysaccharide in Frage. Diese ganz unterschiedlichen Produkte können unter Anwendung an sich bekannter Trennverfahren, wie beispielsweise Zentrifugieren, Membranfϊltration (Mikrofiltration, Ultrafiltration, Nanofiltration), Flüssig-flüssig- oder Festphasenextraktion, Chromatographie, Fällung aus Lösemitteln und dergleichen gewonnen werden. Die noch in den Fermentationsprodukten enthaltenen Mikroorganismen müssen natürlich vor einer Konfektionierung als Endprodukte abgetrennt, zerstört oder inaktiviert werden. Hierzu kommen bekannte Techniken, wie eine thermische Behandlung (Pasteurisierung, Sterilisierung), Zellzerstörung, Mikrofiltration, Zentrifugieren und dergleichen in Betracht. Werden fermentierte Proteine als Endprodukte erhalten, so können diese entweder als feste Niederschläge eingesetzt oder durch Absenken des pH-Wertes als Lösungen verwendet werden.The fermentation products, which are obtained either as soluble fractions as solid residues, are the crude fermentation broth, the crude soluble fractions obtainable therefrom, the low molecular weight metabolites (amino acids, Oligopeptides, oligosaccharides, organic acids, aromatics etc.), the solid residues of the precipitated fermented proteins and the fermented polysaccharides in question. These very different products can be obtained using separation processes known per se, such as, for example, centrifugation, membrane filtration (microfiltration, ultrafiltration, nanofiltration), liquid-liquid or solid-phase extraction, chromatography, precipitation from solvents and the like. The microorganisms still contained in the fermentation products must, of course, be separated, destroyed or inactivated before being made up as end products. Known techniques such as thermal treatment (pasteurization, sterilization), cell destruction, microfiltration, centrifugation and the like can be considered. If fermented proteins are obtained as end products, they can either be used as solid precipitates or used as solutions by lowering the pH.
Kosmetische und/oder pharmazeutische ZubereitungenCosmetic and / or pharmaceutical preparations
Ein weiterer Gegenstand der Erfindung betrifft kosmetische und/oder pharmazeutische Zubereitungen, welche die neuen Wirkstoffe vorzugsweise in Mengen von 0,01 bis 5, insbesondere 0,1 bis 2 und besonders bevorzugt 0,5 bis 1 Gew.-% - bezogen auf die Mittel - enthalten. Gegebenfalls können die Fermentierungsprodukte vor der Einarbeitung in kosmetische und/oder pharmazeutische Mittel mit den üblichen Methoden in Mikro- oder Nanokapseln eingeschlossen werden.The invention further relates to cosmetic and / or pharmaceutical preparations which contain the new active ingredients preferably in amounts of 0.01 to 5, in particular 0.1 to 2 and particularly preferably 0.5 to 1% by weight, based on the composition - contain. If necessary, the fermentation products can be enclosed in micro- or nanocapsules prior to incorporation into cosmetic and / or pharmaceutical agents using the usual methods.
Die erfindungsgemäßen Zubereitungen, wie beispielsweise Haarshampoos, Haarlotionen, Schaumbäder, Duschbäder, Cremes, Gele, Lotionen, alkoholische und wäßrig/alkoholische Lösungen, Emulsionen, Wachs/ Fett-Massen, Stiftpräparaten, Pudern oder können ferner als weitere Hilfs- und Zusatzstoffe milde Tenside, Ölkörper, Emulgatoren, Perlglanzwachse, Konsistenzgeber, Verdickungsmittel, Überfettungsmittel, Stabilisatoren, Polymere, Siliconverbindungen, Fette, Wachse, Lecithine, Phospholipide, biogene Wirkstoffe, UV- Lichtschutzfaktoren, Antioxidantien, Deodorantien, Antitranspirantien, Antischuppenmittel, Filmbildner, Quellmittel, Insektenrepellentien, Selbstbräuner, Tyrosininhibitoren (Depigmen- tierungsmittel), Hydrotrope, Solubilisatoren, Konservierungsmittel, Parfümöle, Farbstoffe und dergleichen enthalten. TensideThe preparations according to the invention, such as, for example, hair shampoos, hair lotions, foam baths, shower baths, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations, powders or can also be used as further auxiliaries and additives, mild surfactants, Oil bodies, emulsifiers, pearlescent waxes, consistency enhancers, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic agents, UV light protection factors, antioxidants, deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, self-repellant inhibitors (Depigmenting agent), hydrotropes, solubilizers, preservatives, perfume oils, dyes and the like. surfactants
Als oberflächenaktive Stoffe können anionische, nichtionische, kationische und/oder ampho- tere bzw. zwitterionische Tenside enthalten sein, deren Anteil an den Mitteln üblicherweise bei etwa 1 bis 70, vorzugsweise 5 bis 50 und insbesondere 10 bis 30 Gew.-% beträgt. Typische Beispiele für anionische Tenside sind Seifen, Alkylbenzolsulfonate, Alkansulfonate, Ole- finsulfonate, Alkylethersulfonate, Glycerinethersulfonate, α-Methylestersulfonate, Sul- fofettsäuren, Alkylsulfate, Fettalkoholethersulfate, Glycerinethersulfate, Fettsäureethersulfa- te, Hydroxymischethersulfate, Monoglycerid(ether)sulfate, Fettsäureamid(ether)sulfate, Mono- und Dialkylsulfosuccinate, Mono- und Dialkylsulfosuccinamate, Sulfotriglyceride, Amid- seifen, Ethercarbonsäuren und deren Salze, Fettsäureisethionate, Fettsäuresarcosinate, Fett- säuretauride, N-Acylaminosäuren, wie beispielsweise Acyllactylate, Acyltartrate, Acylgluta- mate und Acylaspartate, Alkyloligoglucosidsulfate, Proteinfettsäurekondensate (insbesondere pflanzliche Produkte auf Weizenbasis) und Alkyl(ether)phosphate. Sofern die anionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für nichtionische Tenside sind Fettalkoholpolyglycolether, Alk lphenolpolyglycolether, Fettsäurepoly- glycolester, Fettsäureamidpolyglycolether, Fettaminpolyglycolether, alkoxylierte Triglyceride, Mischether bzw. Mischformale, gegebenenfalls partiell oxidierte Alk(en)yloligoglykoside bzw. Glucoronsäurederivate, Fettsäure-N-alkylglucamide, Proteinhydrolysate (insbesondere pflanzliche Produkte auf Weizenbasis), Polyolfettsäureester, Zuckerester, Sorbitanester, Polysor- bate und Aminoxide. Sofern die nichtionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für kationische Tenside sind quartäre Ammoniumverbindungen, wie beispielsweise das Dimethyldistearylammoniumchlorid, und Esterquats, insbesondere quaternierte Fettsäuretrialkanolaminestersalze. Typische Beispiele für ampho- tere bzw. zwitterionische Tenside sind Alkylbetaine, Alkylamidobetaine, Aminopropionate, Aminoglycinate, Imidazoliniumbetaine und Sulfobetaine. Bei den genannten Tensiden handelt es sich ausschließlich um bekannte Verbindungen. Typische Beispiele für besonders geeignete milde, d.h. besonders hautverträgliche Tenside sind Fettalkoholpolyglycol- ethersulfate, Monoglyceridsulfate, Mono- und/oder Dialkylsulfosuccinate, Fettsäureisethionate, Fettsäuresarcosinate, Fettsäuretauride, Fettsäureglutamate, α-Olefinsulfonate, Ethercarbonsäuren, Alkyloligoglucoside, Fettsäureglucamide, Alkylamidobetaine, Amphoacetale und/oder Proteinfettsäurekondensate, letztere vorzugsweise auf Basis von Weizen proteinen. ÖlkörperAnionic, nonionic, cationic and / or amphoteric or zwitterionic surfactants may be present as surface-active substances, the proportion of which in the compositions is usually about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight. Typical examples of anionic surfactants are soaps, finsulfonate alkylbenzenesulfonates, alkanesulfonates, olefinsulfonates, alkyl ether sulfonates, glycerol ether, α-methyl ester sulfonates, sulfonic fofettsäuren, alkyl sulfates, fatty alcohol ether sulfates, Glycerol ether, Fettsäureethersulfa- te, Hydroxymischethersulfate, monoglyceride (ether) sulfates, fatty acid amide (ether) sulfates, mono- and dialkylsulfosuccinates, mono- and dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, N-acylamino acids, such as acyl lactylates, acyl sulfate acetic acid, acyl glolate glucosate, acyl glolate glycate, acyl glolate glucosate fate (especially vegetable products based on wheat) and alkyl (ether) phosphates. If the anionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or alkyl glucoramide acid, vegetable glucoramide acid derivatives, glucoronic acid protein derivatives, and glucoronic acid protein derivatives based on wheat), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides. If the nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts. Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds. Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are Fettalkoholpolyglycol- ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid taurides, fatty acid glutamates, α-olefin sulfonates, ethercarboxylic acids, alkyl oligoglucosides, fatty acid glucamides, alkylamidobetaines, amphoacetals and / or protein fatty acid condensates , the latter preferably based on wheat proteins. oil body
Als Ölkörper kommen beispielsweise Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 Kohlenstoffatomen, Ester von linearen C6-C22-Fettsäuren mit linearen oder verzweigten C6-C 2-Fettalkoholen bzw. Ester von verzweigten C6-Cι3- Carbonsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen, wie z.B. Myristylmyristat, Myristylpalmitat, Myristylstearat, Myristylisostearat, Myristyloleat, Myrist lbehenat, Myristyle- rucat, Cetylmyristat, Cetylpalmitat, Cetylstearat, Cetylisostearat, Cetyloleat, Cetylbehenat, Cetylerucat, Stearylmyristat, Stearylpalmitat, Stearylstearat, Stearylisostearat, Stearyloleat, Stearylbehenat, Stearylerucat, Isostearγlmyristat, Isostearylpa Imitat, Isostearylstearat, I- sostearylisostearat, Isostearγloleat, Isostearylbehenat, Isostear loleat, Oleylmyristat, Oleyl- palmitat, Oleylstearat, Oleylisostearat, Oleyloleat, Oleylbehenat, Oleylerucat, Behenylmy- ristat, Behenylpalmitat, Behenylstearat, Behenylisostearat, Behenyloleat, Behenylbehenat, Behenylerucat, Erucylmyristat, Erucylpalmitat, Erucylstearat, Erucylisostearat, Erucyloleat, Erucylbehenat und Erucylerucat. Daneben eignen sich Ester von linearen C6-C22-Fettsäuren mit verzweigten Alkoholen, insbesondere 2-Ethylhexanol, Ester von Cι8-C38-Alkylhy- droxycarbonsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen, insbesondere Dioctyl Malate, Ester von linearen und/oder verzweigten Fettsäuren mit mehrwertigen Alkoholen (wie z.B. Propylenglycol, Dimerdiol oder Trimertriol) und/oder Guerbetalkoholen, Triglyceride auf Basis C6-Cι0-Fettsäuren, flüssige Mono-/Di-/Triglyceridmischungen auf Basis von C6-Cι8- Fettsäuren, Ester von C6-C22-Fettalkoholen und/oder Guerbetalkoholen mit aromatischen Carbonsäuren, insbesondere Benzoesäure, Ester von C2-Cι2-Dicarbonsäuren mit linearen o- der verzweigten Alkoholen mit 1 bis 22 Kohlenstoffatomen oder Polyolen mit 2 bis 10 Kohlenstoffatomen und 2 bis 6 Hydroxylgruppen, pflanzliche Öle, verzweigte primäre Alkohole, substituierte Cyclohexane, lineare und verzweigte C6-C22-Fettalkoholcarbonate, wie z.B. Dicaprylyl Carbonate (Cetiol® CC), Guerbetcarbonate auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 C Atomen, Ester der Benzoesäure mit linearen und/oder verzweigten Cs-C22-Alkoholen (z.B. Finsolv® TN), lineare oder verzweigte, symmetrische oder unsymmetrische Dialkylether mit 6 bis 22 Kohlenstoffatomen pro Alkylgruppe, wie z.B. Dicaprylyl Ether (Cetiol® OE), Ringöffnungsprodukte von epoxidierten Fettsäureestern mit Polyolen, Siliconöle (Cyclomethicone, Siliciummethicontypen u.a.) und/oder aliphatische bzw. naphthenische Kohlenwasserstoffe, wie z.B. wie Squalan, Squalen oder Dialkylcyclohexane in Betracht. EmulgatorenGuerbet alcohols based on fatty alcohols with 6 to 18, preferably 8 to 10 carbon atoms, esters of linear C 6 -C 22 fatty acids with linear or branched C 6 -C 2 fatty alcohols or esters of branched C 6 -Cι come as oil bodies, for example 3 - carboxylic acids with linear or branched C 6 -C 22 -fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristylisostearat, myristyl, Myrist lbehenat, rucat Myristyle-, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearylmyristat, stearyl, stearyl, Stearylisostearat, stearyl, stearyl, Stearylerucat, Isostearγlmyristat, Isostearylpa imitation Isostearylstearat, I sostearylisostearat, Isostearγloleat, isostearyl behenate, Isostear loleat, oleyl, oleyl palmitate, oleyl stearate, oleyl isostearate ristat, oleate, Oleylbehenat, oleyl, Behenylmy-, Behenyl palmitate, behenyl stearate, behenyl isostearate, Be henyl oleate, behenyl behenate, behenylerucate, erucyl myristate, erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl erucate. In addition, esters of linear C 6 -C 22 fatty acids with branched alcohols, especially 2-ethylhexanol, esters of C 8 -C 38 alkyl hydroxy carboxylic acids with linear or branched C 6 -C 22 fatty alcohols, especially dioctyl malates, esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on C 6 -Cι 0 fatty acids, liquid mono- / di- / triglyceride mixtures based on C 6 -Cι 8 - Fatty acids, esters of C 6 -C 22 fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C 2 -C 2 -dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C 6 -C 22 fatty alcohol carbonates, such as dicaprylyl carb onates (Cetiol® CC), Guerbet carbonates based on fatty alcohols with 6 to 18, preferably 8 to 10 C atoms, esters of benzoic acid with linear and / or branched Cs-C 22 alcohols (eg Finsolv® TN), linear or branched, symmetrical or asymmetrical dialkyl ethers with 6 to 22 carbon atoms per alkyl group, such as dicaprylyl ether (Cetiol® OE), ring opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicon methicone types etc.) and / or aliphatic or naphthenic hydrocarbons such as squalane, Squalene or dialkylcyclohexanes. emulsifiers
Als Emulgatoren kommen beispielsweise nichtionogene Tenside aus mindestens einer der folgenden Gruppen in Frage:Examples of suitable emulsifiers are nonionic surfactants from at least one of the following groups:
> Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/ oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen, an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe sowie Alkylamine mit 8 bis 22 Kohlenstoffatomen im Alkylrest;> Adducts of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide with linear fatty alcohols with 8 to 22 carbon atoms, with fatty acids with 12 to 22 carbon atoms, with alkylphenols with 8 to 15 carbon atoms in the alkyl group and Alkylamines with 8 to 22 carbon atoms in the alkyl radical;
> Alkyl- und/oder Alkenyloligoglykoside mit 8 bis 22 Kohlenstoffatomen im Alk(en)ylrest und deren ethoxylierte Analoga;> Alkyl and / or alkenyl oligoglycosides with 8 to 22 carbon atoms in the alk (en) yl radical and their ethoxylated analogs;
> Anlagerungsprodukte von 1 bis 15 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 1 to 15 moles of ethylene oxide with castor oil and / or hardened castor oil;
> Anlagerungsprodukte von 15 bis 60 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 15 to 60 moles of ethylene oxide with castor oil and / or hardened castor oil;
> Partialester von Glycerin und/oder Sorbitan mit ungesättigten, linearen oder gesättigten, verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of glycerol and / or sorbitan with unsaturated, linear or saturated, branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
> Partialester von Polyglycerin (durchschnittlicher Eigenkondensationsgrad 2 bis 8), Poly- ethylenglycol (Molekulargewicht 400 bis 5000), Trimethylolpropan, Pentaerythrit, Zuckeralkoholen (z.B. Sorbit), Alkylglucosiden (z.B. Methylglucosid, Butylglucosid, Lau- rylglucosid) sowie Polyglucosiden (z.B. Cellulose) mit gesättigten und/oder ungesättigten, linearen oder verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) (e.g. cellulose) saturated and / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 mol ethylene oxide;
> Mischester aus Pentaerythrit, Fettsäuren, Citronensaure und Fettalkohol und/oder Mischester von Fettsäuren mit 6 bis 22 Kohlenstoffatomen, Methylglucose und Polyolen, vorzugsweise Glycerin oder Polyglycerin.> Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol and / or mixed esters of fatty acids with 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol.
> Mono-, Di- und Trialkylphosphate sowie Mono-, Di- und/oder Tri-PEG-alkylphosphate und deren Salze;> Mono-, di- and trialkyl phosphates and mono-, di- and / or tri-PEG-alkyl phosphates and their salts;
> Wollwachsalkohole;> Wool wax alcohols;
> Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;> Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives;
> Block-Copolymere z.B. Polyethylenglycol-30 Dipolyhydroxystearate;> Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
> Polymeremulgatoren, z.B. Pemulen-Typen (TR-l/TR-2) von Goodrich;> Polymer emulsifiers, e.g. Pemulen types (TR-1 / TR-2) from Goodrich;
> Polyalkylenglycole sowie> Polyalkylene glycols as well
> Glycerincarbonat. > Ethylenoxidanlagerungsprodukte> Glycerine carbonate. > Ethylene oxide addition products
Die Anlagerungsprodukte von Ethylenoxid und/oder von Propylenoxid an Fettalkohole, Fettsäuren, Alkylphenole oder an Ricinusöl stellen bekannte, im Handel erhältliche Produkte dar. Es handelt sich dabei um Homologengemische, deren mittlerer Alkoxy- lierungsgrad dem Verhältnis der Stoffmengen von Ethylenoxid und/ oder Propylenoxid und Substrat, mit denen die Anlagerungsreaktion durchgeführt wird, entspricht. C12 18- Fettsäuremono- und -diester von Anlagerungsprodukten von Ethylenoxid an Glycerin sind als Rückfettungsmittel für kosmetische Zubereitungen bekannt.The adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are mixtures of homologs whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. C 12 18 - fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known as refatting agents for cosmetic preparations.
> Alkyl- und/oder Alkenyloligoglykoside> Alkyl and / or alkenyl oligoglycosides
Alkyl- und/oder Alkenyloligoglycoside, ihre Herstellung und ihre Verwendung sind aus dem Stand der Technik bekannt. Ihre Herstellung erfolgt insbesondere durch Umsetzung von Glucose oder Oligosacchariden mit primären Alkoholen mit 8 bis 18 Kohlenstoffatomen. Bezüglich des Glycosidrestes gilt, daß sowohl Monoglycoside, bei denen ein cycli- scher Zuckerrest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Gly- coside mit einem Oligomerisationsgrad bis vorzugsweise etwa 8 geeignet sind. Der Oli- gomerisierungsgrad ist dabei ein statistischer Mittelwert, dem eine für solche technischen Produkte übliche Homologenverteilung zugrunde liegt.Alkyl and / or alkenyl oligoglycosides, their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms. With regard to the glycoside residue, both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable. The degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
> Partialglyceride> Partial glycerides
Typische Beispiele für geeignete Partialglyceride sind Hydroxystearinsäuremonoglycerid, Hydroxystearinsäurediglycerid, Isostearinsäuremonoglycerid, Isostearinsäurediglycerid, Ölsäuremonoglycerid, Ölsäurediglycerid, Ricinolsäuremoglycerid, Ricinolsäurediglycerid, Linolsäuremonoglycerid, Linolsäurediglycerid, Linolensäuremonoglycerid, Linolensäure- diglycerid, Erucasäuremonoglycerid, Erucasäurediglycerid, Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglycerid, Äpfelsäuremo- noglycerid, Apfelsäurediglycerid sowie deren technische Gemische, die untergeordnet aus dem Herstellungsprozeß noch geringe Mengen an Triglycerid enthalten können. E- benfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol E- thylenoxid an die genannten Partialglyceride. > SorbitanesterTypical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, hydroxystearic acid diglyceride, isostearic acid, Isostearinsäurediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolsäuremoglycerid, Ricinolsäurediglycerid, Linolsäuremonoglycerid, Linolsäurediglycerid, Linolensäuremonoglycerid, linolenic acid diglyceride, Erucasäuremonoglycerid, Erucasäurediglycerid, Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglycerid, Äpfelsäuremo- noglycerid, Apfelsäurediglycerid and their technical mixtures, which may still contain small amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the partial glycerides mentioned are also suitable. > Sorbitan esters
Als Sorbitanester kommen Sorbitanmonoisostearat, Sorbitansesquiisostearat, Sorbitan- diisostearat, Sorbitantriisostearat, Sorbita nmonooleat, Sorbitansesquioleat, Sorbitan- dioleat, Sorbitantrioleat, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, Sorbi- tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat, Sorbitansesqui- tartrat, Sorbitanditartrat, Sorbitantritartrat, Sorbitanmonocitrat, Sorbitansesquicitrat, Sorbitandicitrat, Sorbitantricitrat, Sorbitanmonomaleat, Sorbitansesquimaleat, Sorbitan- dimaleat, Sorbitantrimaleat sowie deren technische Gemische. Ebenfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol Ethylenoxid an die genannten Sorbitanester.As sorbitan sorbitan, sorbitan sesquiisostearate, sorbitan come diisostearate, sorbitan triisostearate, Sorbita nmonooleat monooleate, sorbitan dioleate, trioleate, Sorbitanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sorbitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitansesquihydroxystearat, sorbitan tandihydroxystearat, Sorbitantrihydroxystearat, Sorbitan monotartrate, sorbitan sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan dicitrate, sorbitan tricitrate, sorbitan monomaleate, sorbitan sesquimaleate, sorbitan dimalate and technical sorbitan trimaleate, sorbitan trimaleate Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the sorbitan esters mentioned are also suitable.
> Polyglycerinester> Polyglycerol esters
Typische Beispiele für geeignete Polyglycerinester sind Polyglyceryl-2 Dipolyhydroxystea- rate (Dehymuls® PGPH), Polyglycerin-3-Diisostearate (Lameform® TGI), Polyglyceryl-4 Isostearate (Isolan® GI 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Dii- sostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cre- mophor® GS 32) und Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Di- merate Isostearate sowie deren Gemische. Beispiele für weitere geeignete Polyolester sind die gegebenenfalls mit 1 bis 30 Mol Ethylenoxid umgesetzten Mono-, Di- und Triester von Trimethylolpropan oder Pentaerythrit mit Laurinsäure, Kokosfettsäure, Taigfettsäure, Palmitinsäure, Stearinsäure, Ölsäure, Behensäure und dergleichen.Typical examples of suitable polyglycerol esters are polyglyceryl-2 dipolyhydroxystearates (Dehymuls® PGPH), polyglycerol-3-diisostearates (Lameform® TGI), polyglyceryl-4 isostearates (Isolan® GI 34), polyglyceryl-3 oleates, diisostearoyl polyglyceryl-3 dihydrogen - sostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Creophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Isostearate and their mixtures. Examples of other suitable polyol esters are the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, taig fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
> Anionische Emulgatoren> Anionic emulsifiers
Typische anionische Emulgatoren sind aliphatische Fettsäuren mit 12 bis 22 Kohlenstoffatomen, wie beispielsweise Palmitinsäure, Stearinsäure oder Behensäure, sowie Dicar- bonsäuren mit 12 bis 22 Kohlenstoffatomen, wie beispielsweise Azelainsäure oder Seba- cinsäure. > Amphotere und kationische EmulgatorenTypical anionic emulsifiers are aliphatic fatty acids with 12 to 22 carbon atoms, such as, for example, palmitic acid, stearic acid or behenic acid, and dicarboxylic acids with 12 to 22 carbon atoms, such as, for example, azelaic acid or sebacic acid. > Amphoteric and cationic emulsifiers
Weiterhin können als Emulgatoren zwitterionische Tenside verwendet werden. Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine Carboxylat- und eine Sulfonatgruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Alkyl-N,N-dimethylammoniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acylaminopropyl-N,N-dimethylammonium- glycinate, beispielsweise das Kokosacylaminopropyldimethyl-ammoniumglycinat, und 2- Alkyl-3-carboxylmethyl-3-hydroxyethylimidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethyl- glycinat. Besonders bevorzugt ist das unter der CTFA-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat. Ebenfalls geeignete Emulgatoren sind ampholyti- sche Tenside. Unter ampholytischen Tensiden werden solche oberflächenaktiven Verbindungen verstanden, die außer einer C8/i8-Alkyl- oder Acylgruppe im Molekül mindestens eine freie Aminogruppe und mindestens eine -COOH- oder -SO3H-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylpropion-säuren, N-Alkylaminobuttersäuren, N- Alkyliminodipropionsäuren, N-Hydroxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 18 C-Atomen in der Alkylgruppe.. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropionat und das Cι2/i8~Acylsarcosin. Schließlich kommen auch Kationtenside als Emulgatoren in Betracht, wobei solche vom Typ der Esterquats, vorzugsweise methylquaternierte Difettsäu- retriethanolaminester-Salze, besonders bevorzugt sind.Zwitterionic surfactants can also be used as emulsifiers. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-alkyl-N, N-dimethylammonium glycinate, for example the coconut alkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the coconut acylaminopropyldimethylammonium glycinate, and 2-alkyl-3-carboxylm -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. The fatty acid amide derivative known under the CTFA name of Cocamidopropyl Betaine is particularly preferred. Suitable emulsifiers are ampholytic surfactants. Ampholytic surfactants are surface-active compounds which, apart from a C i8-alkyl or acyl group, contain at least contain a free amino group and at least one -COOH or -SO 3 H group 8 / and are capable of forming inner salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group .. Particularly preferred ampholytic surfactants are the N-cocoalkylaminopropionate, the cocoacylaminoethylaminopropionate and the C 2 / i 8 ~ acyl sarcosine. Finally, cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
Fette und WachseFats and waxes
Typische Beispiele für Fette sind Glyceride, d.h. feste oder flüssige pflanzliche oder tierische Produkte, die im wesentlichen aus gemischten Glycerinestern höherer Fettsäuren bestehen, als Wachse kommen u.a. natürliche Wachse, wie z.B. Candelillawachs, Carnaubawachs, Japanwachs, Espartog raswachs, Korkwachs, Guarumawachs, Reiskeimölwachs, Zuckerrohrwachs, Ouricurywachs, Montanwachs, Bienenwachs, Schellackwachs, Walrat, Lanolin (Wollwachs), Bürzelfett, Ceresin, Ozokerit (Erdwachs), Petrolatum, Paraffinwachse, Mikrowachse; chemisch modifizierte Wachse (Hartwachse), wie z.B. Montanesterwachse, Sasolwachse, hydrierte Jojobawachse sowie synthetische Wachse, wie z.B. Polyalkylenwachse und Polye- thylenglycolwachse in Frage. Neben den Fetten kommen als Zusatzstoffe auch fettähnliche Substanzen, wie Lecithine und Phospholipide in Frage. Unter der Bezeichnung Lecithine versteht der Fachmann diejenigen Glycero-Phospholipide, die sich aus Fettsäuren, Glycerin, Phosphorsäure und Cholin durch Veresterung bilden. Lecithine werden in der Fachwelt daher auch häufig als Phosphatidylcholine (PC). Als Beispiele für natürliche Lecithine seien die Kephaline genannt, die auch als Phosphatidsäuren bezeichnet werden und Derivate der 1,2- Diacyl-sn-glycerin-3-phosphorsäuren darstellen. Dem gegenüber versteht man unter Phospholipiden gewöhnlich Mono- und vorzugsweise Diester der Phosphorsäure mit Glycerin (Glycerinphosphate), die allgemein zu den Fetten gerechnet werden. Daneben kommen auch Sphingosine bzw. Sphingolipide in Frage.Typical examples of fats are glycerides, ie solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids, waxes include natural waxes, such as candelilla wax, carnauba wax, Japanese wax, espresso wax, cork wax, guaruma wax, rice germ oil wax, Sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walnut, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, micro waxes; chemically modified waxes (hard waxes), such as, for example, montan ester waxes, Sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as, for example, polyalkylene waxes and polyethylene glycol waxes. In addition to fats, fat-like substances such as lecithins and phospholipids can also be used as additives. The person skilled in the art understands the term lecithins as those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC). Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids. In contrast, phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats. In addition, sphingosines or sphingolipids are also suitable.
Perlglanzwachsepearlescent
Als Perlglanzwachse kommen beispielsweise in Frage: Alkylenglycolester, speziell Ethylengly- coldistearat; Fettsäurealkanolamide, speziell Kokosfettsäurediethanolamid; Partialglyceride, speziell Stearinsäuremonoglycerid; Ester von mehrwertigen, gegebenenfalls hydroxy- substituierte Carbonsäuren mit Fettalkoholen mit 6 bis 22 Kohlenstoffatomen, speziell lang- kettige Ester der Weinsäure; Fettstoffe, wie beispielsweise Fettalkohole, Fettketone, Fettaldehyde, Fettether und Fettcarbonate, die in Summe mindestens 24 Kohlenstoffatome aufweisen, speziell Lauron und Distearylether; Fettsäuren wie Stearinsäure, Hydroxystearinsäu- re oder Behensäure, Ringöffnungsprodukte von Olefinepoxiden mit 12 bis 22 Kohlenstoffatomen mit Fettalkoholen mit 12 bis 22 Kohlenstoffatomen und/oder Polyolen mit 2 bis 15 Kohlenstoffatomen und 2 bis 10 Hydroxylgruppen sowie deren Mischungen.Pearlescent waxes, for example, are: alkylene glycol esters, especially ethylene glycol stearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols having 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.
Konsistenzgeber und VerdickungsmittelConsistency agents and thickeners
Als Konsistenzgeber kommen in erster Linie Fettalkohole oder Hydroxyfettalkohole mit 12 bis 22 und vorzugsweise 16 bis 18 Kohlenstoffatomen und daneben Partialglyceride, Fettsäuren oder Hydroxyfettsäuren in Betracht. Bevorzugt ist eine Kombination dieser Stoffe mit Alkylo- ligoglucosiden und/oder Fettsäure-N-methylglucamiden gleicher Kettenlänge und/oder Po- lyglycerinpoly-12-hydroxystearaten. Geeignete Verdickungsmittel sind beispielsweise Aerosil- Typen (hydrophile Kieselsäuren), Polysaccharide, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Alginate und Tylosen, Carboxymethylcellulose und Hydroxyethyl- und Hydro- xypropylcellulose, ferner höhermolekulare Polyethylenglycolmono- und -diester von Fettsäuren, Polyacrylate, (z.B. Carbopole® und Pemulen-Typen von Goodrich; Synthalene® von Sigma; Keltrol-Typen von Kelco; Sepigel-Typen von Seppic; Salcare-Typen von Allied Col- loids), Polyacrylamide, Polymere, Polyvinylalkohol und Polyvinylpyrrolidon. Als besonders wirkungsvoll haben sich auch Bentonite, wie z.B. Bentone® Gel VS-5PC (Rheox) erwiesen, bei dem es sich um eine Mischung aus Cyclopentasiloxan, Disteardimonium Hectorit und Propylencarbonat handelt. Weiter in Frage kommen Tenside, wie beispielsweise ethoxylierte Fettsäureglyceride, Ester von Fettsäuren mit Polyolen wie beispielsweise Pentaerythrit oder Trimethylolpropan, Fettalkoholethoxylate mit eingeengter Homologenverteilung oder Alkylo- ligoglucoside sowie Elektrolyte wie Kochsalz und Ammoniumchlorid.Suitable consistency agents are primarily fatty alcohols or hydroxy fatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and, in addition, partial glycerides, fatty acids or hydroxy fatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred. Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl and hydro- xypropyl cellulose, also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, (eg Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Coloid ), Polyacrylamides, polymers, polyvinyl alcohol and polyvinyl pyrrolidone. Bentonites such as Bentone® Gel VS-5PC (Rheox), which is a mixture of cyclopentasiloxane, disteardimonium hectorite and propylene carbonate, have also proven to be particularly effective. Surfactants such as, for example, ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as, for example, pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyloligoglucosides and electrolytes such as sodium chloride and ammonium chloride are also suitable.
Überfettungsmittelsuperfatting
Als Überfettungsmittel können Substanzen wie beispielsweise Lanolin und Lecithin sowie polyethoxylierte oder acylierte Lanolin- und Lecithinderivate, Polyolfettsäureester, Monogly- ceride und Fettsäurealkanolamide verwendet werden, wobei die letzteren gleichzeitig als Schaumstabilisatoren dienen.Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
Stabilisatorenstabilizers
Als Stabilisatoren können Metallsalze von Fettsäuren, wie z.B. Magnesium-, Aluminium- und/oder Zinkstearat bzw. -ricinoleat eingesetzt werden.Metal salts of fatty acids, such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate are used.
Polymerepolymers
Geeignete kationische Polymere sind beispielsweise kationische Cellulosederivate, wie z.B. eine quaternierte Hydroxyethylcellulose, die unter der Bezeichnung Polymer JR 400® von Amerchol erhältlich ist, kationische Stärke, Copolymere von Diallylammoniumsalzen und Ac- rylamiden, quaternierte Vinylpyrrolidon/Vinylimidazol-Polymere, wie z.B. Luviquat® (BASF), Kondensationsprodukte von Polyglycolen und Aminen, quaternierte Kollagenpolypeptide, wie beispielsweise Lauryldimonium Hydroxypropyl Hydrolyzed Collagen (Lamequat®L/Grünau), quaternierte Weizenpolypeptide, Polyethylenimin, kationische Siliconpolymere, wie z.B. Amo- dimethicone, Copolymere der Adipinsäure und Dimethylaminohydroxypropyldiethylentriamin (Cartaretine®/Sandoz), Copolymere der Acrylsäure mit Dimethyl-diallylammoniumchlorid (Merquat® 550/Chemviron), Polyaminopolyamide, sowie deren vernetzte wasseήösϊichen Polymere, kationische Chitinderivate wie beispielsweise quatemiertes Chitosan, gegebenenfalls mikrokristallin verteilt, Kondensationsprodukte aus Dihalogenalkylen, wie z.B. Dibrom- butan mit Bisdialkylaminen, wie z.B. Bis-Dimethylamino-l,3-propan, kationischer Guar-Gum, wie z.B. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 der Firma Celanese, quaternierte Ammoniumsalz-Polymere, wie z.B. Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 der Firma Miranol.Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available from Amerchol under the name Polymer JR 400®, cationic starch, copolymers of diallylammonium salts and acrylic amides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® ( BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides, such as, for example, lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers, such as amodimethicone, copolymers of adipic acid and cartiethydroxyaminodiamine (sandethylaraminohydroxy) ), Copolymers of acrylic acid with dimethyl-diallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides, and their cross-linked water-soluble Polymers, cationic chitin derivatives such as, for example, quaternized chitosan, optionally microcrystalline, condensation products of dihaloalkylene, such as, for example, dibromobutane with bisdialkylamines, such as, for example, bis-dimethylamino-1,3-propane, cationic guar gum, such as, for example, Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternized ammonium salt polymers such as Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol.
Als anionische, zwitterionische, amphotere und nichtionische Polymere kommen beispielsweise Vinylacetat/Crotonsäure-Copolymere, Vinylpyrrolidon/Vinylacrylat-Copolymere, Vinylace- tat/Butylmaleat/ Isobornylacrylat-Copolymere, Methylvinylether/Maleinsäureanhydrid-Copoly- mere und deren Ester, unvernetzte und mit Polyolen vernetzte Polyacrylsäuren, Acrylamido- propyltrimethylammoniumchlorid/ Acrylat-Copolymere, Octylacrylamid/Methylmeth-acry- lat/tert.Butylaminoethylmethacrylat/2-Hydroxypropylmethacrylat-Copolymere, Polyvinylpyr- rolidon, Vinylpyrrolidon/Vinylacetat-Copolymere, Vinylpyrrolidon/ Dimethylaminoethyl- methacrylat/Vinylcaprolactam-Terpolymere sowie gegebenenfalls derivatisierte Celluloseether und Silicone in Frage.Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinylpyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobornyl acrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and polyesters and their esters, uncrosslinked , Acrylamido-propyltrimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert.butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / teraminate / vinyl acrylate methacrylate / vinyl methacrylate methacrylate / methacrylate vinyl amide / dimethylamino-cellulose methacrylate and / or methyl-acrylate-methyl-acrylate-methacrylate-methyl-methacrylate-methyl-acrylate-methacrylate-methacrylate-methyl-acrylate-methacrylate and / or methyl-acrylate-methyl-acrylate-methyl-acrylate-methyl-acrylate-and-methyl-acrylate-methyl-methacrylate-methyl-acrylate-and-methyl-methacrylate and silicones in question.
Siliconverbindungensilicone compounds
Geeignete Siliconverbindungen sind beispielsweise Dimethylpolysiloxane, Methylphenylpoly- siloxane, cyclische Silicone sowie amino-, fettsäure-, alkohol-, polyether-, epoxy-, fluor-, gly- kosid- und/oder alkylmodifizierte Siliconverbindungen, die bei Raumtemperatur sowohl flüssig als auch harzförmig vorliegen können. Weiterhin geeignet sind Simethicone, bei denen es sich um Mischungen aus Dimethiconen mit einer durchschnittlichen Kettenlänge von 200 bis 300 Dimethylsiloxan-Einheiten und hydrierten Silicaten handelt.Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino, fatty acid, alcohol, polyether, epoxy, fluorine, glycoside and / or alkyl modified silicone compounds which are both liquid and resinous at room temperature can. Simethicones, which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
UV-Lichtschutzfilter und AntioxidantienUV light protection filters and antioxidants
Unter UV-Lichtschutzfaktoren sind beispielsweise bei Raumtemperatur flüssig oder kristallin vorliegende organische Substanzen (Lichtschutzfilter) zu verstehen, die in der Lage sind, ultraviolette Strahlen zu absorbieren und die aufgenommene Energie in Form längerwelliger Strahlung, z.B. Wärme wieder abzugeben. UVB-Filter können öllöslich oder wasserlöslich sein. Als öllösliche Substanzen sind z.B. zu nennen:UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and absorb the energy absorbed in the form of longer-wave radiation, e.g. To give off heat again. UVB filters can be oil-soluble or water-soluble. As oil-soluble substances e.g. to call:
> 3-Benzylidencampher bzw. 3-Benzylidennorcampher und dessen Derivate, z.B. 3-(4- Methylbenzyliden)campher; > 4-Aminobenzoesäurederivate, vorzugsweise 4-(Dimethylamino)benzoesäure-2-ethyl- hexylester, 4-(Dimethylamino)benzoesäure-2-octylester und 4-(Dimethylamino)benzoe- säureamylester;> 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives, for example 3- (4-methylbenzylidene) camphor; > 4-aminobenzoic acid derivatives, preferably 2-ethyl-hexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
> Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester, 4-Methoxy- zimtsäurepropylester, 4-Methoxyzimtsäureisoamylester 2~Cyano-3,3-phenylzimtsäure-2- ethylhexylester (Octocrylene);> Esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2 ~ cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
> Ester der Salicylsäure, vorzugsweise Salicylsäure-2-ethylhexylester, Salicylsäure-4-iso- propylbenzylester, Salicylsäurehomomenthylester;> Esters of salicylic acid, preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-isopropylbenzyl ester, salicylic acid homomethyl ester;
> Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2- Hydroxy-4-methoxy-4Λ-methylbenzophenon, 2,2-Dihydroxy-4-methoxybenzophenon;> Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4 Λ -methylbenzophenone, 2,2-dihydroxy-4-methoxybenzophenone;
> Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzmalonsäuredi-2-ethylhexyl- ester;> Esters of benzalmalonic acid, preferably 4-methoxybenzmalonic acid di-2-ethylhexyl ester;
> Triazinderivate, wie z.B. 2,4,6-Trianilino-(p-carbo~2,-ethyl-f-hexyloxy)-l,3,5-triazin und Octyl Triazon oder Dioctyl Butamido Triazone (Uvasorb® HEB);> Triazine derivatives, such as, for example, 2,4,6-trianilino- (p-carbo ~ 2 , -ethyl-f-hexyloxy) -l, 3,5-triazine and octyl triazone or dioctyl butamido triazone (Uvasorb® HEB);
> Propan-l,3-dione, wie z.B. l-(4-tert.Butylphenyl)-3-(4λmethoxyphenyl)propan-l,3-dion;> Propane-l, 3-diones, such as l- (4-tert-butylphenyl) -3- (4 λ methoxyphenyl) propan-l, 3-dione;
> Ketotricyclo(5.2.1.0)decan-Derivate.> Ketotricyclo (5.2.1.0) decane derivatives.
Als wasserlösliche Substanzen kommen in Frage:Possible water-soluble substances are:
> 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylam- monium-, Alkanolammonium- und Glucammoniumsalze;> 2-phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts;
> Sulfonsäurederivate von Benzophenonen, vorzugsweise 2-Hydroxy-4-methoxybenzo- phenon-5-sulfonsäure und ihre Salze;> Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzophenone-5-sulfonic acid and its salts;
> Sulfonsäurederivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornylidenme- thyl)benzolsulfonsäure und 2-Methyl-5-(2-oxo-3-bomyliden)sulfonsäure und deren Salze.> Sulfonic acid derivatives of 3-benzylidene camphor, e.g. 4- (2-oxo-3-bornylidene-methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bomylidene) sulfonic acid and their salts.
Als typische UV-A-Filter kommen insbesondere Derivate des Benzoylmethans in Frage, wie beispielsweise l-(4λ-tert.Butylphenyl)-3-(4,-methoxyphenyl)propan-l,3-dion, 4-tert.-Butyl-4,- methoxydibenzoylmethan (Parsol® 1789), l-Phenyl-3-(4-isopropylphenyl)-propan-l,3-dion sowie Enaminverbindungen. Die UV-A und UV-B-Filter können selbstverständlich auch in Mischungen eingesetzt werden. Besonders günstige Kombinationen bestehen aus den Derivate des Benzoylmethans,, z.B. 4-tert.-Butyl-4,-methoxydibenzoylmethan (Parsol® 1789) und 2- Cyano-3,3-phenylzimtsäure-2-ethyl-hexylester (Octocrylene) in Kombination mit Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester und/oder 4- Methoxyzimtsäurepropylester und/oder 4-Methoxyzimtsäureisoamylester. Vorteilhaft werden deartige Kombinationen mit wasserlöslichen Filtern wie z.B. 2-Phenylbenzimidazol-5- sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylammonium-, Alkanolammonium- und Glucammoniumsalze kombiniert.Typical UV-A filters are, in particular, derivatives of benzoyl methane such as l- (4 λ -tert.Butylphenyl) -3- (4-methoxyphenyl) propan-l, 3-dione, 4-tert-butyl -4 , - methoxydibenzoylmethane (Parsol® 1789), l-phenyl-3- (4-isopropylphenyl) propane-l, 3-dione and enamine compounds. The UV-A and UV-B filters can of course also be used in mixtures. Particularly favorable combinations consist of the derivatives of benzoylmethane, for example 4-tert-butyl-4 , methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid 2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate and / or propyl 4-methoxycinnamate and / or isoamyl 4-methoxycinnamate. Such combinations with water-soluble filters such as 2-phenylbenzimidazole-5- are advantageous sulfonic acid and their alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts combined.
Neben den genannten löslichen Stoffen kommen für diesen Zweck auch unlösliche Lichtschutzpigmente, nämlich feindisperse Metalloxide bzw. Salze in Frage. Beispiele für geeignete Metalloxide sind insbesondere Zinkoxid und Titandioxid und daneben Oxide des Eisens, Zirkoniums, Siliciums, Mangans, Aluminiums und Cers sowie deren Gemische. Als Salze können Silicate (Talk), Bariumsulfat oder Zinkstearat eingesetzt werden. Die Oxide und Salze werden in Form der Pigmente für hautpflegende und hautschützende Emulsionen und dekorative Kosmetik verwendet. Die Partikel sollten dabei einen mittleren Durchmesser von weniger als 100 nm, vorzugsweise zwischen 5 und 50 nm und insbesondere zwischen 15 und 30 nm aufweisen. Sie können eine sphärische Form aufweisen, es können jedoch auch solche Partikel zum Einsatz kommen, die eine ellipsoide oder in sonstiger Weise von der sphärischen Gestalt abweichende Form besitzen. Die Pigmente können auch oberflächenbehandelt, d.h. hydrophilisiert oder hydrophobiert vorliegen. Typische Beispiele sind gecoatete Titandioxide, wie z.B. Titandioxid T 805 (Degussa) oder Eusolex® T2000 (Merck). Als hydrophobe Coatingmittel kommen dabei vor allem Silicone und dabei speziell Trialkoxyoctylsilane oder Simethicone in Frage. In Sonnenschutzmitteln werden bevorzugt sogenannte Mikro- oder Nanopigmente eingesetzt. Vorzugsweise wird mikronisiertes Zinkoxid verwendet.In addition to the soluble substances mentioned, insoluble light protection pigments, namely finely dispersed metal oxides or salts, are also suitable for this purpose. Examples of suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof. Silicates (talc), barium sulfate or zinc stearate can be used as salts. The oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics. The particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or shape which differs from the spherical shape in some other way. The pigments can also be surface treated, i.e. are hydrophilized or hydrophobized. Typical examples are coated titanium dioxides, e.g. Titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used.
Neben den beiden vorgenannten Gruppen primärer Lichtschutzstoffe können auch sekundäre Lichtschutzmittel vom Typ der Antioxidantien eingesetzt werden, die die photochemische Reaktionskette unterbrechen, welche ausgelöst wird, wenn UV-Strahlung in die Haut eindringt. Typische Beispiele hierfür sind Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryp- tophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Camosin, D-Camosin, L-Carnosin und deren Derivate (z.B. Anserin), Carotinoide, Caroti- ne (z.B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure), Aurothioglucose, Propylthiou- racil und andere Thiole (z.B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ- Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distea- rylthiodipropionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfoximine, Homocysteinsulfoximin, Butioninsulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen (z.B. pmol bis μmol/kg), ferner (Metall)-Chelatoren (z.B. α- Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lactoferrin), -Hydroxysäuren (z.B. Citronensaure, Milchsäure, Äpfelsäure), Huminsäure, Gallensäure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z.B. γ- Linolensäure, ünolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und Derivate (z.B. Ascorbylpalmitat, Mg-Ascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z.B. Vitamin-E-acetat), Vitamin A und Derivate (Vitamin-A-palmitat) sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, α-Glycosylrutin, Ferulasäure, Furfurylidenglucitol, Carnosin, Butylhydroxytoluol, Butyl- hydroxyanisol, Nordihydroguajakharzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophe- non, Harnsäure und deren Derivate, Mannose und deren Derivate, Superoxid-Dismutase, Zink und dessen Derivate (z.B. ZnO, ZnS04) Selen und dessen Derivate (z.B. Selen- Methionin), Stilbene und deren Derivate (z.B. Stilbenoxid, trans-Stilbenoxid) und die erfindungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nukleoside, Peptide und Lipide) dieser genannten Wirkstoffe.In addition to the two aforementioned groups of primary light stabilizers, secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin. Typical examples of this are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-camosine, D-camosine, L-carnosine and their derivatives (e.g. Anserine), carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (eg dihydrolipoic acid), aurothioglucose, propylthiou-racil and other thiols (eg thioredoxin, Glutathione, cysteine, cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters ) and their salts, dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and their derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, pentathion, hexa-, hexa-, heptoximine low compatible doses (e.g. pmol to μmol / kg), (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, oleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg-ascorbyl phosphate, ascorbyl acetate), Tocopherols and derivatives (eg vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) as well as coniferyl benzoate of benzoin, rutinic acid and its derivatives, α-glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytoluene, butylated hydroxyanisole, nordihydro acid , Nordihydroguajaretsäure, Trihydroxybutyrophe- non, uric acid and its derivatives, mannose and their derivatives, superoxide dismutase, zinc and its derivatives (eg ZnO, ZnS0 4 ) selenium and its derivatives (eg selenium methionine), stilbene and their derivatives (eg stilbene oxide , trans-stilbene oxide) and the derivatives suitable according to the invention (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) thereof Active substances.
Biogene WirkstoffeBiogenic agents
Unter biogenen Wirkstoffen sind beispielsweise Tocopherol, Tocopherolacetat, Tocopherol- palmitat, Ascorbinsäure, (Desoxy)Ribonucleinsäure und deren Fragmentierungsprodukte, ß- Glucane, Retinol, Bisabolol, Allantoin, Phytantriol, Panthenol, AHA-Säuren, Aminosäuren, Ceramide, Pseudoceramide, essentielle Öle, Pflanzenextrakte, wie z.B. Prunusextrakt, Bam- baranussextrakt und Vitaminkomplexe zu verstehen.Examples of biogenic active ingredients are tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, β-glucans, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudo-ceramides, essentielle ceramides, Plant extracts, such as To understand prunus extract, Bambaranus extract and vitamin complexes.
Deodorantien und keimhemmende MittelDeodorants and germ inhibitors
Kosmetische Deodorantien (Desodorantien) wirken Körpergerüchen entgegen, überdecken oder beseitigen sie. Körpergerüche entstehen durch die Einwirkung von Hautbakterien auf apokrinen Schweiß, wobei unangenehm riechende Abbauprodukte gebildet werden. Dementsprechend enthalten Deodorantien Wirkstoffe, die als keimhemmende Mittel, Enzyminhibitoren, Geruchsabsorber oder Geruchsüberdecker fungieren.Cosmetic deodorants counteract, mask or eliminate body odors. Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers.
> Keimhemmende Mittel> Germ inhibitors
Als keimhemmende Mittel sind grundsätzlich alle gegen grampositive Bakterien wirksamen Stoffe geeignet, wie z. B. 4-Hydroxybenzoesäure und ihre Salze und Ester, N-(4- Chlorphenyl)-N '-(3,4 dichlorphenyl)harnstoff, 2,4,4 '-Trichlor-2 '-hydroxy-diphenylether (Triclosan), 4-Chlor-3,5-dimethyl-phenol, 2,2'-Methylen-bis(6-brom-4-chlorphenol), 3- Methyl-4-(l-methylethyl)-phenol, 2-Benzyl-4-chlorphenol, 3-(4-Chlorphenoxy)-l,2- propandiol, 3-Iod-2-propinylbutylcarbamat, Chlorhexidin, 3,4,4 '-Trichlorcarbanilid (TTC), antibakterielle Riechstoffe, Thymol, Thymianöl, Eugenol, Nelkenöl, Menthol, Min- zöl, Farnesol, Phenoxyethanol, Glycerinmonocaprinat, Glycerinmonocaprylat, Glycerin- monolaurat (GML), Diglycerinmonocaprinat (DMC), Salicylsäure-N-alkylamide wie z, B. Salicylsäure-n-octylamid oder Salicylsäure-n-decylamid.In principle, all substances effective against gram-positive bacteria are suitable as germ-inhibiting agents, such as. B. 4-hydroxybenzoic acid and its salts and esters, N- (4-chlorophenyl) -N '- (3,4 dichlorophenyl) urea, 2,4,4' -Trichlor-2 '-hydroxy-diphenyl ether (Triclosan), 4-chloro-3,5-dimethylphenol, 2,2'-methylene-bis (6-bromo-4-chlorophenol), 3-methyl-4- (l-methylethyl) phenol, 2- Benzyl-4-chlorophenol, 3- (4-chlorophenoxy) -l, 2-propanediol, 3-iodo-2-propynyl butyl carbamate, chlorhexidine, 3,4,4 'trichlorocarbanilide (TTC), antibacterial fragrances, thymol, thyme oil, eugenol , Clove oil, menthol, mint oil, farnesol, phenoxyethanol, glycerol monocaprinate, glycerol monocaprylate, glycerol monolaurate (GML), diglycerol monocaprinate (DMC), salicylic acid-N-alkylamides such as, for example, salicylic acid-n-octylamide or decylamide acid ,
> Enzyminhibitoren> Enzyme inhibitors
Als Enzyminhibitoren sind beispielsweise Esteraseinhibitoren geeignet. Hierbei handelt es sich vorzugsweise um Trialkylcitrate wie Trimethylcitrat, Tripropylcitrat, Triisopropyl- citrat, Tributylcitrat und insbesondere Triethylcitrat (Hydagen® CAT). Die Stoffe inhibieren die Enzymaktivität und reduzieren dadurch die Geruchsbildung. Weitere Stoffe, die als Esteraseinhibitoren in Betracht kommen, sind Sterolsulfate oder -phosphate, wie beispielsweise Lanosterin-, Cholesterin-, Campesterin-, Stigmasterin- und Sitosterin- sulfat bzw -phosphat, Dicarbonsäuren und deren Ester, wie beispielsweise Glutarsäure, Glutarsäuremonoethylester, Glutarsäurediethylester, Adipinsäure, Adipinsäuremono- ethylester, Adipinsäurediethylester, Malonsäure und Malonsäurediethylester, Hydroxycarbonsäuren und deren Ester wie beispielsweise Citronensaure, Äpfelsäure, Weinsäure oder Weinsäurediethylester, sowie Zinkglycinat.Esterase inhibitors, for example, are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT). The substances inhibit enzyme activity and thereby reduce odor. Other substances which can be considered as esterase inhibitors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesteric, stigmasterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, glutaric acid monoethyl ester, glutaric acid diethyl ester, Adipic acid, adipic acid monoethyl ester, adipic acid diethyl ester, malonic acid and malonic acid diethyl ester, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester and zinc glycinate.
> Geruchsabsorber> Odor absorber
Als Geruchsabsorber eignen sich Stoffe, die geruchsbildende Verbindungen aufnehmen und weitgehend festhalten können. Sie senken den Partialdruck der einzelnen Komponenten und verringern so auch ihre Ausbreitungsgeschwindigkeit. Wichtig ist, daß dabei Parfüms unbeeinträchtigt bleiben müssen. Geruchsabsorber haben keine Wirksamkeit gegen Bakterien. Sie enthalten beispielsweise als Hauptbestandteil ein komplexes Zinksalz der Ricinolsäure oder spezielle, weitgehend geruchsneutrale Duftstoffe, die dem Fachmann als "Fixateure" bekannt sind, wie z. B. Extrakte von Labdanum bzw. Styrax oder bestimmte Abietinsäurederivate. Als Geruchsüberdecker fungieren Riechstoffe oder Parfümöle, die zusätzlich zu ihrer Funktion als Geruchsüberdecker den Deodorantien ihre jeweilige Duftnote verleihen. Als Parfümöle seien beispielsweise genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten, Stengeln und Blättern, Früchten, Fruchtschalen, Wurzeln, Hölzern, Kräutern und Gräsern, Nadeln und Zweigen sowie Harzen und Balsamen. Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindungen sind Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, p-tert.-Butylcyclohexylacetat, Linalylacetat, Phenylethylacetat, Linalylben- zoat, Benzylformiat, Allylcyclohexylpropionat, Styrallylpropionat und Benzylsalicylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Ketonen z.B. die Jo- none und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aromakomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamillenöl, Nelkenöl, Melissen- öl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetiveröl, Olibanöl, Gal- banumöl, Labdanumöl und Lavandinöl. Vorzugsweise werden Bergamotteöl, Dihydro- myrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzylaceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, Hedio- ne, Sandelice, Citronenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Salbeiöl, ß-Damascone, Geraniumöl Bourbon, Cyclohexylsalicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenylessigsäure, Geranylacetat, Benzylacetat, Rosenoxid, Romilat, Irotyl und Floramat allein oder in Mischungen, eingesetzt.Suitable odor absorbers are substances that absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixators", such as, for example, the main component. B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance. Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts from Flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether, the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, the ketones include, for example, the joonones and methylcedryl ketone, and the alcohols are anethole, Citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly used as aroma components, are also suitable as perfume oils, e.g. sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbaneum oil, labdanum oil and lavandin oil. Bergamot oil, dihydro myrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexyl cinnamaldehyde, geraniol, benzylacetone, cyclamen aldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, citric oil, mandarin allyl oil, mandarin amine oil, orlamine oil, orlamine oil, orlamine oil, orlamine oil, orlamine oil, oramine oil, are preferred , Lavandin oil, muscatel sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilate, irotyl and floramate alone or in mixtures, alone or in mixtures, used.
Antitranspirantienantiperspirants
Antitranspirantien (Antiperspirantien) reduzieren durch Beeinflussung der Aktivität der ekkrinen Schweißdrüsen die Schweißbildung, und wirken somit Achselnässe und Körpergeruch entgegen. Wässrige oder wasserfreie Formulierungen von Antitranspirantien enthalten typischerweise folgende Inhaltsstoffe:Antiperspirants (antiperspirants) reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor. Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
> adstringierende Wirkstoffe,> astringent active ingredients,
> Ölkomponenten,> Oil components,
> nichtionische Emulgatoren, > Coemulgatoren,> nonionic emulsifiers, > Co-emulsifiers,
> Konsistenzgeber,> Consistency generator,
> Hilfsstoffe wie z. B. Verdicker oder Komplexierungsmittel und/oder> Auxiliaries such as B. thickeners or complexing agents and / or
> nichtwässrige Lösungsmittel wie z. B. Ethanol, Propylenglykol und/oder Glycerin.> non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
Als adstringierende Antitranspirant-Wirkstoffe eignen sich vor allem Salze des Aluminiums, Zirkoniums oder des Zinks. Solche geeigneten antihydrotisch wirksamen Wirkstoffe sind z.B. Aluminiumchlorid, Aluminiumchlorhydrat, Aluminiumdichlorhydrat, Aluminium- sesquichlorhydrat und deren Komplexverbindungen z. B. mit Propylenglycol-1,2. Alumi- niumhydroxyallantoinat, Aluminiumchloridtartrat, Aluminium-Zirkonium-Trichlorohydrat, Aluminium-Zirkoniumtetrachlorohydrat, Aluminium-Zirkonium-pentachlorohydrat und deren Komplexverbindungen z. B. mit Aminosäuren wie Glycin. Daneben können in Antitranspirantien übliche öllösliche und wasserlösliche Hilfsmittel in geringeren Mengen enthalten sein. Solche öllöslichen Hilfsmittel können z.B. sein:Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients. Such suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds z. B. with propylene glycol-1,2. Aluminum hydroxyallantoinate, aluminum chloride tartrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate and their complex compounds z. B. with amino acids such as glycine. In addition, conventional oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:
> entzündungshemmende, hautschützende oder wohlriechende ätherische Öle,> anti-inflammatory, skin-protecting or fragrant essential oils,
> synthetische hautschützende Wirkstoffe und/oder> synthetic skin-protecting agents and / or
> öllösliche Parfümöle.> Oil-soluble perfume oils.
Übliche wasserlösliche Zusätze sind z.B. Konservierungsmittel, wasserlösliche Duftstoffe, pH- Wert-Stellmittel, z.B. Puffergemische, wasserlösliche Verdickungsmittel, z.B. wasserlösliche natürliche oder synthetische Polymere wie z.B. Xanthan-Gum, Hydroxyethylcellulose, Polyvinylpyrrolidon oder hochmolekulare Polyethylenoxide.Common water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusting agents, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as e.g. Xanthan gum, hydroxyethyl cellulose, polyvinyl pyrrolidone or high molecular weight polyethylene oxides.
Filmbildnerfilm formers
Gebräuchliche Filmbildner sind beispielsweise Chitosan, mikrokristallines Chitosan, quater- niertes Chitosan, Polyvinylpyrrolidon, Vinylpyrrolidon-Vinylacetat-Copolymerisate, Polymere der Acrylsäurereihe, quaternäre Cellulose-Derivate, Kollagen, Hyaluronsäure bzw. deren Salze und ähnliche Verbindungen.Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
AntischuppenwirkstoffeAntidandruff agents
Als Antischuppenwirkstoffe kommen Pirocton Olamin (l-Hydroxy-4-methyl-6-(2,4,4- trimythylpentγl)-2-(lH)-pyridinonmonoethanolaminsalz), Baypival® (Climbazole), Ketocona- zol®, (4-Acetyl-l-{-4-[2-(2.4-dichlorphenyl) r-2-(lH-imidazol-l-ylmethyl)-l,3-dioxylan-c-4- ylmethoxyphenyl}piperazin, Ketoconazol, Elubiol, Selendisulfid, Schwefel kolloidal, Schwefel- polyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel-teer Destillate, Salicylsäure (bzw. in Kombination mit Hexachlorophen), Undexylensäure Monoethanolamid Sulfosuccinat Na-Salz, Lamepon® UD (Protein-Undecylensäurekondensat), Zinkpyrithion, Aluminiumpyrithion und Magnesiumpyrithion / Dipyrithion-Magnesiumsulfat in Frage. Piroctone olamine (l-hydroxy-4-methyl-6- (2,4,4-trimythylpentγl) -2- (lH) -pyridinone monoethanolamine salt), Baypival® (climbazole), ketocona zol®, (4-acetyl-l - {- 4- [2- (2.4-dichlorophenyl) r-2- (lH-imidazol-l-ylmethyl) -l, 3-dioxylan-c-4-ylmethoxyphenyl} piperazine, ketoconazole, elubiol, selenium disulphide, sulfur colloidal, sulfur polyehtylenglykolsorbitanmonooleat, Schwefelrizinolpolyehtoxylat, Schwfel tar distillate, salicylic acid (or in combination with hexachlorophene), undecylenic acid monoethanolamide sulfosuccinate Na salt, Lamepon® UD (protein undecylenic acid condensate), zinc pyrithione, and Aluminiumpyrithion Magnesium pyrithione / dipyrithione magnesium sulfate in question.
Quellmittelswelling agent
Als Quellmittel für wäßrige Phasen können Montmorillonite, Clay Mineralstoffe, Pemulen sowie alkylmodifizierte Carbopoltypen (Goodrich) dienen.Montmorillonites, clay minerals, pemulene and alkyl-modified carbopol types (Goodrich) can serve as swelling agents for aqueous phases.
Insekten-RepellentienInsect repellents
Als Insekten-Repellentien kommen N,N-Diethyl-m-toluamid, 1,2-Pentandiol oder Ethyl Buty- lacetylaminopropionate in FragePossible insect repellents are N, N-diethyl-m-toluamide, 1,2-pentanediol or ethyl butyl acetylaminopropionate
Selbstbräuner und DepigmentierunqsmittelSelf-tanners and depigmenting agents
Als Selbstbräuner eignet sich Dihydroxyaceton. Als Tyrosinhinbitoren, die die Bildung von Melanin verhindern und Anwendung in Depigmentierungsmitteln finden, kommen beispielsweise Arbutin, Ferulasäure, Kojisäure, Cumarinsäure und Ascorbinsäure (Vitamin C) in Frage.Dihydroxyacetone is suitable as a self-tanner. Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
Hydrotropehydrotropes
Zur Verbesserung des Fließverhaltens können ferner Hydrotrope, wie beispielsweise Ethanol, Isopropylalkohol, oder Polyole eingesetzt werden. Polyole, die hier in Betracht kommen, besitzen vorzugsweise 2 bis 15 Kohlenstoffatome und mindestens zwei Hydroxylgruppen. Die Polyole können noch weitere funktionelle Gruppen, insbesondere Aminogruppen, enthalten bzw. mit Stickstoff modifiziert sein. Typische Beispiele sindHydrotropes such as ethanol, isopropyl alcohol or polyols can also be used to improve the flow behavior. Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are
> Glycerin;> Glycerin;
> Alkylenglycole, wie beispielsweise Ethylenglycol, Diethylenglycol, Propylenglycol, Buty- lenglycol, Hexylenglycol sowie Polyethylenglycole mit einem durchschnittlichen Molekulargewicht von 100 bis 1.000 Dalton;> Alkylene glycols, such as, for example, ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
> technische Oligoglyceringemische mit einem Eigenkondensationsgrad von 1,5 bis 10 wie etwa technische Diglyceringemische mit einem Diglyceringehalt von 40 bis 50 Gew.-%;> technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;
> Methyolverbindungen, wie insbesondere Trimethylolethan, Trimethylolpropan, Trimethy- lolbutan, Pentaerythrit und Dipentaerythrit;> Methyl compounds, such as, in particular, trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
> Niedrigalkylglucoside, insbesondere solche mit 1 bis 8 Kohlenstoffen im Alkylrest, wie beispielsweise Methyl- und Butylglucosid; > Zuckeralkohόle mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Sorbit oder Mannit,> Lower alkyl glucosides, especially those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside; > Sugar alcohols with 5 to 12 carbon atoms, such as sorbitol or mannitol,
> Zucker mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Glucose oder Saccharose;> Sugar with 5 to 12 carbon atoms, such as glucose or sucrose;
> Aminozucker, wie beispielsweise Glucamin;> Aminosugars such as glucamine;
> Dialkoholamine, wie Diethanolamin oder 2-Amino-l,3-propandiol.> Dialcohol amines, such as diethanolamine or 2-amino-l, 3-propanediol.
Konservierungsmittelpreservative
Als Konservierungsmittel eignen sich beispielsweise Phenoxyethanol, Formaldehydlösung, Parabene, Pentandiol oder Sorbinsäure sowie die unter der Bezeichnung Surfacine® bekannten Silberkomplexe und die in Anlage 6, Teil A und B der Kosmetikverordnung aufgeführten weiteren Stoffklassen.Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid, as well as the silver complexes known under the name Surfacine® and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Ordinance.
Parfümöle und AromenPerfume oils and flavors
Als Parfümöle seien genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten (Lilie, Lavendel, Rosen, Jasmin, Neroli, Ylang- Ylang), Stengeln und Blättern (Geranium, Patchouli, Petitgrain), Früchten (Anis, Koriander, Kümmel, Wacholder), Fruchtschalen (Bergamotte, Zitrone, Orangen), Wurzeln (Macis, Ange- lica, Sellerie, Kardamon, Costus, Iris, Calmus), Hölzern (Pinien-, Sandel-, Guajak-, Zedern-, Rosenholz), Kräutern und Gräsern (Estragon, Lemongras, Salbei, Thymian), Nadeln und Zweigen (Fichte, Tanne, Kiefer, Latschen), Harzen und Balsamen (Galbanum, Elemi, Benzoe, Myrrhe, Olibanum, Opoponax). Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindungen sind Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxyethylisobutyrat, p-tert- Butylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat, Phenylethylacetat, Lina- lylbenzoat, Benzylformiat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat und Benzylsalicylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronel- lyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Keto- nen z.B. die Jonone, α-Isomethylionon und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aro- makomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetiveröl, Olibanöl, Galbanumöl, Labolanumöl und Lavandinöl. Vorzugsweise werden Bergamotteöl, Dihydromyrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzylaceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, Hedione, Sandelice, Citronenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Salbeiöl, ß-Damascone, Geraniumöl Bourbon, Cyclohexylsalicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenylessigsäure, Geranylacetat, Benzylacetat, Rosenoxid, Romilllat, Irotyl und Floramat allein oder in Mischungen, eingesetzt.Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, cumin, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), woods (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme) ), Needles and twigs (spruce, fir, pine, mountain pine), resins and balsams (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinyl acetate, phenylethyl acetate, linylbenzoate, benzyl formate, ethylmethylphenylglycinate, allylcyclohexyl benzylatepylpropylate, stylate propionate, stylate propionate. The ethers include, for example, benzyl ethyl ether, the aldehydes include, for example, the linear alkanals having 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, and the ketones include, for example, the jonones, α-isomethyl ionone and methyl cedryl ketone , the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly Mako components are used as perfume oils, such as sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil. Bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexyl cinnamaldehyde, geraniol, benzylacetone, cyclamenaldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, lemon oil, mandarin oil, lavender oil, orange glycolate, almond glycol, alanol glycol, alanol oil, alanol glycolate, alanol glycolate, alanol glycolate, alanol glycolate, alanol glycolate, alanol glycolate, alanol glycolate, alanecalcolate, orange oil, alanol glycolate, alanol glycolate, alanecalcolate, orange oil, alanol glycolate, alanol glycolate, alanecalcolate, orange oil, alanecalcolate, orange oil, aldolate, lamellar oil, orange oil, orange oil, orange oil, aldolate, lemon oil, orange oil, orange oil oil, orange oil oil, alanecalcone oil, orange oil, alanecalcone oil Sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllate, irotyl and floramate alone or in mixtures.
Als Aromen kommen beispielsweise Pfefferminzöl, Krauseminzöl, Anisöl, Sternanisöl, Küm- melöl, Eukalyptusöl, Fenchelöl, Citronenöl, Wintergrünöl, Nelkenöl, Menthol und dergleichen in Frage.Suitable flavors are, for example, peppermint oil, spearmint oil, anise oil, star anise oil, cumin oil, eucalyptus oil, fennel oil, lemon oil, winter green oil, clove oil, menthol and the like.
Farbstoffedyes
Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden. Beispiele sind Kochenillerot A (C.I. 16255), Patentblau V (C.I.42051), Indigotin (C.I.73015), Chlorophyllin (C.L75810), Chinolingelb (C.I.47005), Titandioxid (C.I.77891), Indanthrenblau RS (C.I. 69800) und Krapplack (C.L58000). Als Lumineszenzfarbstoff kann auch Luminol enthalten sein. Diese Farbstoffe werden üblicherweise in Konzentrationen von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, eingesetzt.The dyes which can be used are those which are suitable and approved for cosmetic purposes. Examples are culinary red A (CI 16255), patent blue V (CI42051), indigotine (CI73015), chlorophyllin (C.L75810), quinoline yellow (CI47005), titanium dioxide (CI77891), indanthrene blue RS (CI 69800) and madder varnish ( C.L58000). Luminol may also be present as the luminescent dye. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
Der Gesamtanteil der Hilfs- und Zusatzstoffe kann 1 bis 50, vorzugsweise 5 bis 40 Gew.-% - bezogen auf die Mittel - betragen. Die Herstellung der Mittel kann durch übliche Kalt - oder Heißprozesse erfolgen; vorzugsweise arbeitet man nach der Phaseninversionstemperatur- Methode. The total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition. The agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
Gewerbliche AnwendbarkeitIndustrial applicability
Die neuen Wirkstoffe verfügen über eine Vielzahl von Eigenschaften, die sie für den Schutz und die Pflege von Haut und Haaren interessant machen. Ein weiterer Gegenstand der Erfindung betrifft daher ihre zur Herstellung von kosmetischen oder pharmazeutischen Zubereitungen. Weitere vorteilhafte Ausgestaltungen der Erfindung beziehen sich auf die Verwendung der WirkstoffeThe new active ingredients have a variety of properties that make them interesting for the protection and care of skin and hair. Another object of the invention therefore relates to their for the production of cosmetic or pharmaceutical preparations. Further advantageous embodiments of the invention relate to the use of the active ingredients
> zur Stimulierung des Wachstums und des Überlebens von Fibroblasten;> to stimulate the growth and survival of fibroblasts;
> zur Stimulierung der GHS-Konzentration in den Zellen;> to stimulate the GHS concentration in the cells;
> als anti-inflammatorische Agentien;> as anti-inflammatory agents;
> zum Schutz von Haut und Haaren gegen UV-A-Strahlung und UV-B-Strahlung;> to protect skin and hair against UV-A radiation and UV-B radiation;
> zum Schutz der DNA vor Schäden durch UV-Strahlung;> to protect DNA from damage caused by UV radiation;
> zur Immunstimulation des Metabolismus;> for immune stimulation of the metabolism;
> zur Bekämpfung von Falten sowie zur Vitalisierung und Verjüngung der Haut;> to fight wrinkles and to revitalize and rejuvenate the skin;
> zur Stärkung der Abwehrkräfte von Haut- und Haarfollikeln gegen Umweltgifte und oxi- dativen Stress;> to strengthen the immune system of skin and hair follicles against environmental toxins and oxidative stress;
> zur Stimulation des Haarwachstums;> to stimulate hair growth;
> zur Stimulierung der Fibroblasten zur Bildung von dermalen Makromolekülen, speziell von Kollagen;> to stimulate the fibroblasts to form dermal macromolecules, especially collagen;
> zur Bekämpfung von Akne vulgaris;> to fight acne vulgaris;
> als Feuchtigkeitsregulatoren in der Haut;> as moisture regulators in the skin;
> zur Hautreinigung;> for skin cleaning;
> zur Inhibierung von Collagenasen und Elastasen;> to inhibit collagenases and elastases;
> als Regulatoren für die Melanogenese in Haut und Haaren sowie> as regulators for melanogenesis in skin and hair as well
> als Entschleimungsmittel. > as a degumming agent.
BeispieleExamples
Beispiel 1. 500 g Erbsensaat wurde zerkleinert, in der lOfachen Menge Wasser dispergiert und der pH-Wert durch Zugabe von Schwefelsäure auf 4,7 eingestellt. Danach wurde die Suspension 2 h bei 52 °C gerührt, abgekühlt und die ungelösten Bestandteile durch Zentrifugieren abgetrennt. 0.36 kg des im Sauren ausgefallenen Rückstandes (Pea Acid Precipitate) wurden wiederum in 750 ml Wasser suspendiert, 45 min gerührt und der pH-Wert durch Zugabe von Natronlauge schrittweise bis auf 7,5 angehoben. Anschließend wurden die ungelösten Anteile wiederum abgetrennt. Der lösliche Extrakt (0,8 kg) wurde in einen Fermentationstank überführt, in dem er 20 min bei 90 °C inkubiert wurde. Anschließend wurde die Zubereitung auf 20 °C abgekühlt und mit 0,2 % w/v mit der kommerziell erhältlichen Kultur Cl der Firma Wiesby versetzt, welche die folgenden Mikroorganismen enthielt : Lactococcus lactis, Lactococcus cremoris, Lactococcus deacetylactis, Leuconostoc, Lactobacillus kefyr, Candida kefyr, Saccharomyces kefyr. Die Fermentation wurde im geschlossenen Tank bei 22 °C bei einer Rührgeschwindigkeit von 100 Upm durchgeführt. Nach einer Fermentationszeit von 27,5 h war der pH-Wert bis auf 4,5 abgefallen. Die Fermentationsbrühe wurde zentrifu- giert, die überstehende Lösung 20 min bei 90 °C inkubiert, abgekühlt, unter vermindertem Druck aufkonzentriert und dann gefriergetrocknet. Die Ausbeute betrug 7 Gew.-% bezogen auf die Ausgangsstoffe (g/g Trockengewicht des Pea Acid Precipitate). Das Endprodukt wies einen Stickstoffgehalt von 5 Gew.-% auf.Example 1. 500 g of pea seed was ground, dispersed in a 10-fold amount of water and the pH was adjusted to 4.7 by adding sulfuric acid. The suspension was then stirred at 52 ° C. for 2 h, cooled and the undissolved constituents were separated off by centrifugation. 0.36 kg of the acidic residue (Pea Acid Precipitate) was again suspended in 750 ml of water, stirred for 45 min and the pH was gradually increased to 7.5 by adding sodium hydroxide solution. Then the undissolved portions were separated again. The soluble extract (0.8 kg) was transferred to a fermentation tank where it was incubated at 90 ° C for 20 min. The preparation was then cooled to 20 ° C. and 0.2% w / v of the commercially available culture C1 from Wiesby, which contained the following microorganisms: Lactococcus lactis, Lactococcus cremoris, Lactococcus deacetylactis, Leuconostoc, Lactobacillus kefyr, Candida kefyr, Saccharomyces kefyr. The fermentation was carried out in a closed tank at 22 ° C. with a stirring speed of 100 rpm. After a fermentation time of 27.5 h, the pH had dropped to 4.5. The fermentation broth was centrifuged, the supernatant solution incubated for 20 min at 90 ° C., cooled, concentrated under reduced pressure and then freeze-dried. The yield was 7% by weight based on the starting materials (g / g dry weight of the Pea Acid Precipitate). The end product had a nitrogen content of 5% by weight.
Beispiel 2. Beispiel 1 wurde wiederholt, die Fermentation jedoch mit 800 g Erbsenextrakt, 0,8 Hefeextrakt und 4 g Natriumchlorid durchgeführt. Nach der Gefriertrocknung betrug die Ausbeute an Fermentationsprodukten 9 Gew.-% bezogen auf die Ausgangsstoffe (g/g Trockengewicht des Pea Acid Precipitate). Das Endprodukt wies einen Stickstoffgehalt von 4 Gew.-% auf.Example 2. Example 1 was repeated, but the fermentation was carried out with 800 g of pea extract, 0.8 yeast extract and 4 g of sodium chloride. After freeze-drying, the yield of fermentation products was 9% by weight, based on the starting materials (g / g dry weight of the Pea Acid Precipitate). The end product had a nitrogen content of 4% by weight.
Beispiel 3. Beispiel 2 wurde wiederholt. Nach der Zentrifugation der Fermentationsbrühe wurde die fermentierte Proteinfraktion abgetrennt und im 5fachen Volumen Wasser resuspendiert. Die Suspension wurde 30 min gerührt und der pH-Wert dabei schrittweise durch Zugabe von Natronlauge auf 7,6 eingestellt. Anschließend wurde die Suspension 20 min bei 90 °C inkubiert und gefriergetrocknet. Das Fermentationsprodukt wurde in einer Ausbeute von 8 Gew.-% bezogen auf die Ausgangsstoffe (g/g Trockengewicht des Pea Acid Precipitate) erhalten und wies einen Stickstoffgehalt von 12 Gew.-% auf. Beispiel 4. 5,4 kg gemahlener Samen von Hibiscus esculentus wurden bei 50 °C in 30 kg Wasser dispergiert und mit 0,61 kg NaOH-Plätzchen versetzt. Die Suspension wurde 4 h bei 50 °C gerührt, abgekühlt und zentrifugiert. Es wurden 23,4 kg überstehende Lösung erhalten, die durch Zugabe von Schwefelsäure auf einen pH-Wert von 7,8 eingestellt und dann sprühgetrocknet wurde. Hierbei fielen 900 g Hibiscusextrakt an. 16 g dieses festen Pulvers wurden zusammen mit 0,8 g Hefeextrakt und 4 g Natriumchlorid in einen Fermenter überführt und mit 800 ml Wasser (pH = 7,8) versetzt, in dem sie 15 min bei 121 °C inkubiert wurden. Die Fermentationsbrühe wurde auf 22 °C abgekühlt und dann mit 0,1 % w/v der Kultur Kefir Cl versetzt. Der Extrakt wurde 2 d im geschlossenen Tank bei 22 °C bei einer Rührgeschwindigkeit von 100 Upm fermentiert (pH =4,9), dann 20 min bei 80 °C inkubiert und zentrifugiert. Anschließend wurde die überstehende Lösung unter vermindertem Druck aufkonzentriert und gefriergetrocknet. Das Fermentationsprodukt wurde in einer Ausbeute von 60 Gew. % bezogen auf die Trockensubstanz der Fermentationsbrühe erhalten. Das resultierende Produkt wies einen Stickstoffgehalt von 3,5 Gew.-% auf.Example 3. Example 2 was repeated. After centrifugation of the fermentation broth, the fermented protein fraction was separated and resuspended in 5 times the volume of water. The suspension was stirred for 30 min and the pH was gradually adjusted to 7.6 by adding sodium hydroxide solution. The suspension was then incubated at 90 ° C. for 20 min and freeze-dried. The fermentation product was obtained in a yield of 8% by weight based on the starting materials (g / g dry weight of the Pea Acid Precipitate) and had a nitrogen content of 12% by weight. Example 4. 5.4 kg of ground seeds of Hibiscus esculentus were dispersed in 30 kg of water at 50 ° C. and 0.61 kg of NaOH cookies were added. The suspension was stirred at 50 ° C. for 4 h, cooled and centrifuged. 23.4 kg of supernatant solution were obtained, which was adjusted to pH 7.8 by adding sulfuric acid and then spray-dried. This resulted in 900 g of hibiscus extract. 16 g of this solid powder, together with 0.8 g of yeast extract and 4 g of sodium chloride, were transferred to a fermenter, and 800 ml of water (pH = 7.8) were added, in which they were incubated at 121 ° C. for 15 min. The fermentation broth was cooled to 22 ° C and then 0.1% w / v of the culture Kefir Cl was added. The extract was fermented for 2 d in a closed tank at 22 ° C. at a stirring speed of 100 rpm (pH = 4.9), then incubated at 80 ° C. for 20 min and centrifuged. The supernatant solution was then concentrated under reduced pressure and freeze-dried. The fermentation product was obtained in a yield of 60% by weight, based on the dry matter of the fermentation broth. The resulting product had a nitrogen content of 3.5% by weight.
Beispiel 5. Früchte der Palme Bactris wurden in Gegenwart von Wasser aufgebrochen, wobei eine Suspension mit einem Feststoffgehalt von 10 Gew.-% entstand. Diese wurde 30 min bei 110 °C inkubiert, auf 30 °C abgekühlt und mit dem kommerziell erhältlichen Ferment Kefir Fruit der Firma Yalacta versetzt, welches folgende Mikroorganismen enthielt : Lactococcus lactis, Lactococcus cremorius, Lactococcus dieacetylactis, Leuconostoc, Lactobacillus caucasicus, Lactococcus lactis subsp. lactis und Saccharomyces florentinus. Hierzu wurden 4 g des Ferments in 20 ml einer sterilen 0,9 Gew.-%igen Kochsalzlösung suspendiert und die Palmfrucht-Fermentationsbrühe mit 2 % w/v dieser Lösung versetzt. Die Brühe wurde bei 30 °C und einer Rührgeschwindigkeit von 150 Upm im geschlossenen Tank fermentiert. Nach 24 h war der pH-Wert bis auf 5,0 abgefallen. Die Fermentationsbrühe wurde 30 min bei 90 °C inkubiert, abgekühlt, durch ein Nylonsieb mit einer Maschenweite von 500 μm filtriert, mit 150 ml Wasser gewaschen und dann zentrifugiert. Der Rückstand wurde abermals mit 200 g Wasser gewaschen und die Suspension zentrifugiert. Die überstehenden Lösungen wurden vereinigt, unter vermindertem Druck aufkonzentriert und schließlich gefriergetrocknet. Das Fermentationsprodukt wurde in einer Ausbeute von 45 Gew.-% bezogen auf das Trockengewicht der Fermentationsbrühe gewonnen.Example 5. Fruits of the Bactris palm were broken up in the presence of water, giving a suspension with a solids content of 10% by weight. This was incubated at 110 ° C. for 30 min, cooled to 30 ° C. and mixed with the commercially available Kefir Fruit fermentation from Yalacta, which contained the following microorganisms: Lactococcus lactis, Lactococcus cremorius, Lactococcus dieacetylactis, Leuconostoc, Lactobacillus cauccususlactus, Lactobacillus caucasicus , lactis and Saccharomyces florentinus. For this purpose, 4 g of the ferment were suspended in 20 ml of a sterile 0.9% by weight saline solution and 2% w / v of this solution was added to the palm fruit fermentation broth. The broth was fermented at 30 ° C. and a stirring speed of 150 rpm in a closed tank. After 24 h the pH had dropped to 5.0. The fermentation broth was incubated at 90 ° C. for 30 minutes, cooled, filtered through a nylon sieve with a mesh size of 500 μm, washed with 150 ml of water and then centrifuged. The residue was washed again with 200 g of water and the suspension was centrifuged. The supernatant solutions were combined, concentrated under reduced pressure and finally freeze-dried. The fermentation product was obtained in a yield of 45% by weight based on the dry weight of the fermentation broth.
Beispiel 6. Beispiel 5 wurde wiederholt. Die Fermentationsbrühe wurde mit einem Anfangsgehalt von 5% g/g Trockengewicht der Früchte der Palme Bactris und 1,25 Gew.-% Glucose sowie 0,04 Gew.-% Malzextrakt hergestellt. Das Fermentationsprodukt wurde in einer Ausbeute von 45 Gew.-% bezogen auf das Trockengewicht der Fermentationsbrühe gewonnen. Beispiel 7. 1 kg Maca Wurzel Pulver (Amazonian Natural Product, Peru) wurde in destilliertem Wasser dispergiert, so dass eine 10 Gew. % Dispersion vorlag. Der pH-Wert wurde auf pH 7-7.2 mit einer 4 N Natronlaugelösung eingestellt. Die Suspension wurde bei Raumtemperatur (22°C ± 2 °C) für eine Stunde gerührt und danach mit 0,1% (w:v) einer kommerziellen Kefirkultur (Kefir Cl von Wiesby) inkubiert. Die Maca-Brühe wurde bei Raumtemperatur zwischen 20 und 25°C und einer Rührgeschwindigkeit von 100 rpm fermentiert. Nach 1,5 Tagen (pH 4) wurde die Brühe für 15 Minuten auf 70-80°C erhitzt und nachfolgend zentrifugiert und filtriert um unlösliche Bestandteile abzutrennen. Die so erhaltene Lösung wurde gefriergetrocknet. Es wurde ein Fermentationsprodukt mit einer Ausbeute von 28 Gew.% bezogen auf das Trockengewicht des Maca Pulvers erhalten, das einen Stickstoffgehalt von 2,6 Gew.% aufwies.Example 6. Example 5 was repeated. The fermentation broth was produced with an initial content of 5% w / g dry weight of the fruits of the Bactris palm and 1.25% by weight glucose and 0.04% by weight malt extract. The fermentation product was obtained in a yield of 45% by weight based on the dry weight of the fermentation broth. Example 7. 1 kg of maca root powder (Amazonian Natural Product, Peru) was dispersed in distilled water so that there was a 10% by weight dispersion. The pH was adjusted to pH 7-7.2 with a 4 N sodium hydroxide solution. The suspension was stirred at room temperature (22 ° C ± 2 ° C) for one hour and then incubated with 0.1% (w: v) of a commercial kefir culture (Kefir Cl from Wiesby). The maca broth was fermented at room temperature between 20 and 25 ° C and a stirring speed of 100 rpm. After 1.5 days (pH 4), the broth was heated to 70-80 ° C. for 15 minutes and then centrifuged and filtered to remove insoluble constituents. The solution thus obtained was freeze-dried. A fermentation product was obtained with a yield of 28% by weight, based on the dry weight of the Maca powder, which had a nitrogen content of 2.6% by weight.
Beispiel 8. 5 g Quinoa Samen wurden zerkleinert und zu einer 10 Gew.% Dispersion in destilliertem Wasser dispergiert. Der pH-Wert der Dispersion wurde auf pH 7-7.2 mit einer 4 N Natronlaugelösung eingestellt. Die Suspension wurde bei Raumtemperatur (22°C + 2 °C) für eine Stunde gerührt und danach mit 1% (w:v) einer kommerziellen Kefirkultur (Kefir Cl von Wiesby) inkubiert. Diese Quinoa-Brühe wurde bei Raumtemperatur (22°C ± 2 °C) und einer Rührgeschwindigkeit von 110 rpm fermentiert (Vorkultur). Nach 24 Stunden (pH 4.2) wurde diese Fermentationsbrühe (Vorkultur) zur Inkubation von 5 kg Suspension aus 500 g zerkleinerten Quinoa Samen wie zuvor hergestellt, eingesetzt. Die Quinoa-Brühe wurde bei bei Raumtemperatur (22°C ± 2 °C) und einer Rührgeschwindigkeit von 300 rpm fermentiert. Nach 28 Stunden (pH 4,3) wurde die Brühe für 15 Minuten auf 70-80°C erhitzt und nachfolgend zentrifugiert und filtriert um unlösliche Bestandteile abzutrennen. Die so erhaltene Lösung wurde gefriergetrocknet. Es wurde ein Fermentationsprodukt mit einer Ausbeute von 11 Gew.% bezogen auf das Trockengewicht des Quinoa-Pulvers erhalten, das einen Stickstoffgehalt von 6,9 Gew.% aufwies. Example 8. 5 g of quinoa seeds were crushed and dispersed to a 10% by weight dispersion in distilled water. The pH of the dispersion was adjusted to pH 7-7.2 using a 4 N sodium hydroxide solution. The suspension was stirred at room temperature (22 ° C. + 2 ° C.) for one hour and then incubated with 1% (w: v) of a commercial kefir culture (Kefir Cl from Wiesby). This quinoa broth was fermented at room temperature (22 ° C ± 2 ° C) and a stirring speed of 110 rpm (preculture). After 24 hours (pH 4.2), this fermentation broth (preculture) was used to incubate 5 kg of suspension from 500 g of crushed quinoa seeds as previously prepared. The quinoa broth was fermented at room temperature (22 ° C ± 2 ° C) and a stirring speed of 300 rpm. After 28 hours (pH 4.3), the broth was heated to 70-80 ° C. for 15 minutes and then centrifuged and filtered in order to remove insoluble constituents. The solution thus obtained was freeze-dried. A fermentation product was obtained with a yield of 11% by weight, based on the dry weight of the quinoa powder, which had a nitrogen content of 6.9% by weight.
Regenerative und wachstumsstimulierende WirkungRegenerative and growth stimulating effect
Nach einer Inkubation von 72 h in einer Nährlösung bilden Fibroblasten gesättigte Monolayer aus, die Fibroblasten stellen ihre Aktivität ein und das Wachstum kommt zum Stillstand. Der Zellbrennstoff Adenosintriphosphat (ATP), der im wesentlichen in den Mitochondrien entsteht, wird zur Aktivierung von bestimmten Enzymen benötigt, die beispielsweise das Zellskelett kontrollieren, die Ionenkanäle, die Aufnahme von Nährstoffe und eine ganze Reihe anderer wichtiger biologischer Abläufe. Die Bestimmung des Proteingehaltes in den Zellen erfolgte nach der Methode von Bradford [ vgl. Anal. Biochem. 72, 248-254 (1977) ]. Glutathion (GSH) ist ein spezielles Protein, welches von den Zellen zum Schutz gegen oxida- tiven Stress und Umweltgifte, insbesondere gegen Schwermetalle produziert wird. Die an der reduzierten Form des GSH beteiligten drei Aminosäuren sind mit speziellen cytoplasmati- schen Enzymen verknüpft, die zur Aktivierung ATP benötigen. Ein Anstieg der GSH- Konzentration führt zu einem Anstieg der Glutathion-S-transferase-Aktivität, eines Entgiftungsenzyms. Der GHS-Gehalt wurde nach der Methode von Hissin [vgl. Anal. Biochem. 74, 214-226 (1977)] bestimmt. Die wachstumsstimulierende Wirkung der Testsubstanzen wurden an menschlichen Fibroblasten untersucht. Dazu wurden in einer ersten Testreihe die Fibroblasten in einem Nährmedium 1 Tag bei 37 °C und 5 Vol.-% CO2 inkubiert, das Nährmedium gegen ein Medium, welches die Testsubstanzen enthielt, ausgewechselt und wiederum 3 Tage bei 37 °C inkubiuert. Anschließend wurde der Proteingehalt in den Zellen sowie die ATP-Konzentration bestimmt. Zur Bestimmung der überlebensstimulierenden Wirkung wurden in einer zweiten Testreihe die Fibroblasten zunächst 3 Tage bei 37 °C in einer Nährlösung und dann 3 Tage bei gleicher Temperatur in einer Testlösung inkubiert. Anschließend wurde der Proteingehalt in den Zellen sowie die GSH-Konzentration bestimmt. Die Anzahl der lebenden Zellen wurde in einigen Versuchen durch Messung des Gehaltes an zellulärem ATP und zellulärer DNA gemessen. Die Ergebnisse sind in Tabelle 1 zusammenge- fasst. Angegeben sind die Ergebnisse von jeweils 3 Messreihen mit Dreifachbestimmung in %-rel gegenüber einer Blindprobe.After an incubation of 72 h in a nutrient solution, fibroblasts form saturated monolayers, the fibroblasts cease their activity and growth stops. The cell fuel adenosine triphosphate (ATP), which is mainly produced in the mitochondria, is required to activate certain enzymes that control, for example, the cell skeleton, the ion channels, the absorption of nutrients and a whole range of other important biological processes. The protein content in the cells was determined by the Bradford method [cf. Anal. Biochem. 72, 248-254 (1977)]. Glutathione (GSH) is a special protein that is produced by the cells to protect against oxidative stress and environmental toxins, especially against heavy metals. The three amino acids involved in the reduced form of the GSH are linked to special cytoplasmic enzymes that require ATP for activation. An increase in GSH concentration leads to an increase in glutathione S-transferase activity, a detoxification enzyme. The GHS content was determined using the Hissin method [cf. Anal. Biochem. 74, 214-226 (1977)]. The growth-stimulating effects of the test substances were investigated on human fibroblasts. For this purpose, in a first test series, the fibroblasts were incubated in a nutrient medium for 1 day at 37 ° C. and 5% by volume CO 2 , the nutrient medium was exchanged for a medium which contained the test substances, and again incubated for 3 days at 37 ° C. The protein content in the cells and the ATP concentration were then determined. To determine the survival-stimulating effect, the fibroblasts were first incubated in a nutrient solution at 37 ° C. for 3 days and then in a test solution at the same temperature for 3 days. The protein content in the cells and the GSH concentration were then determined. The number of living cells was measured in some experiments by measuring the content of cellular ATP and cellular DNA. The results are summarized in Table 1. The results of 3 series of measurements with triple determination in% -rel compared to a blank sample are given.
Die Beispiele zeigen, dass die Testsubstanzen den Metabolismus im Hinblick auf das Wachstum und den Schutz der Fibroblasten stimulieren. Tabelle 1The examples show that the test substances stimulate the metabolism with regard to the growth and protection of the fibroblasts. Table 1
Wachstums- und überlebensstimulierende Wirkung (Angabe in %-rel.)Growth and survival stimulating effect (in% rel.)
Anti-inflammatorische WirkungAnti-inflammatory effect
Im Verlauf einer cutanen Inflammation werden Leucocyten, wie beispielsweise die poly- morphonuclearen neutrophilen Granulocyten (PMN) durch Peptide wie etwa Cytokine stimuliert, Botschafterstoffe wie z.B. Leukotrien auszusenden, die von aktivierten oder nekroti- schen Zellen in der Dermis freigesetzt werden. Diese aktivierte PMN setzen nicht nur pro- inflammatorische Cytokine, Leukotriene und Proteasen, sondern auch ROS, wie z.B. Superoxide und Hypochloritanionen frei, welche die Aufgabe haben, eingedrungene pathogene Keime oder Pilze zu vernichten. Diese Aktivität der PMN während der Inflammation ist als sogenannter Atmungsausbruch („respiratory burst") bekannt und kann zu zusätzlichen Schäden im Gewebe führen. Zur Untersuchung, inwiefern die Testsubstanzen den Atmungsausbruch verhindern oder mindern können, wurde eine Zelllinie von menschlichen leukemischen Granulocyten dieser PMN zusammen mit den Testsubstanzen bei 37 °C von 5 Vol.-% CO2 inkubiert. Nach Auslösung des Atmungsausbruchs durch Zugabe eines Hefeextraktes (Zymo- san) zur Zelllösung, wurde die Freisetzung von Superoxidanionen über deren Reaktion mit Luminol bestimmt. Die Ergebnisse sind in Tabelle 2 zusammengefasst. Angegeben sind die Zellzahlen sowie die Menge an freigesetzten ROS in %-rel zum Standard als Mittelwert einer Messreihe mit Dreifachbestimmung.In the course of a cutaneous inflammation, leucocytes, such as the polymorphonuclear neutrophil granulocytes (PMN), are stimulated by peptides such as cytokines to send out messenger substances such as leukotriene, which are released in the dermis by activated or necrotic cells. These activated PMN release not only pro-inflammatory cytokines, leukotrienes and proteases, but also ROS, such as superoxides and hypochlorite anions, which have the task of destroying invaded pathogenic germs or fungi. This activity of the PMN during inflammation is known as a so-called respiratory burst and can lead to additional damage to the tissue. To investigate to what extent the test substances can prevent or reduce the outbreak of breath, a cell line of human leukemic granulocytes of this PMN was put together incubated with the test substances of 5% by volume of CO 2 at 37 ° C. After triggering the respiratory outbreak by adding a yeast extract (zymosan) to the cell solution, the release of superoxide anions was determined by their reaction with luminol 2. The cell numbers and the amount of released ROS are given in% -rel to the standard as the mean value of a series of measurements with triplicate determination.
Die Ergebnisse zeigen, dass die Testsubstanzen einen starken inhibierenden Einfluss auf den Atmungsausbruch menschlicher Granulocyten besitzen, ohne die Granulocyten zu schädigen. Tabelle 2The results show that the test substances have a strong inhibitory influence on the respiratory outbreak of human granulocytes without damaging the granulocytes. Table 2
Anti-inflammatorische Wirkung (Angabe in %-rel.)Anti-inflammatory effect (in% rel.)
Zellschutz gegenüber UV-B-StrahlenCell protection against UV-B rays
Aufgabe dieses Tests war es zu zeigen, dass die Testsubstanzen anti-inflammatorische Eigenschaften gegenüber menschlichen Keratinocyten besitzen. UVB wurde als Stressfaktor ausgewählt, weil die Strahlen durch Aktivierung von Arachidonsäure freisetzenden Enzymen, wie beispielsweise Phospholipase A2 (PLA2) eine cutane Inflammation (Erytheme, Ödeme) hervorrufen. Dies führt in der Folge nicht nur zu einer Schädigung der Membranen, sondern auch zur Bildung von inflammatorisch wirkenden Stoffen, wie beispielsweise Prostaglandinen vom Typ PGE2. Der Einfluss der UVB-Strahlen auf die Keratinocyten wurde in-vitro über die Freisetzung von cytoplasmatischen Enzymen, wie z.B. LDH (Lactat Dehydrogenase) bestimmt, die parallel zur Zellschädigung und der Bildung von PGE2 verläuft. Zur Versuchsdurchführung wurde eine Fibroblastenkultur mit fötalem Kalbsserum angesetzt und 2 Tage später mit den Testsubstanzen geimpft. Nach einer Inkubation von 36 h bei 37 °C und einem CO2-Level von 5 Vol.-% wurde das Nährmedium durch eine Elektrolytlösung ersetzt und die Fibroblasten mit einer definierten UVB-Strahlungsmenge geschädigt (50 mJ/cm2). Die Keratinocytenmenge wurde nach Trypsination über einen Zellzähler ermittelt, die LDH- Konzentration enzymatisch bestimmt und das entstandene PGE2 durch Elisa Test gemessen. Die Ergebnisse sind in Tabelle 3 zusammengefasst. Angegeben ist die Aktivität in %-rel gegen einen Standard als Mittelwert von zwei Testreihen mit Doppelbestimmung. Tabelle 3The aim of this test was to show that the test substances have anti-inflammatory properties against human keratinocytes. UVB was chosen as a stress factor because the rays cause cutaneous inflammation (erythema, edema) by activating arachidonic acid-releasing enzymes, such as phospholipase A2 (PLA2). As a result, this not only leads to damage to the membranes, but also to the formation of inflammatory substances, such as prostaglandins of the PGE2 type. The influence of UVB rays on the keratinocytes was determined in vitro via the release of cytoplasmic enzymes, such as LDH (lactate dehydrogenase), which runs parallel to cell damage and the formation of PGE2. To carry out the experiment, a fibroblast culture with fetal calf serum was set up and vaccinated with the test substances 2 days later. After an incubation of 36 h at 37 ° C and a CO 2 level of 5 vol.%, The nutrient medium was replaced by an electrolyte solution and the fibroblasts were damaged with a defined amount of UVB radiation (50 mJ / cm 2 ). After trypsination, the amount of keratinocytes was determined using a cell counter, the LDH concentration was determined enzymatically and the PGE2 formed was measured by the Elisa test. The results are summarized in Table 3. The activity is given in% -rel against a standard as the mean of two test series with double determination. Table 3
Wirkung gegen UVB-Strahlen (Angabe in %-rel.)Effect against UVB rays (in% rel.)
Die Ergebnisse zeigen, dass die Testsubstanzen die schädigenden Einflüsse von UVB- Strahlen signifikant reduzieren und insbesondere die Freisetzung von LDH und PGE2 vermindern.The results show that the test substances significantly reduce the harmful effects of UVB rays and in particular reduce the release of LDH and PGE2.
Cytophotoprotektion von humanen FibroblastenCytophotoprotection of human fibroblasts
Der Zellschutz vor UV-A-Strahlung wurde durch einen Test an humanen Fibroblasten bewertet, da UV-A-Strahlung durch die Epidermis penetriert und im Bereich der Dermis Schäden durch oxidativen Stress induziert (DALLE CARBONARE M, PATHAK MA ; Skin photosensitizing agents and the role of reactive oxygen species in photoaging ; JOURNAL OF PHOTOCHEMISTRY & PHOTOBIOLOGY, 1992, 14, 1-2, 105-124. (P10482). Das Ausmaß an oxidativem Stress wurde in vitro durch Bestimmung des Gehaltes an freigesetztem Malondi- aldehyd und intracellulärem GSH (reduziertes Glutathion) festgestellt (Moriiere P., Moisan A., Santus R., Huppe G., Maziere J.C., Dubertret L.: UV-A induced lipid peroxydation in cultu- red human fibroblasts . Biochim. Biophys. Acta , 1084, 3:261-269 (1991) .The cell protection against UV-A radiation was assessed by a test on human fibroblasts, since UV-A radiation penetrates through the epidermis and induces damage by oxidative stress in the area of the dermis (DALLE CARBONARE M, PATHAK MA; Skin photosensitizing agents and the role of reactive oxygen species in photoaging; JOURNAL OF PHOTOCHEMISTRY & PHOTOBIOLOGY, 1992, 14, 1-2, 105-124. (P10482) The extent of oxidative stress was determined in vitro by determining the content of released malondialaldehyde and intracellular GSH (reduced glutathione) found (Moriiere P., Moisan A., Santus R., Huppe G., Maziere JC, Dubertret L .: UV-A induced lipid peroxidation in cultivated human fibroblasts. Biochim. Biophys. Acta, 1084, 3: 261-269 (1991).
Methode:Method:
Inoculation humaner Fibroblasten in Nährmedium (Standard Medium mit foetalem Kälberserum (FCS), eine Inkubation erfolgte über 3 Tage bei 37°C und 032=5%. Das Nährmedium wurde durch ein Standardmedium ohne FCS jedoch mit Wirkstoff ausgetauscht und erneut für 3 Tage bei 37°C und CO2=5% inkubiert. Danach wurde das Nährmedium durch isotonische Salzlösung ausgetauscht und die Fibroblasten einer UVA-Strahlung von 20 J/cm2 (black light TFWN lamp ) ausgesetzt. Spektrophotometrisch wurde im überstehenden Medium dann der Gehalt an malonaldialde- hyd bestimmt (MDA-Rate).Inoculation of human fibroblasts in nutrient medium (standard medium with fetal calf serum (FCS), incubation was carried out for 3 days at 37 ° C. and 032 = 5%. The nutrient medium was replaced by standard medium without FCS but with active ingredient and again for 3 days at 37 ° C and CO2 = 5%, then the nutrient medium was replaced with isotonic saline and the fibroblasts were exposed to UVA radiation of 20 J / cm2 (black light TFWN lamp). The content of malonic aldehyde was then determined spectrophotometrically (MDA rate).
Die Anzahl der Zellen wurde durch die Bradford Methode über den Gehlat zellulärer Proteine gemessen. Die Ergebnisse in Tabelle 4 sind in % gegen die Kontrolle (ohne UV- Lichteinwirkung) als Mittelwert von zwei Bestimmungen in dreifacher Durchführung angegeben.The number of cells was measured by the Bradford method on the gehlat of cellular proteins. The results in Table 4 are given in% against the control (without exposure to UV light) as the mean of two determinations in triplicate.
Tabelle 4: Cytophotoprotektion vor UV-A-Strahlung an humanen FibroblastenTable 4: Cytophotoprotection before UV-A radiation on human fibroblasts
Die Ergebnisse zeigen, dass die untersuchten Fermentierungsprodukte zu einer signifikanten Reduktion der Schädigungen durch UV-A-Strahlung führen. Daher sind die Fementie- rungsprodukte vorteilhaft zur Verbesserung der Resistenz von Haut und Haarfollikeln gegen oxidativen Stress, der durch UV-Strahlung , aber auch Umweltgifte ausgeübt wird. Sie schützen Haut und Haarfollikel gegen Alterung.The results show that the fermentation products investigated lead to a significant reduction in the damage caused by UV-A radiation. Therefore, the cementation products are advantageous for improving the resistance of the skin and hair follicles to oxidative stress, which is exerted by UV radiation, but also by environmental toxins. They protect the skin and hair follicles against aging.
Hemmung der ElastaseInhibition of elastase
Elastase ist eine Protease, die von Leukocyten bei einem Entzündungsprozess oder von Fibroblasten nach Exposition von UV-Strahlung oder durch Alterung ausgeschieden wird. Sie ist ein Enzym, das die Zerstörung von wesentlichen dermalen Proteinen, wie beispielsweise Proteoglykanen, Elastin oder Kollagenfasern, katalysiert und auf diese Weise die in- trinsische Alterung ebenso wie die Photo-Alterung von menschlicher Haut induziert. (ROBERT L, LABAT ROBERT J: Vieillissement et tissu conjonctif. Annee Gerontologique, 23-37, 1992).Elastase is a protease that is excreted by leukocytes during an inflammatory process or by fibroblasts after exposure to UV radiation or through aging. It is an enzyme that catalyzes the destruction of essential dermal proteins such as proteoglycans, elastin or collagen fibers and in this way induces intrinsic aging as well as photo-aging of human skin. (ROBERT L, LABAT ROBERT J: Vieillissement et tissu conjonctif. Annee Gerontologique, 23-37, 1992).
Methode:Method:
Untersuchungsmethode gemäß (BIETH J: Elastase: Structure, Function and Pathological Role. Front Matrix Biol., 6:1-82, Karger Basel, 1978).Test method according to (BIETH J: Elastase: Structure, Function and Pathological Role. Front Matrix Biol., 6: 1-82, Karger Basel, 1978).
Der Versuch wurde mit Elastase von Pankreas angefärbt mit Kongorot ausgeführt. Die Inkubationszeit bei Raumtemperatur betrug 30 Minuten und die optische Dichte des freigesetzten Kongorots wurde nach Zentrifugation bei einer Wellenlänge von 520 nm bestimmt. Die Ergebnisse aus Tabelle 5 sind ausgedrückt in % der Hemmung gegen eine Kontrolle (= 0%).The test was carried out with elastase from pancreas stained with Congo red. The incubation time at room temperature was 30 minutes and the optical density of the Congo red released was determined after centrifugation at a wavelength of 520 nm. The results from Table 5 are expressed in% of the inhibition against a control (= 0%).
Tabelle 5 : Elastase - Hemmung in tuboTable 5: Elastase inhibition in tubo
Das untersuchte Fermentationsprodukt wies eine gute Hemmung der Freisetzung von Elastase auf und kann somit erfolgreich gegen Hautalterung und Schädigungen durch UV- Strahlungseinwirkung eingesetzt werden.The fermentation product investigated had a good inhibition of the release of elastase and can therefore be used successfully against skin aging and damage caused by UV radiation.
Modulation der MelanogeneseModulation of melanogenesis
Es wurde der Einfluß auf die Melanogenese mittels eines Tests mit einer in vitro Kultur von B16 melanocyten bestimmt.The influence on melanogenesis was determined by means of a test with an in vitro culture of B16 melanocytes.
Methode :Method:
Melanocyten (B16 Zelllinie) wurden in Standardwachstumsmedium mit foetalem Kälberserum (FCS) für 3 tage bei 37°C und CO2=5% inkubiert. Das Wachstumsmedium wurde gegen Standardmedium mit unterschiedlichen Konzentrationen an Fermentationsprodukt ausgetauscht. Nach einer weiteren Inkubation über 3 Tage wurde die Zahl der lebenden Zellen durch eine Bestimmung von zellulären Proteinen nach der Bradford-Methode ermittelt und der Gehalt an synthetisiertem Melanin durch Messung der optischen Dichte bei 475 nm im Zellhomogenisat detektiert.Melanocytes (B16 cell line) were incubated in standard growth medium with fetal calf serum (FCS) for 3 days at 37 ° C and CO2 = 5%. The growth medium was exchanged for standard medium with different concentrations of fermentation product. After a further incubation over 3 days, the number of living cells was determined by determining cellular proteins using the Bradford method and the content of melanin synthesized was measured by measuring the optical density at 475 nm in the cell homogenate.
Die Ergebinisse in Tabelle 6 sind ausgedrückt in % gegen eine Kontrolle (Zellkultur ohne Fermentationsprodukt). The results in Table 6 are expressed in% against a control (cell culture without fermentation product).
Das untersuchte fermentierte Produkt zeigte ein hohes Potential zur Modulation der Melanin- Synthese in in vitro-Kulturen von Melanocyten.The fermented product investigated showed a high potential for modulating melanin synthesis in in vitro cultures of melanocytes.
Immunstimulationimmune stimulation
Unter Immunstimulation sind biochemische Abläufe zu verstehen, bei denen Botenstoffe, wie beispielsweise Betaglucane die körpereigenen Abwehrkräfte stimulieren, um beispielsweise toxische Stoffe zu binden und auszuscheiden und die Erneuerung von Hautzellen zu beschleunigen. Es ist bekannt, dass Organismen diese Fähigkeit mit zunehmendem Alter verloren geht. Die Immunstimulation kann in-vitro an Hand von menschlichen Leukocyten beobachtet werden, welche zuvor mit einem Hefeextrakt (Zymosan) aktiviert worden sind [vgl. Capsoni et al. Int.J.Immunopharm. 10(2), 121-133 (1998)]. Eine Kultur polymorpho- nuclearer neutrophiler Granulocyten (PMN) wurde zusammen mit den Testsubstanzen über einen Zeitraum von 24 h bei 37 °C und 5 Vol.-% CO2 inkubiert. Durch Zugabe von Zymosan wurde der Atmungsausbruch ausgelöst. Nach 30 min wurde die PMN-Zahl durch einen automatischen Zellzähler und die Menge an freigesetzten reaktiven Sauerstoffspezies (ROS) in der überstehenden Flüssigkeit mit Hilfe von Luminol spektroskopisch bestimmt. Die Ergebnisse sind in Tabelle 4 zusammengefasst und verstehen sich als %-rel gegenüber dem Standard. Angegeben ist der Mittelwert von zwei Messreihen mit Dreifachbestimmung.Immune stimulation is understood to mean biochemical processes in which messenger substances, such as beta glucans, stimulate the body's defenses, for example to bind and excrete toxic substances and to accelerate the renewal of skin cells. It is known that organisms lose this ability with age. The immune stimulation can be observed in vitro using human leukocytes which have been activated beforehand with a yeast extract (zymosan) [cf. Capsoni et al. Int.J.Immunopharm. 10 (2), 121-133 (1998)]. A culture of polymorphonuclear neutrophil granulocytes (PMN) was incubated together with the test substances over a period of 24 hours at 37 ° C. and 5% by volume CO 2 . The respiratory outbreak was triggered by the addition of Zymosan. After 30 min, the PMN number was determined spectroscopically by an automatic cell counter and the amount of reactive oxygen species (ROS) released in the supernatant liquid using luminol. The results are summarized in Table 4 and are understood as% -rel compared to the standard. The average of two series of measurements with triple determination is given.
Tabelle 4Table 4
Immunstimulation (Angabe in %-rel.)Immune stimulation (in% rel.)
Die Ergebnisse zeigen, dass die Testsubstanzen das Immunsystem stimulieren und die körpereigenen Abwehrkräfte insbesondere der Hautzellen nachhaltig stärken. The results show that the test substances stimulate the immune system and sustainably strengthen the body's defenses, especially of the skin cells.
Ex-vivo Bestimmung des Moisturising-EffektesEx vivo determination of the moisturizing effect
Das trockene Stratum Corneum ist ein dielektrisches Medium mit schwacher Leitfähigkeit. Wird ihm Feuchtigkeit zugeführt, nimmt die Leitfähigkeit infolge des bipolaren Charakters der Wassermoleküle zu. Die Konduktometrie stellt daher ein geeignetes Verfahren dar, um den Hydratationszustand des Stratum Corneums zu bestimmen. Wird durch Zugabe von Testsubstanzen die Leitfähigkeit verbessert, kann darauf geschlossen werden, dass diese einen feuchtigkeitsspendenden Effekt besitzen. Zur Untersuchung wurde ein in-vitro Hautmodell verwendet, welches zuvor nach der Vorschrift von Obata und Tagami in J.Soc.Cosmet.Chem., 41, 235-242 (1990) hergestellt worden war. Die Präparate wurden in Kammern definierter Luftfeuchtigkeit equilibriert und dann unter drei bzw. vier verschiedenen Bedingungen getestet:The dry stratum corneum is a dielectric medium with poor conductivity. If moisture is added to it, the conductivity increases due to the bipolar nature of the water molecules. Conductometry is therefore a suitable method for determining the state of hydration of the stratum corneum. If the conductivity is improved by adding test substances, it can be concluded that these have a moisturizing effect. For the investigation, an in vitro skin model was used, which had previously been produced according to the instructions of Obata and Tagami in J. Soc.Cosmet.Chem., 41, 235-242 (1990). The preparations were equilibrated in chambers of defined air humidity and then tested under three or four different conditions:
> Kontrollversuch ohne Behandlung> Control attempt without treatment
> Blindversuch mit Placebo-Behandlung> Blind trial with placebo treatment
> Erfindungsgemäßer Versuch mit Testsubstanz> Test according to the invention with test substance
> Vergleichsversuch mit Standardzubereitung> Comparison test with standard preparation
Die Leitfähigkeitsmessungen wurden jeweils vor der Behandlung und danach über einen Zeitraum von 0,5 bis 24 nach der Behandlung durchgeführt. Die Ergebnisse sind in Tabelle 5 zusammengefasst.The conductivity measurements were carried out before the treatment and then over a period of 0.5 to 24 after the treatment. The results are summarized in Table 5.
Tabelle 5: HydratationsmessungenTable 5: Hydration measurements
Tabelle 5: Hydratationsmessungen (Forts.) Table 5: Hydration measurements (cont.)
Die Beispiele zeigen, dass durch Zugabe der Testsubstanzen der Hydratationszustand des Stratum Corneums auch im Vergleich mit bekannten Feuchtigkeitsmitteln signifikant verbessert wird. Bei Einsatz einer Creme mit 1,5 Gew.-% des Extraktes nach Bsp.4 wurde schon nach 30 min eine Verbesserung der Hydratation um mehr als 160 % festgestellt, während eine Vergleichscreme mit einer gewichtsgleichen Menge an Glycerin nur eine Verbesserung um rund 75 % erbrachte.The examples show that the addition of the test substances significantly improves the state of hydration of the stratum corneum in comparison with known moisturizers. When using a cream with 1.5% by weight of the extract according to Example 4, an improvement in hydration of more than 160% was found after just 30 minutes, while a comparison cream with an equal weight of glycerol only showed an improvement of around 75%. rendered.
In-vivo Messung des Moisturising-EffektesIn-vivo measurement of the moisturizing effect
Analog zur ex-vivo Bestimmung kann der Hydratationszustand der Haut auch in-vivo mit Hilfe der Konduktometrie im Rahmen einer nicht invasiven Messung bestimmt werden. Dazu wird auf einer Fläche von 4 cm2 der Innenseite des Unterarmes zunächst die Leitfähigkeit ohne Behandlung mit der Testsubstanz bestimmt (TO-Wert). Anschließend werden 4 μl/cm2 Testsubstanz aufgetragen, 15 min getrocknet und danach erneut die Leitfähigkeit bestimmt (T15-Wert). Zur Kontrolle wird zudem die Leitfähigkeit einer benachbarten Hautpartie gemessen, die nicht mit der Testsubstanz behandelt worden war. Die Ergebnisse werden als prozentuales Verhältnis T15/T0 ausgedrückt und sind in Tabelle 6 zusammengefasst.Analogous to the ex-vivo determination, the state of hydration of the skin can also be determined in-vivo using conductometry as part of a non-invasive measurement. For this purpose, the conductivity is first determined on an area of 4 cm 2 on the inside of the forearm without treatment with the test substance (TO value). 4 μl / cm 2 of test substance are then applied, dried for 15 minutes and the conductivity is then determined again (T15 value). As a control, the conductivity of a neighboring skin area is also measured, which had not been treated with the test substance. The results are expressed as a percentage ratio T15 / T0 and are summarized in Table 6.
Tabelle 6: Hydratationsmessungen [%-rel.]Table 6: Hydration measurements [% -rel.]
Die Ergebnisse zeigen, dass die Testsubstanzen den Hydratationszustand der Haut signifikant verbessern. Verbesserung der HautrauhigkeitThe results show that the test substances significantly improve the state of hydration of the skin. Improve skin roughness
Den Einfluss, den Testsubstanzen auf die Rauhigkeit bzw. Weichheit der Haut ausüben, kann in vivo mit Hilfe der Friktiometrie bestimmt werden. Das Prinzip dieser Messung beruht darauf, dass mit Hilfe eines Rotationskörpers ein konstanter Druck auf die Hautoberfläche ausgeübt wird. Gemessen wird die dafür erforderliche Kraft über die der Friktionskoeflϊzient ermittelt werden kann. Die aufzuwendende Kraft ist direkt von der Hautrauhigkeit abhängig. Daraus ergibt sich, dass der Koeffizient umso größer ist, je höher der Hydratationszustand der Haut, d.h. die Weichheit ist. Dazu wird auf einer Fläche von 9 cm2 der Innenseite des Unterarmes zunächst die Friktion ohne Behandlung mit der Testsubstanz bestimmt (T0- Wert). Anschließend werden 4 μl/cm2 Testsubstanz aufgetragen, 15 min getrocknet und danach erneut die Friktion bestimmt (T15-Wert). Zur Kontrolle wird zudem die Leitfähigkeit einer benachbarten Hautpartie gemessen, die nicht mit der Testsubstanz behandelt worden war. Die Ergebnisse werden als prozentuales Verhältnis T15/T0 ausgedrückt und sind in Tabelle 7 zusammengefasst.The influence that test substances exert on the roughness or softness of the skin can be determined in vivo with the help of fructiometry. The principle of this measurement is based on the fact that a rotating body exerts constant pressure on the skin surface. The force required for this is measured via which the friction coefficient can be determined. The force to be applied is directly dependent on the roughness of the skin. It follows that the higher the hydration state of the skin, ie the softness, the greater the coefficient. For this purpose, the friction is first determined on an area of 9 cm 2 on the inside of the forearm without treatment with the test substance (T0 value). Then 4 μl / cm 2 of test substance are applied, dried for 15 minutes and then the friction is determined again (T15 value). As a control, the conductivity of a neighboring skin area is also measured, which had not been treated with the test substance. The results are expressed as a percentage ratio T15 / T0 and are summarized in Table 7.
Tabelle 7: Friktionsmessungen [%-rel.]Table 7: Friction measurements [% -rel.]
Die Ergebnisse zeigen, dass die Testsubstanzen die Rauhigkeit der Haut signifikant verbessern und sie deutlich weicher machen.The results show that the test substances significantly improve the roughness of the skin and make it significantly softer.
In der nachfolgenden Tabelle 8 sind eine Reihe von Formulierungsbeispielen gegeben. A number of formulation examples are given in Table 8 below.
Tabelle 8Table 8
Beispiele für kosmetische Zubereitungen (Wasser, Konservierungsmittel ad 100 Gew.-%)Examples of cosmetic preparations (water, preservative ad 100 wt .-%)
(1, 6) Softcreme, (2, 3, 7, 8) Feuchtigkeitsemulsion, (4, 5, 9, 10) Nachtcreme (1, 6) soft cream, (2, 3, 7, 8) moisturizing emulsion, (4, 5, 9, 10) night cream

Claims

Patentansprüche claims
1. Kosmetische und/oder pharmazeutische Wirkstoffe, dadurch erhältlich, dass man Pflanzenbestandteile und/oder pflanzliche Extrakte fermentiert.1. Cosmetic and / or pharmaceutical active ingredients, obtainable by fermenting plant components and / or plant extracts.
2. Verfahren zur Herstellung von kosmetischen und/oder pharmazeutischen Wirkstoffen, bei dem man Pflanzenbestandteile und/oder pflanzliche Extrakte fermentiert.2. Process for the production of cosmetic and / or pharmaceutical active ingredients, in which one fermentes plant components and / or plant extracts.
3. Verfahren nach Anspruch 2, dadurch gekennzeichnet, dass man3. The method according to claim 2, characterized in that one
(a) Pflanzenbestandteile und/oder pflanzliche Extrakte zerkleinert und/oder aus- presst und/oder extrahiert und zu einer Fermentationsbrühe verarbeitet,(a) comminuted plant components and / or plant extracts and / or pressed and / or extracted and processed into a fermentation broth,
(b) gegebenenfalls die Fermentationsbrühe pasteurisiert bzw. sterilisiert,(b) optionally pasteurized or sterilized the fermentation broth,
(c) die so vorbereitete Fermentationsbrühe mit den Mikroorganismen inoculiert,(c) the fermentation broth thus prepared inoculates with the microorganisms,
(d) die so inoculierte Fermentationsbrühe fermentiert, und gegebenenfalls(d) fermenting the fermentation broth thus inoculated, and optionally
(e) nach Beendigung der Fermentation die Fermentationsbrühe aufarbeitet und die Wirkstoffe abtrennt.(e) after the end of the fermentation, the fermentation broth is worked up and the active ingredients are separated off.
4. Verfahren nach den Ansprüchen 2 und/oder 3, dadurch gekennzeichnet, dass man Pflanzenbestandteile und/oder pflanzliche Extrakte fermentiert, die ausgewählt sind aus der Gruppe der Pflanzen, die gebildet wird von Kartoffeln, Reis, Soja, Weizen, Gerste, Hafer, Roggen, Buchweizen, Bohnen, Erbsen, Leinsamen, Baumwolle, Sesam, Lupinen, Raps, Hanf, Cocuspalme, Sonnenblumen,Luzerne, Hibiscus, Maca, Quinoa, Mandel, Moringa, Seide, Baobao, Cassia, Irvinga, Distel und Ölpalme.4. The method according to claims 2 and / or 3, characterized in that fermenting plant components and / or plant extracts which are selected from the group of plants which is formed by potatoes, rice, soybeans, wheat, barley, oats, Rye, buckwheat, beans, peas, linseed, cotton, sesame, lupine, rapeseed, hemp, coconut palm, sunflower, alfalfa, hibiscus, maca, quinoa, almond, moringa, silk, baobao, cassia, irvinga, thistle and oil palm.
5. Verfahren nach mindestens einem der Ansprüche 2 bis 4, dadurch gekennzeichnet dass man als Pflanzenbestandteile pflanzliche Ausgangsstoffe ausgewählt aus der Gruppe der Samen, Knollen, Wurzeln, Blätter, Früchte in zerkleinerter und/oder aus- gepresster und/oder extrahierter Form, sowie Proteinkonzentrate, - hydrolysate oder -isolate einsetzt.5. The method according to at least one of claims 2 to 4, characterized in that plant constituents selected as plant constituents from the group of seeds, tubers, roots, leaves, fruits in comminuted and / or squeezed and / or extracted form, and protein concentrates , - uses hydrolysates or isolates.
6. Verfahren nach mindestens einem der Ansprüche 2 bis 5, dadurch gekennzeichnet, dass man eine Extraktion im schwach alkalischen Bereich durchführt. 6. The method according to at least one of claims 2 to 5, characterized in that one carries out an extraction in the weakly alkaline range.
7. Verfahren nach mindestens einem der Ansprüche 2 bis 6, dadurch gekennzeichnet, dass man die Fermentationsbrühen auf einen pH-Wert im Bereich von 4,5 bis 8,5 einstellt.7. The method according to at least one of claims 2 to 6, characterized in that the fermentation broth is adjusted to a pH in the range from 4.5 to 8.5.
8. Verfahren nach mindestens einem der Ansprüche 2 bis 7, dadurch gekennzeichnet, dass man die Pasteurisierung bzw. Sterilisierung bei einer Temperatur im Bereich von 60 bis 135 °C durchführt.8. The method according to at least one of claims 2 to 7, characterized in that one carries out the pasteurization or sterilization at a temperature in the range of 60 to 135 ° C.
9. Verfahren nach mindestens einem der Ansprüche 2 bis 8, dadurch gekennzeichnet, dass man die Pasteurisierung bzw. Sterilisierung über einen Zeitraum von 1 bis 30 min durchführt.9. The method according to at least one of claims 2 to 8, characterized in that one carries out the pasteurization or sterilization over a period of 1 to 30 min.
10. Verfahren nach mindestens einem der Ansprüche 2 bis 9, dadurch gekennzeichnet, dass man die Fermentation in Gegenwart einer Mischung verschiedener Mikroorganismus durchführt.10. The method according to at least one of claims 2 to 9, characterized in that one carries out the fermentation in the presence of a mixture of different microorganisms.
11. Verfahren nach Anspruch 10, dadurch gekennzeichnet, dass man Mischungen verschiedener Mikroorganismen einsetzt, die wenigstens einen Vertreter aus der Gruppe Lactobacillus, Lactococcus und Leuconostoc enthalten.11. The method according to claim 10, characterized in that mixtures of different microorganisms are used which contain at least one member from the group Lactobacillus, Lactococcus and Leuconostoc.
12. Verfahren nach den Ansprüchen 9 und/oder 11, dadurch gekennzeichnet, dass man Mischungen verschiedener Mikroorganismen einsetzt, die wenigstens eine Hefe enthalten.12. The method according to claims 9 and / or 11, characterized in that mixtures of different microorganisms are used which contain at least one yeast.
13. Verfahren nach mindestens einem der Ansprüche 9 bis 12, dadurch gekennzeichnet, dass man Mikroorganismen einsetzt, die ausgewählt sind aus der Gruppe, die gebildet wird von Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus caucasicus, Lactobacillus cellobiosus, Lactobacillus delbruecki, Lactobacillus helveticus, Lactobacillus hilgardii, Lactobacillus kefir, Lactobacillus kefiranofaciens, Lactobacilluskefirgranum, Lactobacillus parakefir, Lactobacillus plantarum, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetilactis, Lactococcus lactis subsp.lactis, Lactococcus plantarum, Leuconostoc citreum, Leuconostoc citroverum, Leuconostoc dextranicum, Leuconostoc kefir, Leuconostoc mesenteroides, Leuconostoc pseudomesenteroides, Candida kefir, Candida tenuis, Kluyveromyces bulgaricus, Kluyveromyces fragilis, Kluyveromyces lactis, Saccharomyces carbajali, Saccharomyces carlbergensis, Sacharomyces cerevisiae, Saccharomyces delbrueckii, Saccharomyces florentinus, Saccharomyces globosus, Saccharomyces kefir, Saccharomyces marxianus, Saccharomyces, unisporus, Torula homii, Torula kefir, Streptococcus thermophilus, Streptococcus durans, Acetobacter aceti und Acetobacter rasens sowie deren Gemische.13. The method according to at least one of claims 9 to 12, characterized in that microorganisms are used which are selected from the group formed by Lactobacillus acidophilus, Lactobacillus brevis, Lactobacillus casei, Lactobacillus caucasicus, Lactobacillus cellobiosus, Lactobacillus Lactobacillus, Lactobacillus helveticus, Lactobacillus hilgardii, Lactobacillus kefir, Lactobacillus kefiranofaciens, Lactobacilluskefirgranum, Lactobacillus parakefir, Lactobacillus plantarum, Lactococcus lactis subsp. cremoris, Lactococcus lactis subsp. diacetilactis, Lactococcus lactis subsp.lactis, Lactococcus plantarum, Leuconostoc citreum, Leuconostoc citroverum, Leuconostoc dextranicum, Leuconostoc kefir, Leuconostoc mesenteroides, Leuconostoc pseudomesenteroides, Candida kefiricveromyces, Candida kefiromyces, Candida kefiraliomyces Sacharomyces cerevisiae, Saccharomyces delbrueckii, Saccharomyces florentinus, Saccharomyces globosus, Saccharomyces kefir, Saccharomyces marxianus, Saccharomyces, unisporus, Torula homii, Torula kefir, Streptococcus thermophilus, Streptococcus durans, Acetobacter aceti and Acetobacter rasens and mixtures thereof.
14. Verfahren nach mindestens einem der Ansprüche 9 bis 13, dadurch gekennzeichnet, dass man die Milchsäurebakterien in Mengen von 102 bis 108 cfu/ml einsetzt.14. The method according to at least one of claims 9 to 13, characterized in that the lactic acid bacteria are used in amounts of 10 2 to 10 8 cfu / ml.
15. Verfahren nach mindestens einem der Ansprüche 9 bis 14, dadurch gekennzeichnet, dass man die Hefen in Mengen von 102 bis 107 cfu/ml einsetzt.15. The method according to at least one of claims 9 to 14, characterized in that the yeasts are used in amounts of 10 2 to 10 7 cfu / ml.
16. Verfahren nach mindestens einem der Ansprüche 2 bis 15, dadurch gekennzeichnet, dass man die Fermentation bei Temperaturen im Bereich von 10 bis 47 °C durchführt.16. The method according to at least one of claims 2 to 15, characterized in that one carries out the fermentation at temperatures in the range of 10 to 47 ° C.
17. Verfahren nach mindestens einem der Ansprüche 2 bis 16, dadurch gekennzeichnet, dass man die Fermentation über einen Zeitraum von 12 bis 48 h durchführt.17. The method according to at least one of claims 2 to 16, characterized in that one carries out the fermentation over a period of 12 to 48 h.
18. Verfahren nach mindestens einem der Ansprüche 2 bis 17, dadurch gekennzeichnet, dass man die Wirkstoffe von der Fermentationsbrühe durch Zentrifugieren, Membranfiltration, Flüssig-Flüssig-Extraktion, Festphasenextraktion, Chromatographie oder Niederschlagen aus Lösemitteln abtrennt.18. The method according to at least one of claims 2 to 17, characterized in that the active ingredients are separated from the fermentation broth by centrifugation, membrane filtration, liquid-liquid extraction, solid phase extraction, chromatography or precipitation from solvents.
19. Verfahren nach mindestens einem der Ansprüche 2 bis 18, dadurch gekennzeichnet, dass man die in den Fermentationsprodukten noch enthaltenen Mikroorganismen durch thermische Behandlung zerstört oder abtrennt.19. The method according to at least one of claims 2 to 18, characterized in that the microorganisms still contained in the fermentation products are destroyed or separated by thermal treatment.
20. Kosmetische und/oder pharmazeutische Zubereitungen, enthaltend Wirkstoffe nach Anspruch 1.20. Cosmetic and / or pharmaceutical preparations containing active ingredients according to claim 1.
21. Zubereitungen nach Anspruch 20, dadurch gekennzeichnet, dass sie die Wirkstoffe in Mengen von 0,01 bis 5 Gew.-% - bezogen auf die Mittel - enthalten.21. Preparations according to claim 20, characterized in that they contain the active ingredients in amounts of 0.01 to 5 wt .-% - based on the agent.
22. Verwendung von Wirkstoffen nach Anspruch 1 zur Herstellung von kosmetischen oder pharmazeutischen Zubereitungen.22. Use of active ingredients according to claim 1 for the production of cosmetic or pharmaceutical preparations.
23. Verwendung von Wirkstoffen nach Anspruch 1 zur Stimulierung des Wachstums und des Überlebens von Fibroblasten. 23. Use of active ingredients according to claim 1 for stimulating the growth and survival of fibroblasts.
24. Verwendung von Wirkstoffen nach Anspruch 1 zur Stimulierung der GHS-Konzentration in den Zellen.24. Use of active ingredients according to claim 1 for stimulating the GHS concentration in the cells.
25. Verwendung von Wirkstoffen nach Anspruch 1 als anti-inflammatorische Agentien.25. Use of active ingredients according to claim 1 as anti-inflammatory agents.
26. Verwendung von Wirkstoffen nach Anspruch 1 zum Schutz von Haut und Haaren gegen UV-Strahlung.26. Use of active ingredients according to claim 1 for protecting skin and hair against UV radiation.
27. Verwendung von Wirkstoffen nach Anspruch 1 zur Immunstimulation des Metabolismus.27. Use of active ingredients according to claim 1 for immune stimulation of the metabolism.
28. Verwendung von Wirkstoffen nach Anspruch 1 zur Bekämpfung von Falten sowie zur Vitalisierung und Verjüngung der Haut.28. Use of active ingredients according to claim 1 for combating wrinkles and for vitalizing and rejuvenating the skin.
29. Verwendung von Wirkstoffen nach Anspruch 1 zur Stärkung der Abwehrkräfte von Haut- und Haarfollikeln gegen Umweltgifte und oxidativen Stress.29. Use of active ingredients according to claim 1 for strengthening the defenses of skin and hair follicles against environmental toxins and oxidative stress.
30. Verwendung von Wirkstoffen nach Anspruch 1 zur Stimulierung der Fibroblasten zur Bildung von dermalen Makromolekülen.30. Use of active ingredients according to claim 1 for stimulating the fibroblasts to form dermal macromolecules.
31. Verwendung von Wirkstoffen nach Anspruch 1 zur Bekämpfung von Akne vulgaris oder Seborrhoe.31. Use of active ingredients according to claim 1 for combating acne vulgaris or seborrhea.
32. Verwendung von Wirkstoffen nach Anspruch 1 als Feuchtigkeitsregulatoren in der Haut.32. Use of active ingredients according to claim 1 as moisture regulators in the skin.
33. Verwendung von Wirkstoffen nach Anspruch 1 zur Inhibierung von Collagenasen und Elastasen.33. Use of active ingredients according to claim 1 for inhibiting collagenases and elastases.
34. Verwendung von Wirkstoffen nach Anspruch 1 als Regulatoren für die Melanogenese in Haut und Haaren.34. Use of active ingredients according to claim 1 as regulators for melanogenesis in skin and hair.
35. Verwendung von Wirkstoffen nach Anspruch 1 als Entschleimungsmittel.35. Use of active ingredients according to claim 1 as degumming agents.
36. Verwendung von Wirkstoffen nach Anspruch 1 zum Schutz gegen Hautalterung. 36. Use of active ingredients according to claim 1 for protection against skin aging.
37. Verwendung von Wirkstoffen nach Anspruch 1 zum Schutz gegen Umweltgifte.37. Use of active ingredients according to claim 1 for protection against environmental toxins.
38. Verwendung von Wirkstoffen nach Anspruch 1 zur Stimulation des Haarwuchses.38. Use of active ingredients according to claim 1 for stimulating hair growth.
39. Verwendung von Wirkstoffen nach Anspruch 1 zur Herstellung kosmetischer Mittel für die empfindliche Haut.39. Use of active ingredients according to claim 1 for the production of cosmetic compositions for sensitive skin.
40. Verwendung von Wirkstoffen nach Anspruch 1, dadurch gekennzeichnet, dass die Wirkstoffe in Form von Mikro- oder Nanokapseln eingesetzt werden. 40. Use of active ingredients according to claim 1, characterized in that the active ingredients are used in the form of micro- or nanocapsules.
EP03702392A 2002-01-15 2003-01-07 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts Withdrawn EP1461059A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0200423A FR2834718B1 (en) 2002-01-15 2002-01-15 COSMETIC AND / OR PHARMACEUTICAL ACTIVE SUBSTANCES
FR0200423 2002-01-15
PCT/EP2003/000066 WO2003059368A1 (en) 2002-01-15 2003-01-07 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts

Publications (1)

Publication Number Publication Date
EP1461059A1 true EP1461059A1 (en) 2004-09-29

Family

ID=8871287

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03702392A Withdrawn EP1461059A1 (en) 2002-01-15 2003-01-07 Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts

Country Status (6)

Country Link
US (1) US20050089499A1 (en)
EP (1) EP1461059A1 (en)
JP (1) JP2005521649A (en)
AU (1) AU2003205571A1 (en)
FR (1) FR2834718B1 (en)
WO (1) WO2003059368A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111588656A (en) * 2020-04-30 2020-08-28 杭州谦美化妆品有限公司 Application of symbiotic fermentation product of hydrolyzed candida and saccharomyces cerevisiae

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2847426B1 (en) * 2002-11-22 2006-02-24 Jean Morelle FOOD VEGETABLE ANTI-HYDROGEN PEROXIDE
US7041636B1 (en) * 2004-01-22 2006-05-09 Benton Melody M Composition for counteracting hair loss
JP4563225B2 (en) * 2004-03-15 2010-10-13 共栄化学工業株式会社 Cosmetics
JP5147805B2 (en) * 2004-03-15 2013-02-20 共栄化学工業株式会社 Cosmetics
JP2005348698A (en) * 2004-06-14 2005-12-22 Yonezawa Biru System Service:Kk Bacterium separated from kefir granule, bacterial culture obtained by culturing the bacterium or bacterium group containing the same and product obtained by using them
JP2006076927A (en) * 2004-09-09 2006-03-23 Toyo Shinyaku:Kk Fermented material obtained from mango
JP4488861B2 (en) * 2004-10-06 2010-06-23 共栄化学工業株式会社 Cosmetics
FR2879444B1 (en) * 2004-12-22 2007-05-18 Oreal USE OF A COMPOUND CAPABLE OF INCREASING THE GLUTATHION RATE IN MELANOCYTES FOR THE TREATMENT OF CANITIS
JP5020475B2 (en) * 2005-03-14 2012-09-05 共栄化学工業株式会社 Fibroblast activator and skin external preparation containing the same
JP4160964B2 (en) 2005-04-01 2008-10-08 株式会社ファンケル Sweet pea extract-containing cosmetics
JP5129440B2 (en) * 2005-06-14 2013-01-30 共栄化学工業株式会社 Fermented plant and cosmetics containing the same
GB0513193D0 (en) * 2005-06-29 2005-08-03 Quest Int Serv Bv Improvements in skin and hair care
JP5080728B2 (en) * 2005-07-04 2012-11-21 孝仁 徳山 Cell growth promoters and cell repair agents made from grains or beans other than rice
US20070042064A1 (en) * 2005-08-19 2007-02-22 Access Business Group International Llc Extracts of durian fruit for use in skin care compositions
WO2007064966A2 (en) * 2005-12-02 2007-06-07 Howard Murad Pharmaceutical and dermatocosmetic compositions comprising extract of durio zibethinus
FI20065182A0 (en) * 2006-03-20 2006-03-20 Elixi Oil Oy Fermented food
ITPD20060182A1 (en) * 2006-05-10 2007-11-11 Stefano Sala COSMETIC OR PHARMACEUTICAL PRODUCT FOR EXTERNAL USE, BASED ON PAPAYA
WO2007143851A1 (en) * 2006-06-16 2007-12-21 Kefiplant Inc. Fermented plant extracts, methods of production and uses
US10086029B2 (en) 2006-06-16 2018-10-02 Kefiplant Inc. Fermented plant extracts, methods of production and uses
WO2008008544A2 (en) * 2006-07-14 2008-01-17 High Spirit Equine Products, Llc Equine whole food supplements
JP2008024638A (en) * 2006-07-20 2008-02-07 Asahi Breweries Ltd Matrix metalloprotease-1 production inhibitor
WO2008015342A2 (en) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2904544A1 (en) * 2006-08-03 2008-02-08 Soc Extraction Principes Actif Use of herbal extract obtained e.g. from i.e. Theobroma cacao and/or at least another active agent e.g. to enhance augmentation of melanin synthesis in melanocytes of epidermis and to improve natural skin pigmentation
FR2904541B1 (en) * 2006-08-03 2011-05-27 Soc Extraction Principes Actif USE OF SOYBEAN EXTRACT AS ACTIVE AGENT FOR INCREASING THE SYNTHESIS OF MELANIN IN MELANOCYTES
WO2008015341A2 (en) * 2006-08-03 2008-02-07 Societe D'extraction Des Principes Actifs Sa (Vincience) Use of a plant extract as active agent for increasing melanin synthesis in melanocytes
FR2904556B1 (en) * 2006-08-03 2013-12-27 Soc Extraction Principes Actif USE OF PEAS EXTRACT AS ACTIVE AGENT FOR INCREASING THE SYNTHESIS OF MELANIN IN MELANOCYTES
BRPI0717551B1 (en) 2006-09-26 2016-03-29 Basf Beauty Care Solutions Llc “Cosmetic active ingredient, cosmetic composition, use of a sarcodiotheca extract, and cosmetic treatment method”
US20080075680A1 (en) * 2006-09-27 2008-03-27 Chen Jonathan Y Culture of microorganisms endogenous to plants and products thereof
JP5101081B2 (en) * 2006-10-31 2012-12-19 日清丸紅飼料株式会社 Feed for prevention and / or treatment of coccidiosis and clostridiasis
MX2010007939A (en) * 2008-01-22 2010-10-04 Hamlet Protein As Composition comprising protein and disperse fat.
US20090202581A1 (en) * 2008-02-12 2009-08-13 Nathalie Schlemer Cosmetic formulation
FR2929511B1 (en) * 2008-04-02 2010-12-31 Basf Beauty Care Solutions France Sas NEW ACTIVE PRINCIPLE STIMULATING THE PROLIFERATION AND / OR THE ACTIVITY OF FIBROBLASTS.
JP5144362B2 (en) * 2008-05-02 2013-02-13 日本メナード化粧品株式会社 Topical skin preparation
JP2009292755A (en) * 2008-06-04 2009-12-17 Toyobo Co Ltd Vegetable-originated stress-mitigating agent
WO2010022073A1 (en) * 2008-08-19 2010-02-25 Dbc, Llc Compositions and methods for utilizing the same
US20100233301A1 (en) 2009-03-11 2010-09-16 Jing Cheng Topical compositions comprising fermented extracts of traditional chinese medicinal (tcm) ingredients, and methods of making and using same
US20100260695A1 (en) * 2009-04-09 2010-10-14 Mary Kay Inc. Combination of plant extracts to improve skin tone
CN102510723B (en) 2009-09-24 2016-08-10 荷兰联合利华有限公司 Comprise the disinfectant of eugenol, terpinol and thymol
KR101280482B1 (en) * 2010-05-31 2013-07-01 (주)내츄럴코리아 Cosmetic for Improving Skin Wrinkle Comprising polyphosphate of fermented Chrysanthemum indicum .
KR101280481B1 (en) * 2010-05-31 2013-07-01 (주)내츄럴코리아 Cosmetic for Improving Skin Wrinkle Comprising polyphosphate of fermented peppermint.
JP5737896B2 (en) * 2010-10-01 2015-06-17 共栄化学工業株式会社 Cosmetics
CN103354741B (en) 2010-12-07 2016-01-13 荷兰联合利华有限公司 Oral care composition
JP2012176931A (en) * 2011-01-31 2012-09-13 Angfa Co Ltd Hair tonic
KR20140051425A (en) 2011-08-17 2014-04-30 바스프 코포레이션 Marine based cosmetic active ingredients and use thereof
CN103998011B (en) 2011-11-03 2016-11-23 荷兰联合利华有限公司 Personal cleaning compositions
KR101501328B1 (en) * 2011-12-28 2015-03-18 동의대학교 산학협력단 Skin care Composition
FR2988296B1 (en) * 2012-03-23 2017-01-27 Soc D'exploitation De Produits Pour Les Ind Chimiques Seppic NOVEL USE OF QUINOA EXTRACTS AS AN ACTIVE AGENT FOR PREVENTING AND / OR LIMITING THE INESTHETIC EFFECTS GENERATED BY THE HYPOXIA OF ENDOTHELIAL CELLS OF THE HUMAN BODY
JP6474186B2 (en) * 2012-11-26 2019-02-27 共栄化学工業株式会社 Cosmetics
JP5975415B2 (en) * 2012-12-21 2016-08-23 マサ子 松本 Method for producing Moringa fermentation broth
FR2999931A1 (en) 2012-12-21 2014-06-27 Oreal USE OF PROBIOTIC MICROORGANISMS AS AN AGENT PROMOTING MELANIN SYNTHESIS
FR2999932B1 (en) 2012-12-21 2020-01-31 Société des Produits Nestlé S.A. USE OF PROBIOTIC MICROORGANISMS AS A MELANIN SYNTHESIS AGENT
JP6234465B2 (en) * 2013-08-29 2017-11-22 株式会社ヤクルト本社 Collagen fiber bundling ability enhancer
JP2016117683A (en) * 2014-12-22 2016-06-30 株式会社Like Todo Japan製薬 Production method of vascular endothelial growth factor (vegf) production promoter, production method of dermal papilla cell activator, and production method of hair cosmetic
CN107429226A (en) * 2015-01-06 2017-12-01 株式会社露太利温 Luterion and its separation and cultural method
JP6482930B2 (en) * 2015-03-31 2019-03-13 丸善製薬株式会社 Skin cosmetics and foods and drinks
KR101648148B1 (en) * 2015-07-17 2016-08-12 주식회사 단정바이오 Cosmetic composition containing fermented graviola for improving anti-wrinkle and method of preparing the same
WO2017196048A1 (en) * 2016-05-11 2017-11-16 씨제이제일제당 (주) Externally applied composition for alleviating skin wrinkles, containing extract of fermented wheat germ product as active ingredient
KR101929657B1 (en) 2016-05-11 2018-12-18 씨제이제일제당 (주) Skin external agent for improving skin wrinkle comprising an extract of fermented wheat germ
CN106010893A (en) * 2016-07-08 2016-10-12 南通白蒲黄酒有限公司 Low-temperature brewing technology for multifunctional rice wine
US9763976B1 (en) * 2016-08-02 2017-09-19 Zo Skin Health, Inc. Composition and method for treating skin conditions
KR101955111B1 (en) * 2016-09-23 2019-03-07 씨제이제일제당 (주) External composition for soothing effect on the skin comprising an extract of fermented wheat germ
KR101769755B1 (en) * 2016-12-28 2017-08-22 (주)지에프씨 A leuconostoc mesenteroides gfc 160704, cosmetic composition including the leuconostoc mesenteroides gfc 160704 or its culture fluid, and manufacturing method of the cosmetic composition
KR101989407B1 (en) * 2017-03-21 2019-06-14 바이오스펙트럼 주식회사 A composition for promoting melanin synthesis comprising Cirsium japonicum extract
JP6495421B1 (en) * 2017-11-16 2019-04-03 健茂生物科技股▲ふん▼有限公司 Combined fermented beverage process of cactus fruit and red dragon fruit with antioxidant function
KR102485257B1 (en) * 2017-11-28 2023-01-06 (주)아모레퍼시픽 Composition comprising lactic acid bacteria derived from camellia japonica for caring damages of skin cells by microdust
US11007137B2 (en) * 2018-02-12 2021-05-18 Genmont Biotech Incorporation Use of lactobacillus plantarum GMNL-6 composition for skin care
DE102018005470A1 (en) 2018-07-06 2020-01-09 Antal Farago Improved camphor cream
JP6596548B1 (en) * 2018-07-19 2019-10-23 八雲香産株式会社 Method for using pyrogenic composition for improving metabolism, metabolic product and pyrogenic composition for improving metabolism
FR3085270B1 (en) * 2018-09-05 2020-08-14 Le Jardin D'elen - Atelier De Creation FERMENT VIOLET EXTRACT, PROCESS FOR OBTAINING SUCH EXTRACT AND USE IN COSMETICS
KR102319701B1 (en) * 2018-12-28 2021-11-01 (주)아로마뉴텍 Cosmetic composition comprising mixture of fermented extract of Cirsium japonicum and Moringa oleifera
CN110339112B (en) * 2019-07-22 2022-09-09 暨南大学 Composition containing quinoa seed microbial fermentation product and application thereof
CN110664704A (en) * 2019-10-29 2020-01-10 贵州木辣达康养科技有限公司 Moringa oleifera shower gel
CN110664682A (en) * 2019-10-29 2020-01-10 贵州木辣达康养科技有限公司 Moringa shampoo
FR3103826A1 (en) * 2019-12-02 2021-06-04 Biocorium PREPARATION OF MICRO-ORGANISMS FOR THE FERMENTATION OF PLANTS, EXTRACTS OBTAINED AND THEIR USES
WO2021176707A1 (en) * 2020-03-06 2021-09-10 ビーエイチエヌ株式会社 Oral composition for inhibiting elastase and use thereof, elastase inhibitor, and method for inhibiting elastase activity by oral intake of elastase inhibitor
CN111602813B (en) * 2020-05-27 2022-11-15 华熙生物科技股份有限公司 Preparation method of sunflower disc fermentation stock solution for health food and product thereof
TWI750716B (en) * 2020-06-30 2021-12-21 豐華生物科技股份有限公司 Topical composition and its use for preparation of composition for improving skin disease and dermatitis
CN112870418B (en) * 2021-01-15 2022-05-17 宁波芮颂生物科技有限公司 Preparation method of plant compound type efficient antibacterial deodorant based on HQ22 bean extract
CN113230166A (en) * 2021-04-16 2021-08-10 云南白药集团股份有限公司 Mask liquid, preparation method and application thereof
FR3122186A1 (en) * 2021-04-21 2022-10-28 Mirei International Ltd Improved fermentation process using a steel tank whose interior walls are coated with gold nanoparticles
FR3131215A1 (en) * 2021-12-23 2023-06-30 L V M H Recherche Fermented extract of mangosteen fruit peel
KR20240023456A (en) * 2022-08-11 2024-02-22 코스맥스 주식회사 Composition for preventing hair loss and promoting hair growth comprising complex fermented product containing natural vitamins
KR102641057B1 (en) * 2023-08-31 2024-02-27 한국콜마주식회사 Hair dyeing composition comprising fermented mixed extract of uncaria gambir and rhus semialata and manufacturing method thereof

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1467934A1 (en) * 1964-07-10 1969-01-23 Otto Heigl Cosmetic preparations and processes for their manufacture
KR940010265B1 (en) * 1991-12-02 1994-10-22 제일제당 주식회사 Process for making veberage from vegetable by fermentation
CA2115707A1 (en) * 1993-02-16 1994-08-17 Takashi Tokuyama Antiulcer agent
AU670378B2 (en) * 1993-05-11 1996-07-11 Otsuka Pharmaceutical Co., Ltd. Antioxidant food, antioxidant preparation and antioxidization method
FR2718752B1 (en) * 1994-04-15 1996-07-12 World Trust Investment Sa Preparations based on fermented whey and their uses.
US5580725A (en) * 1994-04-19 1996-12-03 North Carolina State Universtiy Method of eliminating genetic routes for bacteriophage evolution and products produced thereby
FR2722100B1 (en) * 1994-07-11 1996-08-23 Oreal PERVENCHE SEED EXTRACT AND COMPOSITION CONTAINING SAME
US5688772A (en) * 1994-08-01 1997-11-18 University Of Saskatchewan Quinoa saponin compositions and methods of use
AU3173497A (en) * 1996-06-21 1998-01-14 Quest International B.V. Fermentation of fruit products
US6046022A (en) * 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
JP3400282B2 (en) * 1997-02-21 2003-04-28 株式会社ヤクルト本社 Lipid metabolism improver and food containing it
KR20010006358A (en) * 1997-04-16 2001-01-26 라보라또아레 세로비오로지끄 (소시에떼 아노님) Use in cosmetics of a protein fraction extracted from okra seeds
KR100585544B1 (en) * 1997-07-29 2007-10-17 액세스 비지니스 그룹 인터내셔날 엘엘씨 Accelerating Cell Regeneration Composition
HU223344B1 (en) * 1997-08-13 2004-06-28 Máté Hidvégi Immunostimulant and metastasis-inhibiting fermented dried material, pharmaceutical compositions containing same, process for its production and its uses
US6379719B1 (en) * 1998-04-08 2002-04-30 Laboratories Serobiologiques (Societe Anonyme) Use of at least one protein fraction extracted from Hibiscus esculentus seeds and cosmetic composition containing such a fraction
WO2000021501A1 (en) * 1998-10-09 2000-04-20 Kabushiki Kaisha Yakult Honsha Skin preparations for external use
JP2001039854A (en) * 1999-07-30 2001-02-13 Sanko Bussan Kk Skin preparation for external use
US6093421A (en) * 1999-08-31 2000-07-25 Biotics Research Corporation Maca and antler for augmenting testosterone levels
EP1611799A1 (en) * 2000-04-06 2006-01-04 Kyowa Hakko Kogyo Co., Ltd. Method of removing off-flavor from foods and deodorizer
US7090875B2 (en) * 2000-12-19 2006-08-15 Kabushiki Kaisha Yakult Honsha External skin preparations and process for producing the same
JP3711377B2 (en) * 2001-01-31 2005-11-02 共栄化学工業株式会社 Emulsifier, emulsified cosmetic and production method thereof
US20020182274A1 (en) * 2001-03-21 2002-12-05 Kung-Ming Lu Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See references of WO03059368A1 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111588656A (en) * 2020-04-30 2020-08-28 杭州谦美化妆品有限公司 Application of symbiotic fermentation product of hydrolyzed candida and saccharomyces cerevisiae

Also Published As

Publication number Publication date
JP2005521649A (en) 2005-07-21
FR2834718A1 (en) 2003-07-18
FR2834718B1 (en) 2004-12-24
AU2003205571A1 (en) 2003-07-30
WO2003059368A1 (en) 2003-07-24
US20050089499A1 (en) 2005-04-28

Similar Documents

Publication Publication Date Title
WO2003059368A1 (en) Active substances for use in cosmetic and/or pharmaceutical products, obtainable from the fermentation of plant components and/or plant extracts
EP1392237B1 (en) Cosmetic preparations containing an extract of germinating rye
EP1253904B1 (en) Use of extracts from residues left in the production of wine as cosmetic care actives for skin and hair
EP1339421B1 (en) Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa
EP1487400A2 (en) Cosmetic agents
EP1239826A2 (en) Cosmetic and/or pharmaceutical preparations
EP1281392A1 (en) Cosmetic or/and pharmaceutical compositions containing plant extracts
WO2003015738A1 (en) Active ingredient mixtures
WO2002089758A1 (en) Use of oligomeric proanthrocyanidins
EP1480603A1 (en) Use of sugar esters in cosmetic and/or pharmaceutical preparations
EP1441747B1 (en) Use of an extract from the vigna aconitifolia plant in a cosmetic and/or dermopharmaceutical composition
EP1213025A1 (en) Cosmetic and/or dermopharmaceutical composition containing extracts obtained from the leaves of Argania spinosa
WO2002002129A1 (en) Use of grifola frondosa fungus extracts
WO2002080949A1 (en) Use of extracts of the plant litchi chinensis sonn.
WO2001062223A2 (en) Cosmetic preparations containing plant extracts
EP1276460B1 (en) Use of preparations containing an extract of the plant argania spinosa in cosmetic care products for hair and skin
WO2004064800A1 (en) Use of oligoglucosamines in cosmetic or dermatological preparations
WO2003043595A1 (en) Anti-aging agents
WO2003070152A2 (en) Anti-aging agents containing plant extracts from the genus arctium
WO2004071480A1 (en) Use of an extract from mycorrhiza fungi

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20040706

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS FRANCE, S.A.S.

17Q First examination report despatched

Effective date: 20091214

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: COGNIS FRANCE, S.A.S.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20100907